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ABSTRACT
 Innate immunity is the first line of defense against invading pathogens. It 
functions to eliminate pathogens and also to control infections.  The innate 
immune response is also important for the development of pathogen-specific 
adaptive immune responses.  As a result, the study of innate immune signaling 
pathways is crucial for understanding the interactions between host and 
pathogen.  Unlike mammals, insects lack a classical adaptive immune response 
and rely mostly on innate immune responses.  
Innate immune mechanisms have been widely studied in the fruit fly, 
Drosophila melanogaster.  The genetic and molecular tools available in the 
Drosophila system make it an excellent model system for studying immunity.  
Furthermore, the innate immune signaling pathways used by Drosophila show 
strong homology to those of vertebrates making them ideal for studying these 
pathways.  Drosophila immunity relies on cellular and humoral innate immune 
responses to fight pathogens.  The hallmark of the Drosophila humoral immune 
response is the rapid induction of antimicrobial peptide genes in the fat body.  
The production of these antimicrobial peptides is regulated by two immune 
signaling pathways-Toll and Immune Deficency  (IMD) pathways. 
The Toll pathway responds to many Gram-positive bacterial and fungal 
infections , while the IMD pathway is potently activated by DAP-type 
peptidoglycan (PGN) from Gram-negative bacteria and certain Gram-positive 
bacteria.  Two receptors, PGRP-LC and PGRP-LE, are able to recognize DAP-
 
 xiii
type PGN at the cell surface or in the cytosol, respectively, and trigger the IMD 
pathway.  Upon binding DAP-type PGN, both PGRP-LC and PGRP-LE dimerize/ 
multimerize and signal to the downstream components of IMD pathway.  It is 
unclear how the receptor activates its downstream components. 
My work has focused on understanding the molecular events that take 
place at the receptors following there activation.  In these studies I have identified 
a common motif in the N-terminal domains of both the receptors, known as the 
RHIM-like domain.  The RHIM-like domain is critical for signaling by either 
receptor, but the mechanism(s) involved remain unclear.  IMD, a downstream 
component of the pathway, associates with both PGRP-LC and -LE but the 
interaction of PGRP-LC with IMD is not mediated through its RHIM-like domain.  
Also, mutations affecting the PGRP-LC RHIM-like motif are defective in all known 
downstream signaling events.  However, the RHIM-like mutant receptors are 
capable of serving as a platform for the assembly of all known components of a 
receptor proximal signaling complex.  These results suggest that another, 
unidentified component of the IMD signaling pathway may function to mediate 
interaction with the RHIM-like motif.  
I performed a yeast two-hybrid screen to identify proteins that might 
interact with the receptor PGRP-LC through its RHIM- like domain.  With this 
approach, two new components of the IMD pathway were identified.  The first 
component I characterized is called Rudra and it is a critical feedback inhibitor of 
peptidoglycan receptor signaling.  The other factor is known as RYBP, it includes 
 
 xiv
a highly conserved ubiquitin binding motif (NZF), and RNAi studies suggest it is a 
critical component of the IMD pathway.  The identification and characterization of 
these two new components of the IMD pathway  has provided a new insight into 
the molecular events that take place proximal to the receptor.  
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PREFACE TO CHAPTER I
Portions of this chapter have been published separately in:
1. Deniz Ertürk–Hasdemir, Nicholas Paquette, Kamna Aggarwal, and Neal Silverman. 
Bug versus Bug: Humoral Immune Responses in Drosophila melanogaster. Chapter in 
Innate Immunity in Plants, Animals, and Man, Nucleic Acids and Molecular Biology, 
volume 21, Edited by Holger Heine
Kamna Aggarwal, Deniz Erturk Hasdemir, Nicholas Paquette and Neal Silverman all 
contributed to the manuscript equally. 
2. Kamna Aggarwal and Neal Silverman. Positive and negative regulation of the 
Drosophila immune response. BMB Rep. 2008 Apr 30;41(4):267–77.
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INTRODUCTION
2
Insects rely primarily on innate immune responses to fight pathogens, and have 
developed multiple mechanisms to recognize and respond to infection.  Even without an 
adaptive immune response, insects respond effectively to a wide range of pathogens.  
The insect and mammalian innate immune responses exhibit a great deal of 
evolutionary conservation.  One of the best examples of this conservation was provided 
by the discovery of the Toll pathway as a key component of the immune system in the 
fruit fly Drosophila melanogaster, and the subsequent identification of the mammalian 
Toll–like Receptors (TLRs).  In addition, both the insect and mammalian immune 
response relies on the evolutionarily conserved NF–κB signaling cascades for the 
control of immune system induced gene expression.  Drosophila employ several distinct 
effector mechanisms for immune protection including clotting, melanization, 
encapsulation, cell–based phagocytosis and the inducible production of a battery of 
antimicrobial peptides (AMPs).  This AMP response is critical for protection against 
many microbial pathogens.  Two signaling pathways regulate the production of these 
AMPs in Drosophila – the IMD and Toll pathways. 
Drosophila is a favorite model system for studying the immune response.  
Although Drosophila are evolutionarily separated from vertebrate organisms, many 
major pathways, including those involved in immunity, DNA damage repair, and 
neurodegeneration, are reasonably well conserved.  Further, while vertebrate systems 
have multiple redundant proteins which can make analysis difficult, Drosophila often do 
not employ the same level of redundancy, thus making the analysis easier. A variety of 
genetic, genomic, and molecular tools are also available for studying Drosophila.  Well 
established tools such as balancers and P–elements allow for easy genome wide 
3
screening.  A number of well established Drosophila cell culture lines are also available. 
Finally, Drosophila have a short generation time and are both cheaper and easier to 
maintain than most mammals.  Overall Drosophila provide versatility and control that 
are ideal for scientific research.
Overview of the Drosophila Immune Response
The immune response against microbes in Drosophila is a multi–layered system.  
Structural barriers such as a chitin–based exoskeleton and the endothelia form the first 
layer of defense.  If a pathogen breaches these barriers, several immune effector 
mechanism are activated, including cellular responses (i.e. phagocytosis, 
encapsulation, melanization) and humoral responses (i.e. AMPs).   This AMP response 
is critical for protection against many microbial pathogens.  AMPs are found both locally, 
at the site of infection, and systemically in the insect sera, or hemolymph.  The local 
response induces AMP gene expression in epithelial tissues, like the trachea and the 
gut while the systemic humoral response induces AMP production in the fat body.  Other 
tissues, including the malphigian tubules and circulating blood cells, known as 
hemocytes also contribute to AMP production during the humoral response (Ferrandon 
et al., 1998; Liehl et al., 2006; Tzou et al., 2000).  
The Drosophila humoral immune system responds to microbial challenge by 
triggering the expression of anti-microbial peptide genes through NF-κB signaling 
pathways.  In fact, NF-κB/Rel proteins control the transcription of almost one half 
(162/400) of the immune responsive genes, including the collection of cationic 
antimicrobial peptides (AMPs) (Irving et al., 2001; De Gregorio et al., 2001; De Gregorio 
et al., 2002).  Genes from many different functional classes are up-regulated in 
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response to immune challenge.  These categories included actin-associated, calcium 
binding, cell adhesion, chaperones, heat-shock proteins, enzyme inhibitors, growth 
factors, carrier proteins, motor proteins, nucleic acid-binding factors, structural proteins 
(cytoskeleton, cuticle, and muscle), transcription factors, and others.  As a result of 
infection-induced NF-κB activation, AMPs that are undetectable in the hemolymph 
(blood) of unchallenged flies are rapidly elevated to concentrations up to 100µM 
(Hoffmann and Reichhart, 2002).  As best we know, the regulation of AMP production 
occurs at the level of gene expression.  AMP genes are direct targets of NF-κB 
activation and their transcription is induced to very high levels rapidly after infection.  
Although the bulk of AMP production occurs in the insect fat body (similar to the 
mammalian liver), AMP genes are also expressed in circulating phagocytic hemocytes 
and local epithelial tissues, particularly, the gut and the trachea (Ferrandon et al., 1998; 
Liehl et al., 2006; Tzou et al., 2000).  Two NF-κB signaling pathways control AMP gene 
expression– the Toll and the IMD pathways.  These pathways are activated by microbial 
cell walls and/or other virulence determinants by circulating, cell surface, and/or 
cytosolic receptors.  Each pathway responds to distinct microbial components and 
induces the expression of somewhat overlapping subsets of AMP and other immune 
responsive genes.  For example, the anti fungals Drosomycin and Metchnikowin are 
strongly induced by the systemic Toll pathway, while the IMD pathway induces 
antibacterial peptides such as Diptericin (Lemaitre et al., 1997)(Tzou et al., 2002).  On 
the other hand, some AMP genes such as Cecropin and Attacin are co-operatively 
regulated by both the pathways (Manfruelli et al., 1999).  Details on these regulatory 
events are discussed in more detail below.
5
The main focus of this thesis is to understand how the receptor signals to its 
downstream components.  The introduction to this work is designed to provide an 
overview of each component of the two different immune signaling pathways and how 
they are activated and regulated, in insects.  Also included are some aspects of how 
these signaling pathways function in mammals.
Microbial Recognition–the Peptidoglycan Recognition Proteins
Recognition of pathogens is the first step in a cascade of events that leads to 
either the Toll or IMD–driven immune responses.  Microbial products, often cell wall 
components, are detected by recognition receptors, which in turn stimulate signaling 
pathways that culminate in the induction of AMP gene expression.  Peptidoglycan 
recognition proteins (PGRPs), are the key receptors that recognize peptidoglycan 
(PGN) and trigger the Toll and IMD pathways. 
PGRP was first identified as a PGN binding factor from the hemolymph of the 
silkworm Bombyx mori, and was shown to be involved in activating the melanization 
cascade in vitro (Yoshida et al., 1996).  PGRPs were subsequently cloned from both 
Bombyx mori and the moth Trichoplusia ni (Kang et al., 1998; Ochiai and Ashida, 1999). 
Drosophila encodes 13 PGRP genes that are spliced into at least 17 PGRP 
proteins (Werner et al., 2000).  All PGRP proteins contain a domain homologous to 
bacteriophage type–2 amidases, enzymes that cleave the lactyl group in acetylmuramic 
acid and L–alanine in the stem–peptide of PGN (Mellroth et al., 2003) (Figure 1.1a).  
Six of the Drosophila PGRPs (PGRP–SB1,–SB2,–SC1a/b,–SC2,–LB) are either known 
or predicted to be type 2 amidases that are involved in degrading PGN and dampening 
immune activation.  The other seven lack type 2 amidase activity but function through 
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binding PGN.  In particular, 4 PGRPs (PGRP–SA,–SD,–LC, and–LE) function as 
receptors in the IMD or Toll pathways, as detailed below (Mellroth et al., 2003; Bischoff 
et al., 2004)(Zaidman-Remy et al., 2006).  PGRP–LF seems to function as a decoy 
receptor, binding PGN but not activating immune signaling (Persson et al., 2007; Maillet 
et al., 2008), while the functions of PGRP–LA and–LD remain elusive (Royet and 
Dziarski, 2007).
The Drosophila PGRPs can also be classified as either short PGRP proteins 
(seven different genes encoding seven proteins) or long PGRP proteins, with extended 
N–termini (ten genes encoding thirteen proteins; (Werner et al., 2000)).  Most short 
PGRP proteins have a signal sequence, lack a transmembrane domain, and are likely 
to be secreted (SA, SB1, SB2, SC1a, SC1b, SC2, SD).  Some long PGRP proteins 
have a single–pass transmembrane domain and are likely transmembrane proteins 
(LAa, LAb, LCa, LCx, LCy, LD, LF).  However, some long PGRP proteins lack both a 
signal peptide and a transmembrane domain (LAc, LB, LE), and are likely intracellular 
proteins, or they could be secreted by a non–canonical mechanism (Takehana et al., 
2002).
Mammals encode four PGRPs, termed PGRP–S, PGRP–L, PGRP–Iα, PGRP–Iβ 
(also referred to as PGLYRP–1, PGLYRP–2, PGLYRP–3, PGLYRP–4).  Of these, only 
PGRP–L has amidase activity (Gelius et al., 2003; Kim et al., 2003).  Mammalian 
PGRPs are expressed in a variety of tissues including bone marrow (PGRP–S), skin 
and intestinal tract (PGRP–Iα, PGRP–Iβ) and liver (PGRP–L; (Kang et al., 1998; Lo et 
al., 2003; Lu et al., 2006; Mathur et al., 2004)).  Unlike the insect PGRPs, the non–
catalytic mammalian PGRPs are bactericidal (Cho et al., 2005; Dziarski et al., 2003; 
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Gelius et al., 2003; Liu et al., 2000; Lu et al., 2006; Tydell et al., 2002; Wang et al., 
2003).  Mice deficient for PGRP–S display increased susceptibility to intraperitoneal 
infections with non–pathogenic Gram–positive bacteria (Dziarski et al., 2003).  PGRP–S 
is present in neutrophil granules and is involved in the intracellular killing of bacteria.  It 
is also found associated with DNA nets released by activated neutrophils, where it is 
implicated in direct bacterial killing, acting synergistically with lysozyme (Cho et al., 
2005; Liu et al., 2000).  PGRP–Iα and–Iβ are secreted as di–sulfide hetero–and 
homodimers that are bactericidal against both pathogenic and non–pathogenic Gram–
positive bacteria but are only bacteriostatic against other normal–flora bacteria.  They 
are also bacteriostatic against some Gram–negative bacteria (Lu et al., 2006).  The 
bactericidal and bacteriostatic mechanisms of the mammalian PGRPs are not yet 
clearly defined.  PGRP–L is produced by the liver and secreted into the bloodstream 
(Zhang et al., 2005).  Recent work by Dizarski and colleagues demonstrates that 
PGRP-L also functions to modulate the immune response by co-operating with other 
innate immune pathogen recognition receptors.  In contrast to previous speculations, 
Saha et al., demonstrate that PGRP–L is pro inflammatory and along with Nod2 and 
TLR4 is required for the development of peptidoglycan induced local inflammation and 
arthritis (Saha et al., 2009)(Fritz et al., 2007; Uehara et al., 2006).
Peptidoglycan
Drosophila recognizes bacteria by detecting specific forms of bacterial PGN via 
the PGRP receptors.  PGN is a polymeric glycopeptide that forms the cell wall of most 
bacteria.  PGN contains long glycan chains usually composed of alternating residues of 
N–acetylglucosamine and N–acetylmuramic acid (MurNAc), with short stem–peptides of 
8
9Figure 1.1: Peptidoglycan structure. 
(a) As shown, peptidoglycan has a common core structure with a great deal of inherent 
variation. Most notably, the constituent of the third position of the stem–peptide can vary, and 
are most commonly L–lysine or meso–DAP. In addition, the amount and exact chemical nature 
of the crosslinking bridges can vary, with some examples noted in the box below. TCT is a 
monomeric unit of the DAP–type peptidoglycan chain, and is indicated in the dashed box. 
(b) Structures of lysine and DAP.
alternating L–and D–amino acids attached to the lactyl group of MurNAc.  These stem–
peptides are often cross–linked to each other to stiffen the cell wall; the precise 
nature of these cross–linking structures is highly variable.  The stem–peptides also 
display a great deal of variation in their amino acid constituents.  The carbohydrate 
backbone is more constant but also can be modified by various chemical 
substitutions, such as acetylation (Schleifer and Kandler, 1972; Mengin-Lecreulx and 
Lemaitre, 2005).  PGN from Gram–negative bacteria and certain Gram–positive 
bacteria (e.g. Bacillus spp, L. monoctyogenes) contain meso–diaminopimelic acid 
(DAP) at the third position of the stem–peptide chain, while other Gram–positive PGN 
contain lysine at this position (Figure 1.1).  Also, the structure and degree of cross–
bridging peptides is highly variable.  The difference in the amino acid at position 3 in the 
stem peptide along with the amount and type of cross–linking accounts for much of the 
variability in the structure of PGN produced by different bacteria (Schleifer and Kandler, 
1972).  Another major difference between Gram–positive and Gram–negative bacteria is 
the localization of the PGN in the cell wall.  Gram–negative bacteria include a thin layer 
of PGN, which is concealed in the periplasmic space between the inner and outer 
membranes.  In contrast, Gram–positive bacteria contain a thick, multilayered PGN cell 
wall at their surface.
The Toll pathway is activated by lysine–type PGN, while the IMD pathway is 
activate by DAP–type PGN (Kaneko et al., 2004; Leulier et al., 2003).  Also, the IMD 
pathway is activated by both polymeric DAP–type PGN and a monomeric fragment of 
DAP–type PGN, known as tracheal cytotoxin [TCT; (Kaneko et al., 2004; Stenbak et al., 
2004)].  TCT is a disaccharide tetra–peptide fragment of DAP–type PGN with a 1,6 
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anhydro–arranged muramic acid that is released in large quantities by some Gram–
negative bacteria, like Bordetella pertussis, Neisseria gonorrhoeae, and Vibrio fischeri 
[(Cookson et al., 1989a; Goldman et al., 1982; Melly et al., 1984; Rosenthal, 1979); 
Figure 1.1].  TCT is linked to the cytopathology caused by Bordetella and Neisseria 
infection, and it is implicated in the developmental tissue degeneration caused by 
successful symbiosis of the squid Euprymna scolopes with V. fischeri (Koropatnick et 
al., 2004).
Recent data show that PGRPs employ several strategies to recognize and 
discriminate between different types of PGN.  One strategy discriminates between DAP 
versus lysine in the third position of the stem–peptide, while another detects the 
presence or absence of a cross–bridging peptide.  The C–terminal PGRP domain of 
PGRP–Iα (PGRP–IαC) binds lysine–type PGN, with or without a penta–glycine cross–
bridge [as seen in S. aureus; (Schleifer and Kandler, 1972)].  PGRP–S and PGRP–LCx 
preferentially recognize uncross–linked DAP–type PGN (Swaminathan et al., 2006; 
Takehana et al., 2002).  PGRP–IαC forms several van der Waals contacts with the 
lysine through two amino acids, Asn236 and Phe237.  By comparison, the 
corresponding residues that recognize DAP–type PGN are Gly–Thr (in PGRP–LCx,–LE 
and human PGRP–S).  Swap experiments demonstrated that these positions are 
involved in determining lysine versus DAP–type binding properties.  In addition, the 
structures of PGRP–LC or PGRP–LE bound to TCT indicate that another important 
residue making specific contact with the DAP residue is a highly conserved arginine 
found at the bottom of the PGN docking groove.  The side–chain carboxylate of DAP 
forms a bidendate salt bridge with the guanidium group of this Arg (residue 254 in
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PGRP–LE, 413 in –LC).  All PGRPs that have the conserved Gly–Thr also have this Arg 
residue.  Thus, these residues likely function together to stabilize the interaction with 
DAP–type PGN (Chang et al., 2006; Guan and Mariuzza, 2007; Lim et al., 2006).
The Toll Pathway
The Toll pathway responds to Gram–positive bacterial and fungal infections 
(Lemaitre et al., 1996).  Unlike human TLRs, Drosophila Toll does not directly bind 
pathogens or microbe–derived compounds.  Instead, Toll functions more like a cytokine 
receptor, binding a processed form of the cytokine Spätzle, a member of the cysteine 
knot family of growth factors and cytokines (Weber et al., 2003; Hu et al., 2004; 
Hoffmann et al., 2008).  Spätzle is made as a pro–protein that circulates in the 
hemolymph.  Upon immune activation (or the perception of developmental cues), serine 
protease cascades are triggered that culminate in the cleavage of Spätzle.  Once 
processed, mature Spätzle binds to and dimerizes the transmembrane receptor Toll, 
initiating the intracellular signaling pathway.  Four different serine protease cascades 
appear to converge on the cleavage of Spätzle.  In early development, the protease 
Easter is responsible for cleaving Spätzle.  During the immune response, bacterial 
PGN, fungal β–glucans, and microbial proteases are sensed by three distinct 
mechanisms, but converge upon activation of one serine protease, known as the 
Spätzle processing enzyme (SPE), which in turn cleaves and activates Spätzle (Figure 
1.2).
The serine protease Persephone appears to function as a sensor for proteases 
secreted by both fungal and bacterial pathogens (Gottar et al., 2006; El Chamy et al., 
2008).  Persephone is likely activated by cleavage after a histidine residue, unlike the 
12
other proteases involved in the Toll signaling pathways, and maybe a good target for 
subtilisin–like proteases produced by microbial pathogens (El Chamy et al., 2008).  The 
activation of the Persephone–Toll pathway by microbial proteases occurs independently 
of recognition of microbial cell wall material, which can also stimulate the Toll pathway 
through more classical receptor–mediated recognition.
For example, β–glucans from the cell wall of yeast are recognized by Gram–
negative binding protein 3 (GNBP3) (Gottar et al., 2006), while two secreted PGRP 
receptors and GNBP1 are involved together in PGN recognition (Gobert et al., 2003; 
Bischoff et al., 2004; Wang et al., 2006; Wang et al., 2008).  Despite their name, none of 
the GNBPs are known to recognize Gram–negative bacteria, but GNBP1 and GNPB3 
are involved in the recognition of fungal or Gram–positive bacterial cell walls.  The N–
terminus of GNBP3 binds to long β–1,3 glucans, common to the cell walls of many 
types of fungi, especially yeast (Mishima et al., 2009).  GNBP1, on the other hand, is 
involved in PGN recognition, although its role is controversial.  Lysine–type PGNs, 
common to many Gram–positive bacteria, are potent agonist of the Toll pathway.  As in 
the IMD pathway, PGRP receptors are critical for the recognition of lysine–type PGN.  In 
particular, two secreted PGRPs, PGRP–SA and–SD, are involved in the Toll pathway.  
Genetic studies have shown that some Gram–positive bacteria and the PGN from these 
same species, such as M. luteus, are sensed through PGRP–SA (Michel et al., 2001).  
In fact, the structure of PGRP–SA bound to a lysine–containing muropeptide has been 
solved.  PGRP–SA can also bind DAP–type PGN, albeit to a lesser degree.  However, 
PGRP–SA appears to be able to specifically cleave DAP–type muropeptides, removing 
the final amino acid in the stem–peptide.  It has been postulated that this 
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Figure 1.2:  Toll signaling pathway. 
The Toll signaling pathway and its multiple modes of activation in the Drosophila immune 
response. Three distinct mechanisms of microbial recognition, leading to the cleavage of 
Spätzle and activation of Toll, are illustrated.  The mechanisms include peptidoglycan 
detection, by PGRP–SA, PGRP–SD and GNBP1, β–glucan detection through GNBP3, and 
protease activity sensing via the serine protease Persephone.  All these detection modalities 
lead to the activation of the Spätzle processing enzyme (SPE) which converts this cytokine into 
its active form, for binding and activating Toll. The intracellular signal transduction downstream 
of Toll is very similar to the MyD88–dependent pathway, which functions downstream of most 
mammalian TLRs.  The key features of this pathway include a trimeric receptor associated 
complex, containing MyD88, Tube and Pelle, which ultimately lead to the phosphorylation and 
degradation of the IκB homolog Cactus and the nuclear translocation of NF–κB homologs DIF 
and Dorsal.  In this schematic representation of the Toll pathway.  Red arrows indicate the Toll 
signaling cascade, including the three microbial recognition systems and the intracellular 
signaling cascade, while the black arrows highlight the negative regulators and their likely 
targets.  See text for more details.
carboxypeptidase activity prevents DAP–type PGN from stimulating the Toll pathway via 
PGRP–SA (Chang et al., 2004).
Interestingly, not all lysine–type PGN require PGRP–SA to trigger the Toll 
pathway.  In particular, S. aureus, E. faecalis, S. pyogenes, and S. saprophyticus 
infections still produce strong AMP gene responses in PGRP–SA mutant (seml) flies.  
Response to these bacteria or their PGNs instead requires either PGRP–SA or PGRP–
SD (Bischoff et al., 2004).  The mechanism of PGRP–SD–mediated recognition of 
some, but not all, lysine–type PGN producing bacteria remains unclear.  One possibility 
is a structural difference common to those PGNs sensed by PGRP–SD, which prevents 
detection by PGRP–SA, or vice versa.  However, biochemical studies of PGRP–SD do 
not support the notion that it is involved in recognizing lysine–type PGN.  
Crystallographic studies show that PGRP–SD has a deep PGN binding cleft, typical of 
all PGRPs, and this binding cleft includes an arginine (Arg90) in the key position typical 
of DAP–PGN specific recognition.  In fact, binding studies confirm that PGRP–SD binds 
DAP–type PGN, from B. subtilis, but not lysine–type from S. aureus (Leone et al., 
2008).  In addition, the moderate induction of Drosomycin observed following either B. 
subtilis or E. coli infection, which is Toll dependent (Leulier et al., 2003), required both 
PGRP–SA and PGRP–SD.  So, somehow PGRP–SA and PGRP–SD function together 
in the recognition of DAP–type PGN, for moderate Toll induction, but function in a more 
redundant manner for the recognition of certain lysine–type PGN, for robust Toll 
induction.  However, the recognition of M. luteus PGN appears to be more simple and 
requires only PGRP–SA.  The molecular mechanisms involved in the recognition of 
various PGNs by PGRP–SA and/or PGRP–SD remain to be determined.  As mentioned 
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above, GNBP1 also functions in PGN recognition and Toll signaling.  In fact, PGRP–
SA,–SD, and GNBP1 form a trimeric complex together in the presence of PGN 
fragments (Wang et al., 2008).  Some groups have reported that GNBP1 provides a 
critical PGN processing activity to this complex, required to generate small PGN 
fragments which are bound by PGRP–SA and/or PGRP–SD for Toll activation (Filipe et 
al., 2005; Wang et al., 2006).  However, another group has reported that they do not 
observe a similar PGN digesting activity associated with GNBP1, in Drosophila or 
Tenebrio molitor (Buchon et al., 2009).  Instead, this group proposes that GNBP1 serves 
to link the PGRPs with the downstream serine protease cascade, described below.  
Thus, it appears that GNBP1 functions in a complex with the PGN sensing receptors 
PGRP–SA and PGRP–SD, but the biochemical mechanism by which it contributes to 
immune recognition or Toll signaling are not yet clear.
Both the GNBP3–mediated recognition of β–glucans and the PGRP–SA/SD/
GNBP1–mediated recognition of bacterial PGNs trigger Toll signaling through the same 
serine protease cascade.  This cascade involves the modular serine protease (ModSP), 
which is probably directly activated by these microbial sensing receptor complexes, and 
at least two downstream CLIP–domain serine proteases–Grass and SPE.  As 
mentioned above, SPE cleaves and thereby activates Spätzle, the ligand for Toll.  
Another protease, known as Spirit may function between Grass and SPE, and other 
non–catalytic serine–protease homologs, Sphinx 1/2 and Spheroide, are also implicated 
in this pathway by RNAi based studies (Kambris et al., 2006).  However, the assignment 
of these factors to this pathway requires further genetic and biochemical 
characterization.  The pathways presented in Figure 1.2 suggests a protease cascade 
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that is consistent with the genetic analysis of mutants in Drosophila and the biochemical 
analysis of the cascade from the hemolymph of Tenebrio.  However, biochemistry of the 
Drosophila serine protease cascade still requires further study, as several issues remain 
unresolved, including the role of Spirit.  In addition, the predicted specificity of the 
Drosophila ModSP does not match the predicted cleavage site of the downstream 
serine protease Grass, and ModSP does not cleave Grass in vitro (Buchon et al., 2009).  
Thus, it remains possible that other factors may be involved.  Currently, it is not clear 
how (or even if) PGN binding to PGRP–SA/SD/GNBP1 leads to the activation of 
ModSP, and, as mentioned above the exact biochemical role of GNBP1 remains 
controversial.  The protease cascade culminates in SPE directly cleaving pro–Spätzle, 
releasing the active C106 fragment (Jang et al., 2006; Kambris et al., 2006).
Spätzle binding induces dimerization of the Toll receptor.  Although the ligand is a 
symmetric dimer, biophysical studies indicate that the Spätzle–induced Toll dimer is 
asymmetrical (Weber et al., 2003).  It is not yet clear whether the asymmetric aspect of 
the ligand–induced Toll dimer is critical for the activation of intracellular signaling.  
Dimerization of the Toll receptor is believed to recruit a pre–existing Myeloid 
differentiation primary response gene 88 (Myd88)/Tube complex that ultimately recruits 
the kinase Pelle, which is homologous to the mammalian IRAK family of kinases.  The 
assembly of the resulting receptor complex occurs via two distinct functional domains.  
While the interaction between Toll and Myd88 occurs via their Toll/IL–1R (TIR) domains, 
Myd88, Tube and Pelle interact in a trimeric complex via death domains (DD) found in 
each protein (Sun et al., 2002b; Sun et al., 2002a; Tauszig-Delamasure et al., 2002; 
Towb et al., 1998).  Although the DDs of these proteins are necessary for their 
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interactions, Myd88 and Pelle do not interact directly; Tube acts as the core of the 
trimeric complex (Sun et al., 2002a).  Thus the activated Toll receptor interacts directly 
with Myd88, which interacts with Tube, which ultimately recruits the kinase Pelle.  
Similar IRAK–kinase recruitment via an adapter complex is seen in mammalian Myd88–
dependent TLR signaling.
Drosophila TNF–receptor–associated factor 2 (dTRAF2), the homolog of 
mammalian TRAF6, may also play a role in Toll signaling; however its role is unclear.  In 
transiently transfected Drosophila cells, Pelle interacts with dTRAF2 and co–expression 
of Pelle and dTRAF2 synergistically activates the Toll pathway target gene Drosomycin 
(Shen et al., 2001).  However RNAi to dTraf2 shows no suppression of AMP gene 
expression after stimulation of the Toll or IMD pathways (Sun et al., 2002a; Zhou et al., 
2005).  In adult flies, over–expression of dTRAF2 is able to induce AMP gene 
expression and nuclear translocation of DIF as well as Relish.  Interestingly, dTraf2 null 
larvae exhibited reduced, but not abolished, levels of AMP gene expression following E. 
coli infection (Cha et al., 2003).  These data suggest that dTRAF2 may function in both 
the IMD and Toll pathways, but bypass mechanisms may be present which circumvent 
dTRAF2 in both cases.
Infections by Gram–positive bacteria and fungi culminate in the nuclear 
translocation of NF–κB proteins DIF and/or Dorsal.  DIF is the main regulator of Toll 
signaling in both adults and larvae, whereas Dorsal is specifically required for the 
immune response in larvae.  Dorsal was first identified for its role in dorso–ventral 
patterning in the developing embryo (Santamaria and Nusslein-Volhard, 1983).  The 
intracellular signaling components that lead to activation of Dorsal are the same in both 
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early embryo and in the immune response (Drier and Steward, 1997).  DIF/Dorsal is 
sequestered in the cytoplasm by its interaction with the IκB protein Cactus.  In the 
embryo, Cactus and Dorsal are found in a complex in which one homodimer of Dorsal 
interacts with one molecule of Cactus (Isoda and Nusslein-Volhard, 1994).  Upon 
signaling, Cactus is degraded and DIF or Dorsal translocate to the nucleus (Belvin et 
al., 1995; Bergmann et al., 1996; Gillespie and Wasserman, 1994; Reach et al., 1996; 
Wu and Anderson, 1998).  Cactus degradation, like IκB degradation, is controlled by 
phosphorylation and ubiquitin/proteasome–mediated degradation (Bergmann et al., 
1996; Reach et al., 1996; Fernandez et al., 2001; Liu et al., 1997).  However, neither of 
the two Drosophila IKK–related kinases (IKKε, IKKβ) are required for Toll–mediated 
Cactus phosphorylation and degradation.  Although Drosophila IKKβ can phosphorylate 
Cactus in vitro (Kim et al., 2000), it is not required for Drosomycin expression in cells or 
in flies (Silverman et al., 2000; Lu et al., 2001; Rutschmann et al., 2000).  Although the 
sequence motifs that are phosphorylated are very similar to those critical for IκBα 
phosphorylation in human cells, the kinase that phosphorylates Cactus is yet to be 
identified.  Once phosphorylated, Cactus is likely ubiquitinated via the Slimb–SCF E3–
ligase complex.  Drosophila embryos mutant for slimb, the βTrCP homolog, are unable 
to activate the Dorsal target genes twist and snail (Spencer et al., 1999).  Interestingly, 
Cactus degradation is required but not sufficient for efficient nuclear translocation of 
Dorsal during development (Bergmann et al., 1996).
Degradation of Cactus and nuclear translocation of DIF (and Dorsal) leads 
directly to the transcriptional induction of many immune responsive genes (De Gregorio 
et al., 2001; De Gregorio et al., 2002; Irving et al., 2001).  For example, the well 
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characterized AMP genes Defensin, Drosomycin, Cecropin and Metchnikowin are 
activated by Toll signaling.  The promoter/enhancer regions of all these AMP genes 
include κB–sites where DIF or Dorsal bind (Senger et al., 2004).  In addition, Toll 
signaling leads to the activation of other less well characterized genes, some of which 
may be AMPs while others may control different facets of the immune response.  For 
example, Toll signaling is linked to the activation of the cellular immune response and 
the proliferation of hemocytes (Zettervall et al., 2004; Qiu et al., 1998).  Also, many 
components of the Toll pathway are regulated by Toll signaling itself (De Gregorio et al., 
2002; Lemaitre et al., 1996).  Most notably, Cactus is up–regulated in response to 
immune challenge via the Toll pathway.  This generates a negative feedback loop to 
down–modulate the cascade (Nicolas et al., 1998). 
The Toll and IMD pathways are thought to be activated independently and initiate 
specific responses to different microorganisms.  However, some AMPs are activated by 
both the Toll and IMD pathways.  Tanji et al. (2007) have demonstrated that some AMP 
genes have distinct κB elements in their enhancer region (e.g. Drosomycin).  These 
elements respond to either Relish or DIF, with optimal gene induction occurring only 
when both the Toll (DIF) and IMD (Relish) pathways are activated, suggesting 
synergistic regulation of AMPs by two pathways (Tanji et al., 2007).
The IMD Pathway
The IMD pathway is potently activated by DAP–type PGN derived from Gram–
negative bacteria and certain Gram–positive bacteria, such as Bacillus spp.  Initial 
studies suggest that the IMD pathway is activated preferentially by Gram–negative 
bacteria, which lead many to assume that LPS, the most potent activator of the 
20
mammalian innate immune response, would be the main agonist of this pathway 
(Werner et al., 2003; Samakovlis et al., 1992).  However, a careful analysis of published 
results suggested otherwise.  In addition to Gram–negatives, certain Gram–positive 
bacteria, e.g., Bacillus spp, are also IMD pathway activators (Lemaitre et al., 1997).  
Subsequently, Lemaitre’s group showed that DAP–type PGN, from E. coli or B. 
thurengensis, activate the IMD pathway, while our group demonstrated that purified LPS 
samples are unable to trigger the IMD pathway, and IMD agonistic activity could be 
traced to DAP–type PGN (Leulier et al., 2003; Kaneko et al., 2004).  Lemaitre’s group 
also show that the Toll pathway is activated by PGN, but in this case lysine–type PGN 
from Gram–positives like M. luteus and E. fecalis was more potent (Leulier et al., 2003). 
Recognition of DAP–type PGN involves the receptors PGRP–LC and PGRP–LE 
(Takehana et al., 2002; Leulier et al., 2003; Ramet et al., 2002; Gottar et al., 2002; Choe 
et al., 2002).  PGRP–LC encodes three alternatively spliced transcripts PGRP–LCa,–
LCx,–LCy.  All three isoforms encode single–pass transmembrane cell surface 
receptors.  They each have distinct extracellular domains, which include a PGRP motif, 
anchored to the identical transmembrane and cytoplasmic domains (Werner et al., 
2000).  PGRP–LE encodes only one protein, which lacks both a signal sequence and a 
transmembrane domain.  Although PGRP–LC null flies, which lack all three isoforms, 
produce dramatically reduced levels of AMPs following infection with Gram–negative 
bacteria such as E. coli and A. tumefaciens, they are not particularly susceptible to 
infection by all Gram–negative bacteria.  For example, PGRP–LC mutants are sensitive 
to A. tumefaciens, E. carotovora carotovora, and E. cloacae, but not E. coli and B. 
megaterium. (Gottar et al., 2002; Choe et al., 2002; Takehana et al., 2002).  In contrast, 
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mutants that abolish signaling through the IMD pathway, such as null alleles in IKK 
genes, are highly susceptible to all Gram–negative bacteria.  Therefore, it was 
hypothesized that another receptor must also recognize and respond to Gram–negative 
bacteria.  Moreover, it was suggested that relatively low levels of AMP gene induction, 
as observed in PGRP–LC mutants, are sufficient to protect against infection with many 
Gram–negative bacteria.  Genetic experiments suggested that PGRP–LE is the 
alternate receptor for the IMD pathway.  Double PGRP–LC, PGRP–LE mutants are 
hypersusceptible to most Gram–negative bacteria, similar to other null mutants in the 
IMD pathway, and these double mutants do not induce detectable level of AMP genes 
following infection.  Over–expression of either PGRP–LC or PGRP–LE, in flies or in cell 
culture, is sufficient to drive AMP expression through the IMD pathway.  PGRP–LE 
over–expression also activates the phenoloxidase cascade (Park et al., 2007; Takehana 
et al., 2002).  While both PGRP-LC and PGRP-LE are potent activators of the IMD 
pathway, PGRP-LE can also trigger an autophagic response through a Relish (NF-κB)-
independent pathway that is critical to protect the animal against intracellular pathogens 
like Listeria (Yano et al., 2008). 
 TCT binds PGRP–LCx directly, and then this ligand/receptor complex interacts 
with PGRP–LCa (Chang et al., 2005; Mellroth et al., 2003).  The crystal structure of 
TCT bound to the ectodomains of PGRP–LCx and –LCa has been solved.  TCT binds in 
the deep PGN binding cleft of PGRP–LCx, typical of PGRP–muropeptide interactions.  
The disaccharide unit of TCT makes important contributions to the interactions between 
PGRP–LCx (bound to TCT) and PGRP–LCa (Chang et al., 2006).  The interactions 
responsible for TCT–induced PGRP–LE multimerization are very similar in molecular 
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Figure 1.3:  IMD signaling pathway.  
This pathway is preferentially triggered by DAP–type peptidoglycan, common to Gram–negative 
bacteria and certain Gram–positives, especially Bacillus spp.  DAP–type peptidoglycan can be 
recognized by different receptors, depending on its location and size.  In addition, DAP–type 
peptidoglycan that reaches the cytosol can trigger another receptor, PGRP–LE.  Both PGRP–
LC and PGRP–LE trigger a similar intracellular signal transduction pathway, as outlined here, 
that culminates in the activation of the NF–κB precursor Relish.  In addition, recognition of 
intracellular DAP–type peptidoglycan by PGRP–LE also triggers an autophagic response, which 
is important in the protection against intracellular bacteria.  After activation of the receptor, IMD 
is cleaved by the caspase DREDD.  Cleavage of IMD leads to its interaction with the ubiquitin 
E3 ligase DIAP2 and in concert with the E2 conjugating enzymes IMD is then K63–
polyubiquitinated.  K63 poly–ubiquitnated IMD acts as a scaffold to recruit TAK1 and IKK.  
TAK1/TAB2 are responsible for the activation of the NF–κB/Relish branch of the IMD pathway 
which is critical for the induction of AMP gene expression.  In this schematic representation of 
the IMD pathway.  Red arrows indicate the IMD signaling cascade while the black arrows 
highlight the negative regulators and their likely targets.  The dashed black line suggests a 
hypothetical interaction between Caspar and the SCF complex, as discussed in the text.
detail to those responsible for the TCT–mediated PGRP–LCx/LCa dimer.  Because 
PGRP–LCa cannot bind TCT in a typical PGN binding cleft [the LCa cleft is occluded;
(Chang et al., 2006; Chang et al., 2005)], the LC complex is limited to a dimeric form, 
while PGRP–LE forms a head–to–tail multimer, with each subunit binding to TCT and 
interacting with another subunit (Lim et al., 2006).  The molecular mechanism by which 
PGN binding to either PGRP–LC or PGRP–LE leads to activation of the IMD pathway is 
the subject of my thesis work.  
 Upon binding PGN, the PGRP–LC receptor leads to the activation of downstream 
signaling events in which the adaptor protein IMD is cleaved by the caspase Death 
related ced–3/Nedd2–like protein (DREDD).  Cleavage of IMD exposes an Inhibitor of 
apoptosis (IAP) binding motif allowing IMD to interact with the Baculovirus IAP Repeat 
(BIR) 2 & 3 domains of the ubiquitin E3 ligase Drosophila Inhibitor of apoptosis 2 
(DIAP2).  In concert with the E2 conjugating enzymes, Uev1a, Bendless and Effete, the 
E3 ligase DIAP2 leads to K63 polyubiquitination of IMD.  In a manner similar to 
mammalian NF–κB signaling, it is then proposed that this K63–polyubiquitin chain acts 
as a scaffold to recruit downstream kinase TGFβ activating kinase 1 (TAK1 (Paquette et 
al., 2010)).  TAK1 binding protein (TAB2) contains a highly conserved K63–polyubiquitin 
binding domain and is required for the activation of the downstream Janus kinase (JNK) 
and Relish/NF–κB arms of the IMD pathway.  TAB2 is spliced into two different splice 
forms, while both arms can utilize the long (full length) TAB2 isoform, the short isoform 
is only able to promote activation of the Relish/NF–κB pathway (Alain C unpublished).  
In addition, auto–phosphorylation of S176, within the activation loop of TAK1, is also 
required for activation of the kinase (Paquette N unpublished).  In concert with TAB2, 
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activated TAK1 can then initiate signaling to one or both downstream arms of the IMD 
pathway.
 The JNK arm of the IMD pathway is activated by the TAK1–mediated signaling to 
Hemipterous, the Drosophila MKK7/JNKK homolog (Sluss et al., 1996; Holland et al., 
1997; Chen et al., 2002).  Hemipterous then goes on to phosphorylate the basket 
protein (JNK), which activates Drosophila Activator protein 1 (AP–1).  Signaling through 
the IMD/JNK pathway has been linked to the up–regulation of wound repair and stress 
response genes (Boutros et al., 2002; Silverman et al., 2003).  Yet, the precise role that 
JNK signaling plays in the IMD pathway is controversial.  Several reports have 
concluded that JNK signaling is not involved in AMP gene induction.  Instead, AMP gene 
expression relies entirely on the NF–κB/Relish branch of the IMD pathway (Boutros et 
al., 2002; Silverman et al., 2003).  In fact, it is proposed that an unidentified product of 
the Relish branch of the IMD pathway inhibits JNK signaling (Park et al., 2004), while 
the JNK pathway is proposed to directly inhibit AMP gene expression by recruiting 
histone deacetylases (Kim et al., 2005).  However, Delaney and colleagues (2006) have 
demonstrated that the TAK1/JNK branch of the IMD pathway is critical for AMP gene 
induction, at least in clones of JNK–deficient cells within the larval fat body (Delaney 
and Mlodzik, 2006).  The role of the JNK pathway in antimicrobial gene expression 
remains controversial and further work will be necessary to clarify whether JNK has a 
positive and/or, negative role in the process.
 In parallel to JNK activation TAK1 is also required for induction of the NF–κB/
Relish branch of the IMD pathway, through activation of the Drosophila IKK complex 
(Vidal et al., 2001; Silverman et al., 2003).  The Drosophila IκB kinase (IKK) complex 
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contains two subunits: a catalytic kinase subunit encoded by ird5 (IKKβ) and a 
regulatory subunit encoded by kenny (IKKγ; (Silverman et al., 2000; Rutschmann et al., 
2000)).  In S2 cells, it was clearly demonstrated that the IKK complex is activated 
rapidly following immune stimulation and this activation requires TAK1 (Silverman et al., 
2003; Silverman et al., 2000).  Activated IKK complex can directly phosphorylate Relish.  
Relish is a bipartite protein similar to mammalian NF–κB precursors p100 and p105.  It 
contains an N–terminal Rel homology domain (RHD) and an inhibitory IκB domain with 
six ankyrin repeats that retain the protein in the cytoplasm.  Upon infection with Gram–
negative bacteria, Relish expression is strongly induced in adult flies (Dushay et al., 
1996).  Relish mutant flies show extreme sensitivity to infections and fail to induce 
antimicrobial genes after bacterial infection (Hedengren et al., 1999).  Although the 
Relish locus encodes an embryo specific isoform, Relish does not appear to have a role 
in development as homozygous Relish mutants continue to be viable and fertile.  
In mammals, the NF–κB precursors p100 and p105 are processed by the 
proteasome and their C–terminal region is degraded to produce p50 and p52, 
respectively.  This processing is regulated by phosphorylation of C–terminal serine 
residues, which leads to ubiquitination and partial proteasome degradation of the C–
terminus (Perkins et al., 1997).  In contrast, Relish processing does not depend on 
proteasomal degradation.  Relish is instead endo–proteolytically cleaved by a caspase, 
producing a N–terminal RHD transcription factor module that translocates to the nucleus  
to activate immune genes, while the stable C–terminal domain remains in the cytoplasm 
(Stöven et al., 2000).  Relish cleavage occurs after residue D545, within a typical 
caspase target motif, 542LQHD545.  DREDD, in addition to its previously mentioned role 
26
upstream in the pathway, also appears to function downstream and is a likely candidate 
for the caspase responsible for cleavage of Relish.  DREDD and Relish physically 
interact under cell culture conditions and Dredd RNAi prevents AMP gene expression 
induced by an activated allele of TAK1 (Zhou et al., 2005).  Dredd mutants also fail to 
cleave Relish, are unable to induce AMP gene expression and are highly sensitive to 
Gram–negative bacterial infections (Stöven et al., 2003; Leulier et al., 2000).  
Furthermore, over expression of DREDD is sufficient to cause Relish cleavage and 
purified DREDD cleaves Relish in vitro (Erturk-Hasdemir et al., 2009).
Phosphorylation of Relish occurs in a signal dependent manner by the 
Drosophila IKK complex and the C–terminus of Relish is required for both its 
phosphorylation and cleavage (Stöven et al., 2003).  2 serine residues, (528 and 529), 
in the N–terminal of Relish are phosphorylated by Drosophila IKKβ.  However, these 
residues are not required for Relish cleavage.  Instead, phosphorylation of these 
residues appears critical for the proper transcriptional activation of Relish targets via 
efficient recruitment of RNA polymerase II to the promoters of AMP genes.  Apart from 
its role in phosphorylation, the IKK complex also functions non–catalytically in the 
cleavage of Relish (Erturk-Hasdemir et al., 2009).  In total, Relish activity is coordinately 
regulated by 2 distinct mechanisms; cleavage by DREDD and phosphorylation by the 
IKK complex (Figure 1.3). 
Many questions remain unanswered about molecular mechanisms required for 
IMD signaling.  It is clear that DAP–type peptidoglycan is the major activator of this 
pathway, through PGRP–LC and PGRP–LE.  It is also well established that many of the 
components involved are homologous to factors involved in mammalian NF–κB 
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pathways.  In particular the involvement of a RIP1–like molecule, IMD, highlights 
similarity to the TNFR and TRIF–dependent TLR pathways.  However, more study is 
needed to elucidate the molecular events proximal to the receptor as well as 
mechanisms required for TAK1 activation, Relish cleavage, and the transcriptional 
activation of AMP genes, all of which occurs very rapidly after PGN recognition.
Recent work has shown that the intensity and duration of the Drosophila immune 
response is tightly regulated.  As in mammals, hyper–activated immune responses are 
detrimental, and the proper down–modulation of immunity is critical for protective 
immunity and health.  In order to keep the immune response properly modulated, the 
Toll and IMD pathways are controlled at multiple levels by a series of negative 
regulators.  In the next few pages, we focus on recent studies identifying and 
characterizing the negative regulators of these pathways.
Down–regulation of Immune Signaling Pathways by PGN Digesting Enzymes
The PGRP family of proteins are similar in structure to N–acetylmuramoyl–L–
alanine amidases (NAMLAA), enzymes that degrade PGN by removing the stem–
peptide from the glycan backbone of PGN (Mellroth et al., 2003).  The PGRP proteins 
that function as receptors in the IMD and Toll pathways lack a critical cysteine residue 
that is required for catalysis and thus function only as PGN binding receptors.  On the 
other hand, PGRP–LB,–SB1, and–SC1 encode active amidases, and PGRP–SB2 and–
SC2 are predicted amidases (Royet and Dziarski, 2007; Mellroth et al., 2003; Werner et 
al., 2000).  Digestion of PGN with type 2 amidases, like these PGRPs, significantly 
reduces its immunostimulatory activity (Werner et al., 2003; Kaneko et al., 2004).  
PGRP–LB digests only DAP–type PGN, whereas PGRP–SC digests both DAP–type 
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and lysine–type PGN (Zaidman-Remy et al., 2006)(Mellroth et al., 2003).  Depletion of 
PGRP–SC1/2 or PGRP–LB by RNAi in vivo leads to markedly higher levels of Diptericin 
expression following infection.  PGRP–LB and PGRP–SC are expressed in the gut 
epithelial and PGRP–LB regulates the immune reactivity of the gut to ingested bacteria.  
In the gut, the IMD pathway is activated only when the PGN–degrading activity of 
PGRP–LB is saturated or inactivated.  Also in infected larvae, RNAi knockdown of 
PGRP–SC1/2 leads to increased developmental defects and lethality (Bischoff et al., 
2006).  This further supports the idea that PGN–degrading PGRPs prevent potentially 
pathological consequences to host tissues because of prolonged immune activity.  
PGRP–LB and PGRP–SC are both targets of IMD signaling (like the AMP genes) 
and thus form a critical link in a negative feedback loop whereby activation of IMD 
signaling, by PGN, leads to the production of enzymes which digest this stimulating 
microbial compound.  Additionally, another report shows that PGRP–SC1 mutants affect 
Toll signaling and may also play a role in phagocytosis of S. aureus (Garver et al., 
2006).
Although PGRP–LF is a non–catalytic PGRP, it also seems to play an inhibitory 
role in immunity.  PGRP–LF is a transmembrane receptor but it contains only a 23 
amino acid intracellular tail.  PGRP–LF encodes two PGRP domains in its extracellular 
portion, which show different affinity for DAP–type PGN and low affinity towards lysine–
type PGN.  Depletion of PGRP–LF leads to infection independent activation of the IMD 
pathway in cells and flies.  It also leads to the activation of the JNK pathway and hence 
developmental deffects (Persson et al., 2007; Maillet et al., 2008).
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Negative Regulation in the Toll Pathway 
In addition to the control of the upstream serine proteases by the serpin necrotic, 
the Toll pathway is repressed by an intracellular negative feed–back loop controlled by  
wnt inhibitor of Dorsal (WntD), a member of the wnt family of ligands.  Activation of the 
Toll pathway leads to the transcription of wntD (Gordon et al., 2005; Ganguly et al., 
2005).  The earliest role of WntD in the embryo is to restrict the field of Dorsal activation 
by inhibiting its translocation into the nucleus.  This ensures the establishment of a 
proper boundary between the developing ventral and terminal domains.  WntD is able to 
block the translocation of Dorsal in cactus mutants.  Therefore, WntD blocks nuclear 
translocation of Dorsal downstream of, or in parallel to Cactus.  In addition to its role in 
embryonic patterning, WntD also regulates the Toll pathway in the context of immunity.  
For example, wntD mutants induce higher levels of some AMP genes.  wntD mutants 
are also more sensitive to infection with L. monocytogens.  It is hypothesized, that the 
wntD mutants have a higher mortality following infection due to the hyper–activation of 
Dorsal target genes (Gordon et al., 2005).
Negative Regulation in the IMD Pathway
Recent work has demonstrated that IMD is cleaved in a signal dependent 
manner and then K63 polyubiquitnated.  K63 polyubiquitnation of IMD is required for the 
activation of downstream signaling (Paquette et al., 2010).  Thevenon et al (2009) have 
characterised a deubiquitnating enzyme, Drosophila Ubiquitin specific protease 36 
(dUSP36), that negatively regulates the IMD pathway.  dUsp36 mutant flies show 
constitutive activation of the IMD pathway and are more sensitive to infection.  dUSP36 
is required for immune tolerance in that it prevents the activation of IMD pathway in 
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response to environmental bacteria.  Further, they show that dUSP36 blocks signaling 
at the level of IMD.  dUSP36 interacts with the N terminus of IMD removing K63 
polyubiquitin chains from IMD and promoting K48 polyubiquitnation and subsequent 
degredation (Thevenon et al., 2009). 
TAK1 plays a critical role in the IMD pathway, serving as the branch point for JNK 
and NF–κB/Relish activation.  In turn, these two modules of the IMD pathway negatively 
regulate each other.  IMD regulates the JNK branch by inducing certain genes, via 
Relish, that lead to the degradation of dTAK1 (Park et al., 2004).  JNK activation is 
prolonged when the Relish branch of the IMD pathway is inhibited.  Relatedly, Tsuda et 
al. (2006) showed that Plenty of SH3 (POSH) regulates the termination of IMD–>JNK 
signaling.  POSH mutant flies also exhibit increased mortality following E.coli infection, 
possibly because of a hyperactive immune responses (Tsuda et al., 2006).  POSH 
encodes a Really interesting new gene (RING) finger, a signature ubiquitin E3–ligase 
motif, and is auto–ubiquitnated.  Also POSH immunoprecipitates with TAK1 and over–
expression of POSH reduces the stability of TAK1.  Thus, it is hypothesized that POSH 
negatively regulates the IMD–>JNK pathway by regulating the stability of TAK1 via the 
ubiquitin/proteosome degredation pathway.  On the other hand, JNK signaling also 
inhibits Relish–mediated transcriptional activation, via the recruitment of a 
‘repressosome’ to AMP genes, as discussed in more detail below (Kim et al., 2007; Kim 
et al., 2005).
The IMD pathway may also be inhibited by another E3 protein, know as Defense 
repressor 1 (Dnr1), a conserved protein with an N–terminal ezrin/radixin/moesin domain 
and a C terminal RING finger.  Dnr1 RNAi stimulated a diptericin–lacZ reporter, even in 
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the absence of immune stimulation, in Drosophila cells.  Dnr1 appears to have a 
complex relationship to the caspase DREDD.  On one hand, Dnr1 is believed to function 
as an inhibitor of DREDD.  On the other hand, immune stimulation stabilizes Dnr1, in a 
DREDD–dependent manner.  Therefore, Dnr1 may provide another feedback loop 
where immune stimulation, via DREDD, promotes accumulation of a DREDD inhibitor 
(Foley and O'Farrell, 2004)(Guntermann et al., 2009).
Another negative regulator of IMD signaling is Caspar.  Interestingly, Caspar is 
homologous to human Fas associated factor 1 (hFAF1), which associates with various 
components of the TNF/NF–κB pathway like FAS, Fas–Associated protein with Death 
Domain (FADD), caspase–8 and NF–κB (Park et al., 2004; Chu et al., 1995; Ryu et al., 
2003).  caspar mutant flies show constitutive expression of Diptericin, even in the 
absence of infection.  And, mutation of caspar actually protects flies against mildly 
pathogenic bacteria (Kim et al., 2006), unlike several other mutants where hyper–
activation of IMD signaling causes hyper–susceptibility to infection (Kim et al., 2007; 
Thevenon et al., 2009; Tsuda et al., 2006)(Zaidman-Remy et al., 2006).  Over–
expression of Caspar inhibits AMP gene induction and causes decreased viability after 
infection with these same mildly pathogenic bacteria.  It is hypothesized that Caspar 
blocks Relish cleavage by interfering with DREDD.  Caspar contains two ubiquitin 
related domains:  a so–called UAS (or UBA) domain  and a ubiquitin–like domain (UBx), 
as well as FAS–and DED–interaction domains, all of which are found in hFAF1.  These 
later two domains may mediate interaction between Caspar and either DREDD or 
dFADD, but this has not yet been demonstrated.  The ubiquitin related domains suggest 
that Caspar may regulate protein degradation of IMD pathway components, but this also
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awaits experimental data. 
The possible connection between Dnr1 or Caspar and the Ub/proteasome 
mediated degradation of IMD components is reminiscent of an earlier publication.  
Khush et al., (2002) found that mutations in skpA constitutively induce IMD signaling, 
but not the Toll pathway (Khush et al., 2002b).  SkpA is the homolog of the human Skp1 
protein, a subunit of SCF–E3 ubiquitin ligase which targets substrates for K48–
polyubiquitination and degradation by the 26S proteasome.  Other mutants that also 
effect the Drosophila SCF component, i.e. slimb and dCullin1, also induce Diptericin 
expression in the absence of infection.  In cells, RNAi targeting skpA or slimb leads to 
the accumulation of both the full length and cleaved forms of Relish. Therefore, it was 
hypothesized that the SkpA, Slimb and dCullin regulate the IMD pathway by controlling 
Relish stability.  Potentially these SCF–dependent effects  could be mediated through 
Caspar (see dashed line in Figure 1.3).  
Transcriptional regulation of the Drosophila immune response
Proper regulation of NF–κB transcription factors is critical for health.  The lack of 
NF–κB signaling or inappropriate activation of NF–κB can lead to serious conditions 
such as cancer, (auto) inflammatory diseases or developmental defects.  Consequently, 
animals have evolved complex mechanism to keep NF–κB, per se, in–check once it is 
activated.  For example, the JNK branch of the IMD pathways appears to induce the 
formation of a repressing complex, the ‘repressosome,’ that inhibits AMP genes. 
As mentioned above the JNK and Relish branches of the IMD pathway are 
thought to mutually inhibit each other (Park and Gambhir, 2005).  The down–regulation 
of the IMD pathway by the JNK pathway involves the transcription factor dAP–1, a well 
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established target of JNK signaling in flies and mammals (Kim et al., 2005; Davis, 
1999).  AP–1 functions together with the Drosophila Signal transducers and activator of 
transcription (STAT) protein, Stat92E, to negatively regulate Relish and AMP gene 
expression.  Stat92E is a transcription factor that is activated by the JAK/STAT pathway.  
Bacterial infections are known to induce this transcription factor via the production of 
Unpaired–3 (UPD3), a ligand for the JAK/STAT pathway receptor Domeless.  UPD3 
production following infection requires IMD–>Relish signaling in hemocytes (Agaisse et 
al., 2003).  Several Relish–dependent AMP genes, especially AttacinA, have AP–1 and 
Stat92E binding sites, in addition to κB sites, in their promoter/enhancer regions. In 
some cases the Stat92E site overlaps the Relish binding site.  Mutation of the AP1 or 
Stat92E binding site leads to 3–fold higher levels of an AttacinA reporter (Kim et al., 
2007).  AP1 and Stat92E bind the AttacinA promoter cooperatively, with the aid of the 
High mobility group (HMG) protein Dispersed 1 (Dsp1), and then recruit the histone 
deacetylase dHDAC1 to form a repressosome complex.  Flies with reduced levels of 
Stat92E, Jun (known as Jun related antigen, Jra, in Drosophila) or Dsp1 induce higher 
levels of AttacinA transcript following bacterial infection.  Also, these mutants display 
reduced survival following infection with mildly pathogenic bacteria like E.coli.  
Heterozygosity for a Relish null allele suppresses these phenotypes, consistent with the 
idea that the respressosome competes with Relish.  For example, Relish is recruited 
quickly to the AttacinA promoter, within 15 minutes of PGN stimulation.  But, after longer 
periods of stimulation, loss of Relish binding is observed while the repressosome shows 
sustained binding.  Repressosome recruitment to the AttacinA promoter also leads to its 
hypoacetylation.  The repressosome–mediated down regulation of Relish–mediated 
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transcription of AttacinA is not unique; the AMP genes AttacinB, Cecropin A1, Drosocin 
and Metchnikowin show a pattern similar to AttacinA.  Thus, the inhibitory affect of the 
repressosome complex on NF–κB is important for maintaining a balanced immune 
response (Kim et al., 2005; Kim et al., 2007).
Tissue specific immune regulation
In most of the work discussed above, the systemic Drosophila immune response 
was studied.  This response relies primarily on the inducible expression of AMP genes 
in the fat body, the insect liver.  In addition, many studies have also been performed in 
immune responsive Drosophila cell lines, which are hemocyte–derived.  However, IMD 
and Toll signaling also occurs in many other tissues.  For example, the Toll pathway 
plays critical roles in hematopoeitic development and function.  The transcription factors  
DIF and Dorsal are required for hemocyte proliferation and to prevent apoptosis.  DIF 
and Dorsal also contribute to the control of systemic infections by regulating 
phagocytosis (Matova and Anderson, 2006).  The IMD pathway is present and 
functional in almost all epithelial cells.  However, the responses in these tissues are not 
identical to that observed in the fat body (or in cell culture).  In particular, the outputs of 
IMD signaling are significantly modified in the gut. 
Although Drosophila harbor a substantial number of resident bacteria in their 
alimentary tract (Ryu et al., 2008; Ren et al., 2007; Cox and Gilmore, 2007), AMP genes 
are not expressed in the gut epithelia of healthy animals.  Recent studies have shown 
that these resident microbes still induce IMD signaling in the gut–as assayed by Relish 
translocation and expression of the PGN–digesting PGRP–LB and–SC.  However, other 
Relish target genes, especially the AMP genes, are mostly silent.  Ryu et al. (2008) 
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further showed that the gut specific inhibition of AMP gene expression is mediated by 
the homeobox transcription factor Caudal (Cad).  Caudal is best known for the critical 
role it plays in development of the mesoderm and gut (Lengyel and Iwaki, 2002).  A 
Caudal–response element, essential for the suppression of CecropinA expression in the 
gut, was characterized in the promoter/enhancer region of this AMP gene.  Moreover, 
knockdown of caudal in the gut, by tissue–specific RNAi, caused constitutive expression 
of Cecropin in this tissue.  AMP gene expression required IMD signaling components, 
like TAK1 or DREDD, as well as resident gut bacteria.  Germ–free animals showed little 
or no AMP expression, even in the absence of Caudal.  Expression of AMPs in the gut, 
with caudal RNAi, caused a shift in the bacterial populations resident in the gut.  In 
particular, one Acetobacteraceae species was greatly reduced while a Gluconobacter 
species flourished.  The Gluconobacter sp. was pathogenic, causing significant gut 
epithelial apoptosis and reduced survival (Figure 1.4).  These findings not only 
characterized a novel means of regulating immune signaling in a tissue specific manner, 
but also highlight the critical importance that proper immune regulation plays in health 
and disease, even in the fruit fly (Ryu et al., 2008).
Several studies using a gut infection model system have shown that the redox 
system plays an essential role in host survival by generating microbicidal effectors such 
as reactive oxygen species (ROS) (Ha et al., 2005a; Ha et al., 2005b).  In this redox 
system, dual oxidase (DUOX), a member of the nicotinamide adenine dinucleotide 
phosphate (NADP)H oxidase family, is responsible for the production of ROS in 
response to gut infection (Ha et al., 2005a).  Following microbe–induced ROS 
generation, ROS is eliminated by immune–regulated catalase (IRC), thereby protecting 
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the host from excessive oxidative stress (Ha et al., 2005b).  The DUOX–dependent 
ROS serves on the front line of microbicidal function and the IMD pathway functions as 
a second line of defense in the gut.  DUOX expression and activity are regulated in 
response to the microbial fluctuation in the gut.
DUOX activity is regulated by the Gαq–PLCβ–Ca2+ signaling pathway.  Basal 
Gαq–PLCβ–DUOX activity is sufficient for host survival.  Under conventional conditions, 
PLCβ is constitutively active at a low level and this helps maintain a low DUOX activity.  
This DOUX activity is essential for normal host survival.  However, in the case of high 
bacterial burden the DOUX–ROS system is strongly activated for full microbicidal 
activity.  Flies that have an impaired Gαq–PLCβ–Ca2+–DUOX have a shorter life span 
under natural rearing conditions and also under gut infection studies.  However, flies 
with impaired Gαq–PLCβ–Ca2+–DUOX pathway survive normally following septic injury 
indicating that the systemic immune response is distinct from the mucosal immune 
pathway.  It is not clear how Gαq and PLCβ induced Ca2+ modulates DUOX enzyme 
activity (Ha et al., 2009a).  In addition to regulation of its enzymatic activity, DUOX 
expression is also regulated.
DUOX expression pathway is activated when the host encounters bacterial 
invasion in the gut epithelia.  p38 pathway is mostly responsible for the activation of 
DUOX expression through activation of the transcription factor ATF2.  p38 mediated 
activation of DUOX is critical, because loss of p38 pathway components leads to host 
death following oral infection.  Unlike the DOUX activity pathway, the DOUX expression 
is activated only in response to infection.  Another important difference between the two 
pathways is that the DOUX activity pathway functions in an IMD independent way.  
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However, the DOUX expression pathway functions in both IMD dependent and 
independent ways.  PLCβ mediates the PGN independent pathway and PGRP–LC and 
IMD but not Relish are required for the PGN mediated activation of the p38 pathway.  
Thus, the PGN independent PLCβ and PGN dependent IMD pathway merge at MEKK1 
(MAPKK) to create a new p38–dependent DUOX expression pathway.  Like the DOUX 
activation pathway the DOUX expression pathway is not required to fight systemic 
infections.  However, MEKK1 and p38 are indispensable for host resistance to gut 
infection (Figure 1.4).  
ROS is a highly toxic and diffusible molecule and thus ROS generation is tightly 
regulated.  Cross–talk between the DUOX expression and activity pathways help fine 
tune ROS production depending on whether the gut encounters infectious or 
commensal microbes.  In the presence of a normal bacterial burden, PLCβ is activated 
at low levels by the basal concentration of non–PGN ligands and it subsequently down–
regulates PGN–dependent activation of p38 through the sequential induction of 
calcineurin B (CanB) and MAP kinase phosphatase–3 (MKP3) (Ha et al., 2009b).  
Maintenance of DUOX expression at the basal level is important to reduce the oxidative 
damage that occurs during the commensal–gut interaction.  And under, high microbial 
burdens, DUOX–activity and DUOX–expression pathways co–operate for full activation 
of DUOX which leads to high levels of ROS production.
Recent studies have revealed striking similarities and dissimilarities in the 
signaling pathways used by humans and flies to activate their innate immune 
responses.  In both cases, infection leads to the activation of TLRs, which in turn initiate 
intracellular signaling cascades that culminate in the activation of NF–κB/Rel family of 
38
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Figure 1.4:  Gut immunity.  
(a) Schematic representation of the signaling cascade activated in the gut under normal and 
infectious conditions.  Under conventional conditions IMD and MEKK1–p38 pathway is 
activated by commensal bacteria and PLCβ is also activated at the basal level by non PGN 
ligand.  In this condition PGRP amidases, Caudal and PLCβ–CanB–MKP3 helps down regulate 
AMP and DUOX expression.  (b) However, under infectious conditions high concentration of 
PGN overcomes the negative regulation and leads to AMP production by IMD pathway and also 
DUOX expression.  In addition non PGN ligands increase ROS production by activating both 
DUOX activity and induction pathway.  See text for more detail.
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transcription factors.  However, the Drosophila Toll functions as a cytokine receptor 
while the mammalian TLRs are directly involved in microbial recognition.  To understand 
these similarities and dissimilarities better the next few pages, highlight the innate 
immune signaling pathways present in mammals.
Mammalian NF–κB signaling
Mammals utilize an arsenal of defense mechanisms to combat infection.  The 
innate immune system is the first line of defense.  Innate immunity functions to eliminate 
pathogens and also to control infections.  The innate immune response is also important 
for the development of pathogen specific adaptive immune response which is mediated 
by the B and T cells (Pasare and Medzhitov, 2004).
The immune cells express different Pathogen Recognition Receptors (PRRs) like 
Toll–like receptors (TLRs), Retinoic acid–inducible gene (RIG)–I–like receptors (RLRs) 
and Nucleotide oligomerization domain (NOD)–like receptors (NLRs) in various 
compartments and trigger the release of inflammatory cytokines and type I interferons in 
response to an infection (Beutler, 2009; Medzhitov, 2007; Janeway and Medzhitov, 
2002; Akira et al., 2006).
In mammals, 12 different members of the TLR family have been identified.  TLRs 
are type I integral member glycoproteins.  The extracellular N–terminal domain of TLRs 
contain Leucine Rich Repeats (LRR) which recognize and bind different Pathogen 
associated molecular patterns (PAMPs) and activate downstream signaling which 
culminates in the translocation of NF–κB into the nucleus.  Two other signaling 
pathways the tumor necrosis factor receptors (TNFR) and the interleukin–1 receptor 
(IL–1R) also signal through the canonical NF–κB pathway.  Unlike the TLRs, TNFR and 
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IL–1R do not bind PAMPs but instead bind the cytokines TNF and IL–1, respectively, 
which are produced during an infection.  Although the extracellular domains of TLRs 
and IL–1R show striking differences, there intracellular domain show striking homology 
and is called the Toll/IL–1 receptor (TIR) domain (O'Neill, 2003; Dunne and O'Neill, 
2003).  And even though these receptors bind different ligands they are able to activate 
similar downstream signaling pathways.
TLRs family members can be categorized into two sub–populations depending 
on their cellular localization.  TLR–1,–2,–4,–5,–6 and–11 are expressed exclusively on 
the cell surface and recognize microbial components like lipids, lipoproteins and 
proteins.  On the other hand TLR–3,–7,–8 and –9 are localized in intracellular vesicles 
such as endosomes and the endoplasmic reticulum and mostly recognize microbial 
nucleic acids (Nishiya et al., 2005; Latz et al., 2004).
Upon ligand binding TLRs oligomerize causing a conformational change which 
results in the recruitment of the downstream adaptor proteins such as Myeloid 
differentiation primary response gene 88 (MyD88), toll–interleukin 1 receptor (TIR) 
domain containing adaptor protein (TIRAP also called Mal), TIR–domain–containing 
adapter–inducing interferon–beta (TRIF), and TRIF–related adaptor molecule (TRAM) 
(Horng and Medzhitov, 2001; Fitzgerald et al., 2001; Yamamoto et al., 2003a; 
Yamamoto et al., 2002; Wesche et al., 1997; Muzio et al., 1997).  Binding of TLR–1,–2,–
4,–5,–6,–7,–8,–9 and–11 to their respective ligands recruits MyD88 (Wesche et al., 
1997; Burns et al., 1998).  In addition to MyD88, TLR1,–2,–4 and–6 recruit TIRAP which 
serves as a linker protein between the TIR domain of TLRs and MyD88 (Fitzgerald et 
al., 2001; Schilling et al., 2002; Yamamoto et al., 2002).  Ligand binding by TLR–3 and–
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4 leads to the recruitment of TRIF (Yamamoto et al., 2002; Yamamoto et al., 2003b).  
TLR–4 recruits TRIF through TRAM which again acts as a linker protein to bring 
together the TIR domains of TLR and TRIF (Fitzgerald et al., 2003; Yamamoto et al., 
2003a).  The TLR signaling pathways are categorized as MyD88 dependent and 
independent pathways.
The MyD88 dependent pathway is utilized by all TLR’s except TLR–3.  Ligand 
binding to the receptor leads to activation of IKK and NF–κB via tumor necrosis factor 
receptor associated factor 6 (TRAF6), which is recruited to the receptor in a MyD88 and 
IL–1 receptor–associated kinase (IRAK) dependent manner .(Cao et al., 1996a; Cao et 
al., 1996b).  IRAK4 is initially activated by phosphorylation followed by the sequential 
activation of IRAK1 and IRAK2 (Suzuki et al., 2002; Qin et al., 2004).  The activation of 
IRAKs results in TRAF6 activation which once activated interacts with the ubiquitin E2 
complex of Uev1A and Ubc13.  Using its own RING finger to act as an E3 ligase, 
TRAF6 promotes its own K63–polyubiquitination (Deng et al., 2000; Lamothe et al., 
2007; Wang et al., 2001; Wooff et al., 2004).
Polyubiquitinated TRAF6 acts as a scaffold to recruit downstream kinases.  The 
MAP3 kinase TGFβactivated kinase1 (TAK1) is recruited by ubiquitin–binding motifs in 
its binding partners TAK1–binding protein 2 (TAB2) and TAB3 (Kanayama et al., 2004).  
TAB2 and TAB3 serve as adaptors between TRAF6 and TAK1.  The TAB2 and TAB3 
proteins contain two ubiquitin–binding motifs, an N–terminal CUE domain and a C–
terminal nuclear protein localization four zinc finger (NZF) domain (Ishitani et al., 2003; 
Cheung et al., 2004; Kanayama et al., 2004; Takaesu et al., 2000).  Although the NZF 
appears to play a significant role in binding TAB2/3 to ubiquitinated TRAF6, the CUE 
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domain appears to be dispensable for NF–κB signaling (Kanayama et al., 2004; Kishida 
et al., 2005).
Binding of the TAB2/3–TAK1 complex to ubiquitinated TRAF6 leads to activation 
of TAK1, and initiation of downstream signaling pathways (Takaesu et al., 2001; Jiang et 
al., 2002; Wang et al., 2001; Sakurai et al., 2000; Kishimoto et al., 2000; Xia et al., 
2009).  TAK1 phosphorylates the multi–protein IKK complex composed of three 
proteins; two catalytic subunits, IKKα and IKKβ, and a scaffold protein IKKγ (NEMO) 
(Hacker and Karin, 2006; Mercurio et al., 1997; Rothwarf et al., 1998; Zandi et al., 
1997).  IKKγ is necessary for activation of the classical NF–κB pathway.  Of the two 
catalytic subunits IKKβ is the major kinase.  Once activated by phosphorylation and 
perhaps ubiquitination, the IKK complex phosphorylates the NF–κB inhibitory protein 
IκB leading to its K48–polyubiquitination and degradation by the proteosome (Chen, 
2005; Hacker and Karin, 2006).  NF–κB can then freely translocate into the nucleus 
where it binds any number of κB sites activating various inflammatory cytokines and cell 
survival genes (Hoffmann and Baltimore, 2006).
Activated TAK1 not only activates NF–κB signaling but also phosphorylates 
various MAP2 kinase proteins, such as MKK3,–4,–6, and–7 (Chang and Karin, 2001).  
Phosphorylation of these proteins leads to the activation of both p38 and c–Jun N–
terminal kinase (JNK).  This results in the activation and nuclear translocation of 
activator protein 1 (AP1), which promotes the induction of various pro–inflammatory 
cytokines (Chang and Karin, 2001; Shim et al., 2005).
MyD88–independent signaling pathways are also present downstream of TLR–4 
(and TLR–3).  The TLR–4 pathway can lead to the activation of NF–κB or the activation 
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Figure 1.5 Mammalian NF–κB signaling
Upon recognition of microbial products TLR4 dimerizes and leads to the recruitment of the 
adaptor proteins MyD88 and Mal.  MyD88 interacts with IRAK via homeotypic death domain 
interactions and binds TRAF6.  Activated IRAK auto–phosphorylates and TRAF6 is then 
released into the cytoplasm.  In the cytoplasm, TRAF6 interacts with the E2 enzymes Uev1a, 
Ubc13, and Ubc5 promoting its own K63–polyubiquitination.  K63–polyubiquitination of 
upstream pathway members leads to the recruitment of TAK1 via ubiquitin binding domains 
found in TAB2/3.  Activated TAK1 then phosphorylates and activates the IKK complex resulting 
in the phosphorylation and K48–polyubiquitin mediated degradation of IκBα, releasing NF–κB 
into the nucleus.  TAK1 also phosphorylates MKK3,–4,–6 and–7 activating JNK/p38 mediated 
AP1 signaling.  In a second MyD88 independent pathway TLR4 activation leads activation of 
NF–κB or the activation of the transcription factors IRF3 and IRF7.  It is unclear how TRAF6 or 
RIP1 activate NF–κB.
of the transcription factors interferon regulatory factor 3 and 7 (IRF3 and IRF7).  In case 
of IRF3 and IRF7 activation, the adaptors TRIF and TRAM associate with the proteins 
TRAF3 and TANK to induce signaling to the IKK–like proteins TBK1 and IKKε 
(Yamamoto et al., 2003b; Hacker and Karin, 2006; Oganesyan et al., 2006; Sato et al., 
2003).  However, recent work by Kawagoe et al shows that TANK is not required for the 
type I interferon pathway.  Analysis of Tank–/– mice shows TANK is instead an essential 
negative regulator of the canonical NF–kB signaling pathway (Kawagoe et al., 2009).  
Once activated IKK and TBK1 phosphorylate the transcription factors IRF3 and IRF7, 
causing them to dimerize and translocate into the nucleus where they activate the 
production of type I interferons (Sharma et al., 2003; Fitzgerald et al., 2003).
The MyD88–independent signaling pathway activates NF–κB signaling through 
TRAF6 or RIP1.  The N–terminal of TRIF contains 3 putative motifs that bind TRAF6 
and activates NF–κB signaling (Sato et al., 2003).  An alternative pathway leading to 
NF–κB activation involves the C–terminal of TRIF, which contains the RIP–homotypic 
interaction motif (RHIM).  TRIF interacts with RIP1 through its RHIM domain and 
recruits it to the receptor and activates NF–κB signaling.  RHIM mutant of TRIF is 
unable to activate NF–κB and IFN–β signaling.  RIP3 negatively regulates this signaling 
pathway by inhibiting the interaction of RIP1 and TRIF. RIP1 gets poly ubiquitnated 
when it is recruited to the receptor (Cusson-Hermance et al., 2005; Meylan et al., 2004).  
However, it is unclear how TRAF6 or RIP1 activate NF–κB.  
In addition to TLRs that detect PAMPs either on the cell surface or in the lumen 
of intracellular vesicles there are other PRRs present that detect intracellular PAMPs.  
NLRs and RLRs are two such family of proteins that recognize intracellular danger 
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signals (Dinarello, 2002; Dinarello, 2005).  NLRs are a family of receptors that are 
characterized by the presence of NOD domains.  NLRs are tripartite proteins that have 
a C terminal leucine rich repeat domain, a central NOD domain and a variable N 
terminal domain that can be either a caspase activation and recruitment domain 
(CARD), a Pyrin domain (PYD) or a baculovirus inhibitor of apoptosis repeat domain 
(BIR) (Martinon and Tschopp, 2005; Franchi et al., 2009).  The leucine rich repeats are 
implicated in recognizing the ligands.  The NOD domains are similar to NB–ARC motif 
of APAF1.  APAF1 is a protein involved in apoptosis and the NB–ARC motif mediates 
ATP dependent oligomerization of APAF1 upon binding cytochrome c and activates the 
apoptosis cascade.  The CARD, PYD and BIR domains mediate protein–protein 
interaction and facilitate downstream signaling.  Most NLRs are involved in activating 
the inflammasome but some NLRs like NOD1 and NOD2 also activate NF–κB signaling 
pathway.  NOD1 binds γ–D–glutamyl–diaminopimelic acid (iE–DAP) and NOD2 binds 
muramyl dipeptide (MDP) and activate downstream signaling by recruiting RIP2 via the 
CARD domain.  RIP2 is polyubiquitinated by cIAP1 or cIAP2.  This modification of RIP2 
allows TAK1 binding which leads to IKK activation and subsequent activation and 
translocation of NF–κB (Inohara et al., 2003; Inohara et al., 1999; Ogura et al., 2001; 
Viala et al., 2004; Hasegawa et al., 2008)(Bertrand et al., 2009). 
Recent work has shown that DNA–dependent activator of IRFs (DAI) functions 
as a cytosolic receptor for DNA.  However, DAI is not the only cytosolic receptor that 
recognizes DNA since DAI knockout mice are not essential for either innate or adaptive 
immune responses to B-DNA or DNA vaccination.  DAI binds to transfected DNA and 
activates IFN and NF-κB signaling.  DAI interacts with TBK1 to activate IRF3 signaling.  
46
DAI contains two RIP homotypic interaction motifs (RHIM) and these are important for 
recruitment of RIP1 and RIP3 and activation of NF-κB signaling.  DAI and RIP1/3 
interact with each other through the RHIM domain and both the RHIM domains of DAI 
are important for the activation of NF-κB signaling (Rebsamen et al., 2009; Ishii et al., 
2008).
RLRs recognize intracellular RNA patterns produced by viruses.  The RLR family 
has 3 members retinoic acid inducible gene I (RIG–I), melanoma differentiation–
associated gene 5 (MDA5), and laboratory of genetics and physiology 2 (LGP–2) 
(Meylan et al., 2006).  All the three proteins have a DExD/H box RNA helicase domain.  
In addition, RIG–I and MDA5 have two N terminal caspase activation and recruitment 
domains (CARD).  CARDs mediate the interaction of activated RIG–I and MDA5 with 
the adaptor mitochondrial antiviral signaling (MAVS, also known as IPS–1, VISA, and 
Cardif), which localizes to the outer mitochondrial membrane.  MAVS in turn mediates 
downstream signaling by activating the kinases TANK binding kinase 1 (TBK1) and IKKε 
which in turn activate the transcription factors IRF3, IRF7 and NF–κB (Meylan et al., 
2005)
Negative Regulation in the TLR Pathway
TLR signaling pathway is activated in response to various pathogens and stress 
proteins, hence if left unchecked TLR signaling pathways lead to an over–activated 
immune response.  Therefore, it is necessary to keep the TLR pathways under tight 
regulation.  To this effect TLR signaling pathways employ many different negative 
regulators.  In the following section I will summarize some of the important negative 
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regulators of TLR signaling based on there location and function (Lang and Mansell, 
2007; Wang et al., 2009; Liew et al., 2005).
 Extracellular regulation
The first line of regulation is provided by the soluble decoy receptors.  Soluble 
TLRs act as decoy receptors by competing with TLR agonists.  sTLR–2 is a naturally 
occurring soluble TLR2 that is constitutively released by normal monocytes and is 
present in the human plasma and breast milk.  sTLR–2 not only functions as a decoy 
receptor but also inhibits TLR signaling by binding CD14 the co–receptor for TLR2 
signaling (LeBouder et al., 2003; Iwaki et al., 2002).  Even though there is a single copy 
of the TLR–4 gene, multiple mRNA products have been detected in mouse and human.  
This includes an mRNA encoding a soluble TLR–4 (Qureshi et al., 1999).  In vitro 
studies using recombinant sTLR–4 have shown that it can block LPS induced NF–kB 
activation and TNF production.  The mechanism by which sTLR–4 inhibits signaling is 
unclear, however, it is hypothesized that like sTLR–2 it acts as a decoy receptor and 
also blocks the interaction between TLR–4 and its co–receptors CD14 and MD2 (Iwami 
et al., 2000).
Transmembrane Protein Regulators
 Another strategy involving negative regulators is transmembrane proteins that 
inhibit signaling by either sequestering the adaptor proteins or by interfering with binding 
of the ligand to the specific TLR.  Several transmembrane proteins like Suppressor of 
tumorigenicity 2 (ST2), Single immunoglobulin IL–1 related protein (SIGIRR), 
Radioprotective 105 (RP105) and TNF–related apoptosis–inducing ligand receptor 
(TRAILR) belong to this family (Brint et al., 2004; Schmitz et al., 2005; Divanovic et al., 
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2005a; Divanovic et al., 2005b; Diehl et al., 2004).  One of the best characterized 
member of this family is SIGIRR. 
SIGIRR is also a member of the TIR superfamily like ST2.  SIGIRR is expressed 
by epithelial cells and immature dendritic cells (Thomassen et al., 1999; Wald et al., 
2003; Garlanda et al., 2004).  Over–expression of SIGIRR by dendritic cells leads to 
inhibition of NF–kB activation by IL–1 and IL–8, and SIGIRR knockout mice have 
increased cytokine production in response to TLR–4 and TLR–9 ligands but not TLR–3 
(Garlanda et al., 2004).  Data suggests that SIGIRR interferes with the receptor 
proximal complex by interacting with TRAF6 and IRAK1 also, SIGIRR has been shown 
to interact with IL–IR and TLR–4 (Wald et al., 2003).  However, the exact mechanism is 
unclear and more work is needed to elucidate how SIGIRR functions as a negative 
regulator.
Intracellular Protein Regulators
The intracellular regulators down modulate TLR signaling using various different 
mechanisms.  For example IRAKM, MyD88s,Toll interacting protein (TOLLIP), and 
Sterile–alpha and armadillo motif protein (SARM) negatively regulate TLR signaling by 
interacting with various components of the TLR pathway and inhibiting there function 
(Janssens et al., 2002; Burns et al., 2003; Carty et al., 2006; Burns et al., 2000).
In particular, IRAKM is a member of the IRAK family of kinases that is composed 
of four members.  In contrast to IRAKM, the other three family members IRAK1, IRAK2 
and IRAK4 are activators of TLR signaling.  IRAKM shares about 30–40% homology 
with the other IRAK members and unlike the other IRAKs it has restrictive expression 
(Wesche et al., 1999).  IRAKM is expressed predominantly in the monocytes/
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macrophages and weakly in other tissues and IRAKM expression is upregulated in 
response to LPS.  In vitro, macrophages from IRAKM deficient mice produce higher 
levels of cytokines in response to TLR–4 and TLR–9 ligands.  Additionally IRAKM 
deficient mice have an impaired LPS tolerance against endotoxin shock when 
compared to wild–type mice.  Over–expression studies suggest that IRAKM 
downregulates TLR signaling by inhibiting the dissociation of IRAK1 and IRAK4 from the 
TLR complex by either stabilizing the TLR–MyD88–IRAK4 complex or by inhibiting the 
phosphorylation of IRAK1 and IRAK4 (Kobayashi et al., 2002).  In addition to IRAKM 
two of the four splice variants of IRAK2 (IRAK2c and IRAK2d) also down modulate TLR 
signaling when over–expressed in 3T3 fibroblasts.  IRAK2c and IRAK2d lack a death 
domain and IRAK2c is upregulated when RAW264.7 cells are stimulated with LPS for 1 
and 3 hours indicating a negative feedback mechanism (Hardy and O'Neill, 2004).
Another strategy utilized by intracellular proteins is to function as a transcriptonal 
repressor.  Activating transcription factor 3 (ATF3) is a member of the CREB family of 
basic leucine zipper transcription factors (Mayr et al., 2001).  ATF3 has been 
demonstrated to be both an activator or repressor of transcription depending on the cell 
type and stimulus (Kawauchi et al., 2002).  In the context of TLR signaling Gilchrist et al 
took a system biology’s approach and showed that ATF3 represses the transcription of 
Il6 and Il12b.  IL6 and IL12b among 30 other genes were identified to have a putative 
ATF3 site within 100 base pairs of a NF–κB site and 500 base pairs of a transcriptional 
start site.  They further demonstrated that ATF3 deficient mice have atleast 10 times 
higher levels of circulating IL6 and IL12 in response to LPS when compared to wild type 
mice.  Also ATF3 deficient mice succumb to endotoxic shock with 24 hours of 
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intrperitoneal LPS administration.  ATF3 exerts transcriptional repression by chromatin 
remodeling.  ATF3 in conjunction with HDAC deacetylates histones and thus alters 
chromatin structure to limit transcription factors like NF–κB from DNA (Gilchrist et al., 
2006).
Intracellular Proteins that negatively regulate TLR signaling by degradation
One of the most commonly utilized mechanisms for regulating TLR signaling is 
the degradation or destabilization of components of the TLR signaling pathway.  Several 
negative regulators of TLR signaling function as ubiquitin modifying enzymes.  For 
example, Suppressor of cytokine signaling–1 (SOCS–1), Pin1 and Triad3A negatively 
regulate TLR signaling pathways by targeting various components of the TLR pathway 
for polyubiquitnation followed by proteosomal degradation.  SOCS–1 is one of the best 
characterized negative regulator in this category and is described in detail below.
SOCS–1 is one of the 8 members of the SOCS family.  SOCS–1 was first 
identified as an intracellular protein that negatively regulates cytokine production by the 
JAK/STAT pathway (Alexander, 2002).  SOCS–1 deficient mice die within 3 weeks of 
birth due to multi– organ inflammation and this phenotype can be rescued by crossing 
to IFNγ deficient mice (Starr et al., 1998; Naka et al., 1998).  However, these double 
deficient mice are still hypersensitive to LPS.  Also, SOCS–1 deficient mice are highly 
susceptible to sepsis and SOCS–1 deficient macrophages produce elevated levels of 
cytokines such as IL–6 and TNF in response to LPS.  All this data together indicates 
that SOCS–1 negatively regulates TLR signaling pathway (Nakagawa et al., 2002; 
Kinjyo et al., 2002).  Work by Mansell et al shows that SOCS–1 negatively regulates 
TLR–2 and TLR–4 pathway by targeting the adaptor protein Mal for polyubiquitnation 
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followed by proteosomal degradation.  SOCS–1 inhibits Mal mediated phosphorylation 
of the p65 subunit of NF–κB and hence its transactivation (Mansell et al., 2006).
Intracellular Proteins that negatively regulate TLR signaling by deubiquitnation
Protein ubiquitination not only leads to the degradation of proteins but it also 
plays a key role in regulation of TLR signaling.  Like phosphorylation, protein 
ubiquitination is also reversible and involves deubiqitinases, specialized proteases that 
act on ubiquitin.  Several deubiquitinases like A20, deubiquitnating enzyme A (DUBA) 
and cylindromatosis protein (CYLD) also function in the TLR pathways.  A20 was the 
first deubiquitinase to be discovered in the TLR pathway (Kayagaki et al., 2007; 
Regamey et al., 2003; Trompouki et al., 2003; Yoshida et al., 2005).
A20 is a negative regulator that down modulates both TNFR1 and TLR mediated 
NF–κB pathways.  A20 is expressed in many cell types and its expression is rapidly 
upregulated by LPS and TNF (Krikos et al., 1992; Opipari et al., 1990).  Work by Ma and 
colleagues shows that TNFR1 and A20 doubly deficient mice develop spontaneous 
inflammation like the A20 deficient mice indicating that A20 regulates TNF independent 
pro–inflammatory signals.  Also, mice reconstituted with hematopoietic stem cells from 
A20 deficient mice rapidly die following LPS stimulation.  This data shows that A20 is 
important for protecting the host from endotoxic shock.  However, A20 does not play an 
important role in LPS tolerance.  A20 is a cysteine protease deubiquitinating enzyme 
and it removes K63–linked ubiquitin molecules from TRAF6 and hence down modulates 
TLR signaling.  TRAF6 is a component used by all TLR signaling pathways hence A20 
regulates both TLR–dependent and independent pathways (Boone et al., 2004).
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Figure 1.6: Negative Regulators of Toll–like receptor.  Schematic representation of the TLR 
pathway showing only the basic outline.  The black arrows highlight the negative regulators that 
are discussed in the text and their likely targets.
Thesis objective
Currently there are a lot of open questions about what regions of the innate 
immune receptors are important for signaling and how the signal is transmitted to it 
down stream components.  In the work presented here I use Drosophila as a model 
system to try and answer some of these questions.  In particular, this thesis elucidates 
some receptor proximal events that regulate IMD signaling both positively and 
negatively.  
In these studies I have identified a common motif in the N-terminal domains of 
both the receptors, known as the RHIM-like domain.  The RHIM-like domain is critical 
for signaling by either receptor, but the mechanism(s) involved remain unclear.  IMD, a 
downstream component of the pathway, associates with both PGRP-LC and -LE but the 
interaction of PGRP-LC with IMD is not mediated through its RHIM-like domain.  Also, 
mutations affecting the PGRP-LC RHIM-like motif are defective in all known 
downstream signaling events.  However, the RHIM-like mutant receptors are capable of 
serving as a platform for the assembly of all known components of a receptor proximal 
signaling complex.  These results suggest that another, unidentified component of the 
IMD signaling pathway may function to mediate interaction with the RHIM-like motif.  
I performed a yeast two-hybrid screen to identify proteins that might interact with 
the receptor PGRP-LC through its RHIM- like domain.  With this approach, two new 
components of the IMD pathway were identified.  The first component I characterized is 
called Rudra and it is a critical feedback inhibitor of peptidoglycan receptor signaling.  
The other factor is known as RYBP, it includes a highly conserved ubiquitin binding motif 
(NZF), and RNAi studies suggest it is a critical component of the IMD pathway.  The 
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identification and characterization of these two new components of the IMD pathway 
has provided a new insight into the molecular events that take place proximal to the 
receptor. By studying Drosophila innate immune signaling I hope to contribute to the 
ever growing body of knowledge regarding innate immunity.
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PREFACE TO CHAPTER II
This chapter was previously published in Nature Immunology (2006):
Takashi Kaneko, Tamaki Yano, Kamna Aggarwal, Jae-Hong Lim, Kazunori Ueda, 
Yoshiteru Oshima, Camilla Peach, Deniz Erturk-Hasdemir, William E Goldman, Byung-
Ha Oh, Shoichiro Kurata & Neal Silverman.  PGRP-LC and PGRP-LE play essential yet 
distinct roles in the Drosophila immune response to monomeric DAP-type 
peptidoglycan. Nat Immunol. 2006 Jul;7(7):715-23.
Kamna Aggarwal performed all PGRP-LE RHIM-like domain related cell culture 
experiments (Figure 2.7d, Figure 2.8b) and characterized the PGRP-LCx transgenic 
flies (Figure 2.9c).  Also, I wrote the manuscript with Takashi Kaneko and Neal 
Silverman.
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CHAPTER II
PGRP-LC and PGRP-LE play essential yet distinct roles in the Drosophila immune 
response to monomeric DAP-type peptidoglycan 
57
Abstract
Studies of Drosophila immunity in tissue culture suggest that recognition of 
polymeric peptidoglycan (PGN) requires only peptidoglycan recognition protein-LCx 
(PGRP-LCx), while recognition of monomeric PGN requires a heterodimeric complex of 
PGRP-LCa and PGRP–LCx.  Here we present in vivo studies indicating that either 
PGRP-LC or PGRP-LE is sufficient to mediate responses to monomeric PGN, while 
recognition of polymeric PGN depends solely on PGRP-LC.  In addition, we 
demonstrate that full-length PGRP-LE acts as an intracellular receptor for monomeric 
PGN.  However, a version of PGRP-LE containing only the PGRP domain functioned 
extracellularly, as a CD14-like accessory factor capable of enhancing PGRP-LC-
mediated PGN recognition.  Interaction with IMD was not required for PGRP-LC 
signaling.  Instead, PGRP-LC and PGRP-LE signal through a RHIM-like motif.
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Introduction
Infection with gram-negative bacteria results in activation of the Drosophila IMD 
signaling pathway, which, via activation of the NF-κB homolog Relish, drives expression 
of genes encoding antimicrobial peptides(Kaneko and Silverman, 2005).  Bacterial 
peptidoglycan (PGN) are responsible for the activation of the IMD pathway (Leulier et 
al., 2003; Kaneko et al., 2005; Kaneko et al., 2004).  Specifically, diaminopimelic acid-
containing PGN (DAP-type) potently activates the IMD pathway while lysine-containing 
PGN (Lys-type) activates the Toll innate immune signaling pathway.  Host cell 
recognition of PGN requires peptidoglycan recognition proteins (PGRPs).  PGRP-SA 
and PGRP-SD recognize Lys-type PGN, which is produced by many Gram-positive 
bacteria, and PGRP-LC and PGRP-LE recognize DAP-type PGN, which is produced by 
Gram-negative bacteria (Kaneko and Silverman, 2005).  
The Drosophila genome encodes 17 PGRP gene products which are often 
characterized as either short or long form PGRPs.  Short form PGRPs consist solely of 
a PGRP domain, and usually contain a signal sequence, which results in production of 
secreted proteins such as PGRP-SA and PGRP-SD.  Long form PGRPs contain an 
extended N-terminal region, which often includes a transmembrane domain, in addition 
to their C-terminal PGRP domain.  For example, PGRP-LC encodes three distinct 
proteins, generated via alternative splicing, each of which contain identical N-terminal 
cytoplasmic signaling and transmembrane domains but unique C-terminal extracellular 
PGRP domains (Werner et al., 2003).  
In contrast, the long form PGRP-LE contains no predicted transmembrane 
domain or signal sequence, and is thus predicted to be an intracellular PGRP.  With the 
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exception of their PGRP domains, PGRP-LC and PGRP-LE share little apparent 
homology (Werner et al., 2003) .  PGRP-LE binds specifically to DAP-type but not to 
Lys-type PGN (Takehana et al., 2002).  Surprisingly, the PGRP-domain of endogenous 
PGRP-LE (PGRP-LEpg) can be found outside the cell, in the hemolymph.  Consistent 
with this extracellular localization of  PGRP-LEpg, IMD signaling induced by PGRP-LE 
over-expression occurs in a non-cell autonomous manner and depends in large part on 
PGRP-LC (Takehana et al., 2004).  PGRP-LE also exhibits PGRP-LC-independent 
activity, but it is not clear if this occurs within the cell or via an alternate cell surface 
receptor.  
PGRP-LC mutant flies exhibit greatly reduced antimicrobial peptide gene 
expression following infection with E. coli (Gottar et al., 2002; Choe et al., 2002; Ramet 
et al., 2002), and are hyper-susceptible to infection with some gram-negative bacteria, 
such as Erwinia caratova.  However, PGRP-LC mutant flies exhibit normal resistance to 
infection with E. coli (Gottar et al., 2002).  PGRP-LE mutant flies display normal 
antimicrobial peptide gene expression after, and are resistant to, E. coli infection.  
However, flies expressing mutant forms of both PGRP-LC and PGRP-LE are highly 
susceptible to E. coli and other DAP-type PGN-containing bacteria (Takehana et al., 
2004).  These results suggests that PGRP-LC and PGRP-LE have some redundant 
functions and are individually capable of preventing E. coli-induced lethality, although 
why PGRP-LC mutants withstand E. coli infection, even when their antimicrobial peptide 
gene expression is severely reduced, is not clear.   
In addition, the mechanisms by which PGRP-LE- or PGRP-LC-induced signals 
are transmitted through the cell interior are not completely understood.  A recent report 
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suggested that the first 263 amino acids of the cytoplasmic domain of PGRP-LC are 
required for signaling, and that this cytoplasmic domain of PGRP-LC interacts with IMD 
(Choe et al., 2005).  However, the inactive mutant analyzed in this report lacks almost 
the entire PGRP-LC cytoplasmic domain.  Therefore, specific motif(s) involved in 
PGRP-LC signaling were not defined.  Moreover, interaction between IMD and PGRP-
LC was shown only when these proteins were over-expressed, and this interaction was 
not functionally linked to PGRP-LC signal transduction.  
Here, we demonstrate that recognition of the monomeric DAP-type PGN tracheal 
cytotoxin (TCT) requires either PGRP-LC or PGRP-LE.  PGRP-LE-mediated recognition 
of TCT can occur intracellularly, and extracellular PGRP-LEpg may stimulate IMD 
signaling by facilitating the interaction of PGN with PGRP-LC, in a CD14-like manner.  
In addition, we define a previously-undetected RHIM-like motif in the cytoplasmic 
domains of PGRP-LC and PGRP-LE that is essential for signaling, but dispensable for 
interaction with IMD, suggesting that interaction with IMD is not critical for PGRP-LC 
and PGRP-LE signaling.
Results
PGRP-LE and PGRP-LC recognize TCT 
TCT is a dissacharide-tetrapeptide fragment of PGN that contains a 1,6-anhydro 
arranged muramic acid and a DAP residue at the third position of the stem-peptide 
(Cookson et al., 1989b), and activates the IMD pathway in Drosophila and in a 
Drosophila cell line (S2*) (Kaneko et al., 2004).  RNA interference studies demonstrated 
that TCT-mediated IMD activation in S2* cells requires two splice-isoforms of PGRP-LC, 
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PGRP-LCa and PGRP–LCx.  To examine the role of various PGRP-LC isoforms in TCT 
recognition in vivo, two PGRP-LC mutant strains were injected with TCT.  PGRP-LC1 
contains an 858 base pair insertion in the exon encoding the common N-terminal 
domain of PGRP-LC, and is therefore thought to be a null allele.  PGRP-LC2 contains a 
point mutation specifically affecting the PGRP-LCx isoform (Choe et al., 2002).  Both 
mutants responded to TCT challenge with induction of the antimicrobial peptide genes 
diptericin (Figure 2.1a), cecropin and attacin (data not shown).  In contrast, both PGRP-
LC mutants failed to upregulate antimicrobial gene expression after infection with E. coli 
or injection of polymeric E. coli PGN.  It remained possible that neither mutation 
generated a complete null PGRP-LC allele.  Therefore, we assessed flies carrying the 
PGRP-LC∆E allele, which lacks the entire PGRP-LC locus, and noted similar 
responsiveness to monomeric TCT (Figure 2.1b).  Dose response analysis 
demonstrated that the PGRP-LC mutants were approximately 50% less responsive to 
TCT, compared to wild-type (WT) flies (Figure 2.2).  However, TCT responsiveness was 
completely dependent on the IMD pathway.  Neither kenny1 nor imdShadok mutant flies 
both null alleles of essential components in the IMD pathway) responded to TCT 
challenge (Figure 2.1c). These results suggest the existence of another receptor 
capable of recognizing TCT and activating IMD signaling.  PGRP-LE is known to bind 
DAP-type PGN and also protect flies from gram-negative infection, thus it is a candidate 
for this alternate TCT receptor.
To test the possibility that PGRP-LE is also capable of recognizing TCT and 
activating IMD signaling, PGRP-LE mutant and PGRP-LE, PGRP-LC double mutant 
flies were injected with TCT.  While PGRP-LE mutants exhibited normal responses, the 
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Figure 2.1:  PGRP-LE is a second receptor for monomeric DAP-type peptidoglycan.
(a-c) Indicated adult flies (2-5 days old) were injected with monomeric DAP-type peptidoglycan 
(TCT), polymeric DAP-type peptidoglycan (PGN) or live E. coli.  RNA was extracted 24 h after 
injection, and expression of genes encoding the antimicrobial peptide gene diptericin and the 
ribosomal protein RpL32 (loading control) was assessed by Northern blot. PGRP-LC1 and 
PGRP-LC∆E, PGRP-LC null alleles; PGRP-LC2, PGRP-LCx-specific allele; PGRP-LE112, PGRP-
LE null allele; imdshadok, imd null allele; key1, kenny null allele.  WT strain in panel b is an 
isogenic white strain.  (d)  Oligomerization of recombinant purified PGRP-LEpg was assessed in 
the presence (solid line) and absence (dashed line) of TCT by size exclusion chromatography 
(Superdex 75). Lighter solid lines indicate elution of (1) BSA (67kDa), (2) ovalbumin (43kDa) 
and (3) chymotripsinogen A (25kDa) controls.  For all panels, results typical from at least two 
independent experiments.
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Figure 2.2  TCT-induced immune activation is reduced but not eliminated in PGRP-LC 
mutant flies.
(a)  Northern blots depict diptericin induction following injection of increasing doses of TCT into 
PGRP-LC1 homozygous mutants or their heterozygous (PGRP-LC1/TM6B) siblings. (b)  
Phosphoimager quantification of the data presented in (a).  Representative of two independent 
experiments.
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double PGRP-LC, PGRP-LE mutants failed to respond to TCT, E. coli PGN or live E. 
coli (Figure 2.1b).  These results suggest that PGRP-LE is a second receptor for TCT.  
S2* cells do not express PGRP-LE.  Therefore, in S2* cells, the response to TCT is 
strictly dependent on PGRP-LC (Figure 2.3a). 
Consistent with the notion that PGRP-LE is a second TCT receptor, recent 
studies demonstrated that PGRP-LEpg binds TCT, with an apparent Kd of ~27 nM.  In 
addition, the recently-solved structure of a co-crystal of PGRP-LEpg bound to TCT 
suggested that TCT binding results in PGRP-LEpg multimerization (Lim et al., 2006).  To 
determine whether TCT binding induced PGRP-LEpg multimerization, PGRP-LEpg, with 
or without TCT, was fractionated by gel filtration chromatography.  In the presence of 
TCT, PGRP-LEpg eluted near the void volume with the molecular weight marker 
thyroglobulin on a Superdex 75 column, suggesting a molecular weight of at least 669 
kDa (the molecular weight of thyroglobulin), while in the absence of TCT, PGRP-LEpg 
eluted at ~25 kDa, near the predicted monomeric size of 20 kDa.  Together, the results 
presented here and in our previous report clearly show that TCT-binding induces 
PGRP-LEpg oligomerization, and suggest that ligand-induced oligomerization may play a 
role in PGRP-LE signaling (Lim et al., 2006). 
PGRP-LE, an intracellular TCT receptor
PGRP-LE functions independently of PGRP-LC in responding to TCT (Figure 
2.1b), and PGRP-LE encodes neither a signal peptide nor a transmembrane domain.  
Therefore, PGRP-LE might function as an intracellular receptor for TCT.  However, a 
previous report clearly demonstrated that PGRP-LE can function in a cell non-
autonomous manner when over-expressed in the fat body, and PGRP-LEpg can be 
65
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Figure 2.3:  PGRP-LE is not expressed in cultured S2* cells.
(a)  Total RNA was extracted from adult flies or S2* cells, and PGRP-LE transcripts were 
detected by RT-PCR. RpL32, PGRP-LCx and PGRP–LCa are presented as controls.  No 
reverse transcriptase (RT(–)) control is indicated. (b)  Diptericin (top), PGRP-LE (middle) and 
PGRP-LC (bottom) transcripts were detected by real-time RT-PCR (normalized to RpL32 
transcripts) in  S2 cells stably transfected with a metallothionein promoter driven PGRP-LE 
expression construct.  PGRP-LE was expressed in two quantities, by addition of either 10 or 
100 µM copper sulfate for 40 hours, then cells were stimulated (or left unstimulated) with 100 
nM TCT for 12 hours.  RNAi to PGRP-LC and/or PGRP-LE was used to determine the relative 
contribution of these two receptors to TCT-mediated diptericin induction, as indicated.  In these 
conditions, the response to TCT is almost entirely dependent on PGRP-LC, even when PGRP-
LE is expressed in either low or high amounts.  Representative of least three independent 
assays.
found in the hemolymph despite lacking a predicted signal sequence (Takehana et al., 
2004).  These data do not preclude the possibility that PGRP-LE also functions, in other 
situations, intracellularly in a cell-autonomous manner.  To examine this possibility, 
PGRP-LE was expressed within clones of cells in the malphigian tubules (the insect 
kidney) using a combination of the flp-FRT and GAL4-UAS systems (Ito et al., 1997).  
Malphigian tubules are an immune responsive organ with autonomous IMD signaling 
activity (McGettigan et al., 2005).  In this system, an actin promoter-driven GAL4 
transgene is nonfunctional due to the insertion of transcriptional termination signals 
flanked by two FRT sequences in the initial state (Ay-GAL4).  Expression of the flp 
recombinase induces recombination between these the two FRT sequences and 
removes the terminator, generating a functional actin-GAL4 that drives the expression of 
PGRP-LE and GFP transgenes, which are controlled by a UASGal promoter.  Expression 
of flp recombinase is controlled by the hsp70 promoter and is induced clonally by a brief 
heat shock.  Diptericin expression was monitored with a dipt-LacZ reporter transgene, 
while PGRP-LE expression was reported by a UAS-GFP transgene.  In malphigian 
tubules, expression of PGRP-LE was sufficient to induce diptericin expression, which 
occurred exclusively in a cell-autonomous manner (Figure 2.4a). The dipt-LacZ reporter 
was only expressed in cells expressing PGRP-LE, suggesting that PGRP-LE may 
function as an intracellular TCT receptor in this tissue.
To directly test this possibility, whole organs were collected from dipt-LacZ larvae, 
washed extensively to remove all hemolymph, and stimulated with TCT.  IMD activation 
was assayed by staining for β-galactosidase activity (Yajima et al., 2003).  TCT induced 
dipt-LacZ reporter expression in 96% of malphigian tubules from WT flies (Figure 2.4b).  
67
This response was completely dependent on the addition of TCT (Figure 2.4c).  
Moreover, this response was strongly dependent on PGRP-LE and only mildly involved 
PGRP-LC.  27% of PGRP-LE, and 79% of PGRP-LC, mutant malphigian tubules 
exhibited dipt-LacZ expression (Figure 2.4d).  Expression of the diptericin reporter was 
detected in only 6% of malphigian tubules from double PGRP-LC, PGRP-LE mutants.  
The data in Figure 2.4d represent the percentage of tubules that contained one or more 
cells expressing the dipt-lacZ reporter.  Consistent with these results, anti-PGRP-LE 
antisera detected full length (45 kDa) PGRP-LE in immunoblots from lysates from WT, 
but not PGRP-LE112, malphigian tubules (Figure 2.4e).
S2 cells do not express PGRP-LE (Figure 2.3a).  In most cases, expression of 
PGRP-LE was not sufficient to allow them to respond to TCT, independently of PGRP-
LC, when TCT was added directly to the culture media (Figure 2.6a and Figure 2.3b).  
We speculated that this poor response was due to a failure of S2 cells to import TCT 
into the cytoplasm, where it can be recognized by intracellular PGRP-LE.  To test this 
hypothesis, TCT was delivered directly into the cytoplasm of S2 cells by transfection 
with calcium phosphate.  TCT induced diptericin and drosomycin transcription only in S2 
cells expressing PGRP-LE (Figure 2.4f).  In the copper treated cells, the response to 
TCT was largely independent of PGRP-LC, consistent with intracellular recognition 
(data not shown).  Note that the relatively unresponsive S2 cells, not the highly 
responsive S2* sub-line, were used for these experiments (Samakovlis et al., 1990). 
Next, we directly demonstrated that PGRP-LE is expressed within cells of the 
malphigian tubules and in the cytoplasm of S2 cells.  PGRP-LE was detected 
intracellularly in malphigian tubules by confocal immunofluorescence with anti-PGRP-
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Figure 2.4:  PGRP-LE is an intracellular receptor for TCT.
(a)  Immunofluorescence analysis of diptericin expression (via diptericin-LacZ reporter 
transgene) following clonal expression of  PGRP-LE (monitored via UAS-GFP reporter 
transgene) in malphigian tubules.  Representative of ten mosaic tubules.  (b-d)  After extensive 
washing to remove hemolymph, malphigian tubules from diptericin-LacZ larvae were challenged 
in culture with 10 µM TCT.  The immune response was monitored by staining with X-gal and 
DAPI.  Malphigian tubules from WT or mutant were compared, and the percentage of tubules 
with one or more LacZ expressing cells is indicated in (d).  48 tubules were examined for each 
genotype. (e)  PGRP-LE expression in WT and PGRP-LE112 malphigian tubules was monitored 
by immunoblotting with anti-PGRP-LE.  Representative of at least two independent 
immunoblots.  (f)  Parental (PGRP-LE-deficient) S2 cells and S2 cell lines stably transfected 
with a metallothionein-PGRP-LE construct were treated with 100 µM copper sulfate for one hour 
(or left untreated), after which they were transfected with the indicated amounts of TCT.  Twelve 
hours later RNA was extracted and expression of diptericin, drosomycin and RpL32 
(normalization control) was assessed by real-time RT-PCR.  Note, the sub-line of S2 cells used 
in this experiment responded poorly to TCT, compared to the S2* cells used elsewhere in this 
study and previously2.  Error bars indicate s.d.  Representative of two independent experiments, 
each in duplicate.  (a-c) , magnification 200x.
LE (Figure 2.5a).  When expressed in S2 cells, V5-tagged PGRP-LE was observed in 
the cytoplasm, as detected by whole cell immunofluorescent microscopy (Figure 2.5b).  
When expressed in S2* cells, YFP-tagged PGRP-LE was found to be cytoplasmic by 
confocal fluorescent microscopy (Figure 2.5c).  These localization and functional data 
clearly illustrate that full-length PGRP-LE can function as an intracellular receptor for 
TCT. 
CD14-like activity of PGRP-LEpg
Unlike full-length intracellular PGRP-LE, a truncated form of PGRP-LE, which 
consists of the PGRP-domain (PGRP-LEpg), is easily detected extracellularly in 
hemolymph (Takehana et al., 2004).  To compare the activity of full-length PGRP-LE and 
PGRP-LEpg, both forms were stably expressed from a copper-inducible promoter in S2 
cells (Figure 2.6a).  Full-length PGRP-LE potently induced diptericin expression, in a 
manner independent of PGRP-LC but dependent on IMD (Figure 2.6, left).  In contrast, 
PGRP-LEpg did not induce diptericin expression, but instead robustly enhanced TCT-
mediated diptericin induction in a PGRP-LC-dependent manner (Figure 2.6a, right).  
Full-length PGRP-LE did not enhance TCT-mediated diptericin induction (Figure 2.6a, 
left).  
The requirement for PGRP-LC in the PGRP-LEpg-enhanced response to TCT 
suggests that PGRP-LEpg functions outside the cell.  Consistent with this possibility, 
PGRP-LEpg was detected in significant quantities in the conditioned media of PGRP-
LEpg-expressing S2 cells (Figure 2.6b).  Moreover, after addition of TCT, soluble PGRP-
LEpg associated with S2 cells (Figure 2.6c), and this cell association required PGRP-LC 
(data not shown).  Serine 232 in PGRP-LE and serine 391 in PGRP-LCx are critical for 
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Figure 2.5:  Intracellular localization of PGRP-LE. 
(a)  Endogenous PGRP-LE in WT or PGRP-LE112 malphigian tubules was detected by staining 
with anti-PGRP-LE (which was pre-absorbed with PGRP-LE112 tissues).  Staining was visualized 
by confocal microscopy.  Magnification 200x. Representative of two independent experiments 
(b)  S2 cells engineered to express high amounts of V5-tagged PGRP-LE were stained with 
anti-V5 (to detect PGRP-LE), DAPI, and phalloidin (to detect the actin network).  Staining was 
visualized by whole cell microscopy.  Magnifcation 1200x. Representative of six independent 
experiments (c)  S2* cells engineered to express YGP-tagged PGRP-LE were stained with 
Hoechst.  Staining and YFP expression was visualized by fluorescent confocal microscopy.  
Magnification 63x and then enlarged another 3.44x.  Representative of three independent 
experiments.
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TCT-induced dimerization of two PGRP-domains (Lim et al., 2006) (Chang et al., 2006).  
The PGRP-LEpgS232E mutant failed to enhance TCT-induced diptericin expression 
(Figure 2.6d) and failed to associate with S2 cells after addition of TCT (data not 
shown).  However, PGRP-LEpgS232E was detected in the cell culture media in amounts 
similar to WT PGRP-LEpg (Figure 2.6b).  These results suggest that PGRP-LEpg 
functions in a CD14-like manner by binding TCT in solution and carrying it to the cell 
surface, where it interacts with PGRP-LC to induce signal transduction.  
PGRP signaling through a RHIM-like motif
The molecular mechanisms by which PGRP-LC and PGRP-LE activate 
intracellular signaling are unclear.  Overexpression of either PGRP-LC or PGRP-LE in 
S2* cells or in vivo is sufficient to activate IMD signaling and drive antimicrobial peptide 
expression in the absence of microbial challenge.  Using PGRP-LC overexpression-
induced diptercin expression as an assay, we identified regions within the intracellular 
domain of PGRP-LCx that are required for signaling.  A series of seven internal 
deletions, each removing approximately 50 amino acids, and in total spanning the entire 
intracellular domain, were expressed using a copper-inducible promoter in stable S2* 
cell transfectants.  Two adjacent deletions, ∆5 and ∆6, failed to induce diptericin, while 
the other deletions behaved similarly to WT PGRP-LCx (Figure 2.7a).  These results 
are supported by and expand upon the recent findings of Choe et al, who assayed the 
effects of large N-terminal PGRP-LC deletions (Choe et al., 2005).  All deletion mutants 
presented here were expressed on the cell surface, as analyzed by live cell flow 
cytometry (data not shown).  The region defined by the two signal deficient deletions 
(residues 175-243) was further dissected with five additional ~20 amino acid deletions 
72
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Figure 2.6:  CD14-like activity of the PGRP domain of PGRP-LE.
(a)  S2 cells stably transfected with metallothionein promoter-driven transgenes encoding either 
full length PGRP-LE (PGRP-LEfull) or the PGRP domain of PGRP-LE (PGRP-LEpg), were 
transfected with the indicated dsRNAs and treated with copper for 40 h, followed by TCT 
stimulation for an additional 12 h, as indicated.  RNA was extracted and diptericin and RpL32 
were quantified by real-time RT-PCR.  PGRP-LEfull induced diptericin expression and this 
activity did not require PGRP-LC.  Expression of PGRP-LEpg did not activate diptericin 
expression but robustly enhanced the PGRP-LC-dependent response to TCT.  Representative 
two independent experiments, both performed in duplicate.  (b)  Extracellular  PGRP-LEpg was 
detected by anti-V5 immunoblot of lysates and culture medium from S2 cells stably expressing 
V5-tagged PGRP-LEpg or PGRP-LEpgS232E.  Representative of two independent assays. (c)  
TCT-induced cell surface association PGRP-LEpg was detected by staining S2 cells stably 
expressing V5-tagged PGRP-LEpg, in the presence or absence of 1µM TCT, with anti-V5 and 
DAPI.  Representative of five experiments.  (d)  Requirement for interaction between TCT-
bound PGRP domains was detected treating S2 cells stably expressing copper-responsive 
transgenes encoding PGRP-LEpg and PGRP-LEpgS232E as in (a).  Error bars indicate s.d. 
Representative of three independent experiments, each performed in duplicate.
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(∆11-∆15).   Deletions 13, 14 and 15 failed to induce diptericin when overexpressed 
(Figure 2.7b).  These results clearly define a region, within residues 205-242, as critical 
for IMD pathway activation.  Interestingly, this region contains a stretch of amino acids 
bearing similarity to other PGRP proteins, including the Anopheles mosquito PGRP-LC 
homolog and Drosophila PGRP-LAa and PGRP–LE (Figure 2.7c).  The homology 
between these proteins, outside of their C-terminal PGRP domains is limited to just this 
short stretch.  A PGRP-LE deletion mutant removing 15 residues spanning this 
conserved motif (∆98-113), failed to induce diptericin expression when overexpressed in 
S2* cells (Figure 2.7d).  WT and mutant versions of PGRP-LE were expressed in 
similar amounts in these stable transfectants.  These results define a conserved motif 
found in PGRP-LC and PGRP-LE which is required for signal transduction.
To define more precisely which residues within this PGRP signaling motif are 
critical for signaling, a series of alanine substitution mutants in PGRP-LC and PGRP–LE 
were similarly assayed.  Using stable transfectants and a copper inducible promoter, 
thirteen PGRP-LC substitution mutants, focusing on the conserved residues indicated in 
Figure 2.7c, were overexpressed in S2* cells.  Five residues (L210, T217, F218, G219 
and G226) were found to be absolutely essential for IMD signaling.  In addition, three 
other residues (V216, D220, and V228) appeared to contribute to IMD signaling, as S2* 
cells expressing these mutants produced significantly fewer diptericin transcripts when 
compared to S2* cells expressing WT PGRP-LCx (Figure 2.8a).  Note, V228A was 
variable, ranging from reduced to abolished diptericin induction.  These results clearly 
define a core motif of four amino acids (216VTFG219) as well as some outlying residues 
(L210, D220, G226, and V228) that are critical for PGRP-LC-induced IMD activation.  
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Figure 2.7:  PGRP-LC and PGRP-LE signal via a conserved motif.  
(a)  S2* cells stably expressing metallothionein promoter-driven transgenes encoding T7-tagged 
full length and deleted versions (diagram, bottom) of PGRP-LCx were treated with copper, and  
diptericin expression was assayed by Northern blot.  Expression of each transgene-encoded 
construct was detected by anti-T7 immumoblot.  All deletion mutants carried a C-terminal T7 
tag, and WT PGRP-LCx was tested without a tag as well as with either N-or C-terminal T7 tags, 
as indicated. (b)  S2* cells stably expressing metallothionein promoter-driven transgenes 
encoding a PGRP-LC genes containing smaller deletions spanning the region deleted in Δ5 and 
Δ6 constructs were analyzed as in (a). (c) Conservation of this signaling motif in mosquito 
PGRP-LC1 and in Drosophila PGRP-LE and PGRP-LAa.  Clustal X alignments are shown and 
the regions of the deletions used in (b) are indicated.  (d)  S2* cells stably transfected with 
metallothionein promoter driven transgenes encoding Flag-tagged WT PGRP-LE or PGRP-LE 
lacking the conserved signaling motif were analyzed as in (a).  (a) and (b-c) representative of at 
least three independent assays.
Alanine substitutions of PGRP-LE revealed similar requirements (102VHIG105 in PGRP-
LE), further highlighting the importance of this conserved core motif (Figure 2.8b).
This core motif displays sequence similarity with the recently-defined RIP 
homotypic interaction (RHIM) motif (Figure 2.8c).  This domain was identified in TRIF 
and RIP1 and is required for the interaction between these two proteins and for TRIF 
and TLR3-induced NF-κB activation (Meylan et al., 2004; Sun et al., 2002b).  The RHIM 
core amino acid motif (VQIG) resembles the motif in the center of the signaling region of 
PGRP-LC (VTFG).  Additional similarities between the RHIM domain and the PGRP-LC 
signaling domain are found outside this core motif, including identity at residues L210, 
N212, S213, and T214.  Likewise, the region of PGRP-LE that is homologous to PGRP-
LC and is required for LE-mediated IMD activation contains similar homologies to the 
RHIM motif, including a VHIG motif, with homology extending beyond this core motif.  
Although the homologies between Drosophila PGRPs and the mammalian RHIM 
domain proteins are weak, the fact that they coincide with residues required for 
signaling is highly suggestive of a conserved structural element involved in signal 
transduction in mammalian TLR3 (MyD88-independent) and Drosophila IMD signaling 
pathways.
IMD–PGRP-LC interaction is dispensable for signaling
Among the known intracellular components of the IMD pathway, the IMD protein 
is thought to function most proximal to the receptor(s).  To examine the potential 
interaction between IMD and PGRP-LC more precisely, the collection of in-frame 
PGRP-LC deletion mutants (Figure 2.7a) was co-expressed with IMD in S2* cells by 
transient transfection, and their interaction was examined by co-immunoprecipitation.  In 
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Figure 2.8:  RHIM-like features of the conserved PGRP signaling motif.  
(a,b)  S2* cells stably transfected with metallothionein promoter-driven transgenes expressing 
PGRP-LC (a) or PGRP-LE (b) genes containing the indicated alanine substitutions were 
analyzed as in Figure 2.7a.  (c)  Clustal alignment of the signaling motif conserved in PRGP-
LC and PGRP–LE with the RHIM motifs in human RIP1 and TRIF.  Box shading depicts 
degree of conservation (gray, similar amino acid; black, identical amino acid).  Amino acids 
critical for signaling are highlighted in bold, as determined in (a) and (b).  (a) and (b) 
representative of at least three independent assays.
78
!"#!$ %&
!'#!$ )*+,
!"#!$%&'$%&
()*$)*+, - . - - - - - - - -
+
/012
3
. -
+
,
+
,
!
"
#
!
$%
&
'
"4
!
"
#
!
$%
&
'
"5
!
"
#
!
$%
&
'
"6
!
"
#
!
$%
&
'
"3
!
"
#
!
$%
&
'
"7
!
"
#
!
$%
&
'
"8
!
"
#
!
$%
&
'
"&
. -. - . - . -. - . - . - . - . -
!"#!$ %&
!'#!$ %&
!'#!$ )*+,
9:;+<=
.
>
"?@";$%&
- - -
/012
3
()*$)*+,
. - . - . -
9:;+<=
!"#!$ %&
!'#!$ )*+,
!"#!$ %&
!'#!$ %&
!'#!$ )*+,
. !
"
#
!
$%
&
'
!
"
#
!
$%
-
A
!"#!$%&' <B+C;,=C=
1<BDC, =EFB=;;GDC H=+I =EFB=;;GDC
/01
#0234
-5 672( . -
!
"
#
!
$%
&
'
84
9:
;
!
"
#
!
$%
&
'
+
,
!
"
#
!
$%
&
9
<
99
9:
. -. - . - . - . - . - . -. -
!
"
#
!
$%
&
'
"9
=
!
"
#
!
$%
&
'
"3
!
"
#
!
$%
&
'
84
9:
;
!
"
#
!
$%
&
'
"9
=
!
"
#
!
$%
&
'
"3
Figure 2.9:  The interaction between PGRP-LC and IMD is not essential for signal 
transduction.
(a,b)  S2* cells were transiently transfected with metallothionein promoter expression plasmids 
for T7-tagged PGRP-LCx (a) or T7-tagged PGRP-LE (b) and Flag-tagged IMD, and treated with 
copper, where noted.  Cell lysates were subjected to indicated immunoprecipitations and 
immunoblotting.  (c) E. coli was injected, where noted, into PGRP-LC1 adult flies carrying UAS 
promoter-driven transgenes encoding indicated PGRP-LC mutants.  Strong expression was 
achieved with the C564 Gal4 driver, and low expression without a Gal4 driver.  Eight hours after 
infection, RNA was isolated, and diptericin and RpL32 expression was assessed by Northern 
blot.  All panels representative of at least three independent assays.
agreement with previous reports (Choe et al., 2005), we detected a clear interaction 
between IMD and WT PGRP-LC (Figure 2.9a).  IMD also interacted with PGRP-LE, 
although not as robustly as with PGRP-LC (Figure 2.9b).  However, PGPR-LC 
deletions that interrupt the RHIM-like domain (∆5 and ∆6) interacted with IMD, while a 
deletion removing amino acids 87-148 (∆3), which retained the ability to induce 
diptericin expression (Figure 2.7a), failed to interact with IMD (Figure 2.9a).   Similarly, 
strong expression of the ∆3 PGRP-LC deletion, but not the RHIM-like mutants ∆14 and 
F218A, in adult flies drives robust diptericin expression (Figure 2.9c).  Moreover, when 
expressed in lower amounts, the ∆3 PGRP-LC deletion, but not the ∆14 or F218A 
mutants, supported E.coli infection-induced diptericin expression.  These results 
demonstrate that IMD–PGRP-LC interaction is not essential for activation of IMD 
signaling, while the RHIM-like motif is critical in vivo.
Discussion
In our model (Figure 2.10), intracellular PGRP-LE oligomerizes following TCT 
binding and is sufficient to mediate TCT-induced IMD activation, while extracellular 
PGRP-LEpg serves to enhance PGPR-LC-mediated TCT-induced IMD activation.  The 
RHIM-like domains of PGPR-LC and PGRP-LE play an important role in activation of 
the IMD signaling pathway. 
In cultured Drosophila cells, TCT is recognized by a heterodimeric PGRP-LCa–
PGRP-LCx receptor complex (Kaneko et al., 2004).  TCT binds to the PGRP domain of 
PGRP-LCx and recruits the PGRP-LCa PGRP domain (Chang et al., 2006; Chang et 
al., 2005; Mellroth et al., 2005).  In addition to inducing this dimerization of PGRP-LCa 
and PGRP-LCx, TCT induced oligomerization of PGRP-LEpg.  These TCT-induced 
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Figure 2.10:  Model of PGRP-LC and PGRP-LE-mediated recognition of monomeric and 
polymeric DAP-type peptidoglycan.
Monomeric DAP-type PGN (TCT) is recognized by a heterodimer of PGRP-LCa and PGRP–
LCx on the cell surface, or by PGRP-LE within the cell.  TCT binding to PGRP-LCx causes its 
dimerization with PGRP-LCa, while TCT binding to PGRP-LE causes its oligomerization.  
Subsequent intracellular signaling is transduced through the RHIM-like motif found in all PGRP-
LC isoforms and in PGRP-LE, although the function and/or binding partner (factor ‘X’ in 
diagram) of this motif is not yet identified.  PGRP-LC and PGRP-LE also interact with IMD, 
although this interaction does not appear to be essential for signal transduction.  Polymeric PGN 
requires only PGRP-LCx for signaling, and the polymeric repetitive nature of this ligand may be 
sufficient to cluster this receptor and activate signaling.  The PGRP-domain of PGRP-LE can 
also function outside of the cell in a CD14-like manner, by presenting PGN to cell surface 
PGRP-LC receptors.
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oligomers are very large, fractionating in (or near) the void volume during gel filtration, 
and, like the PGRP-LC dimers, they may play an important role in activating IMD signal 
transduction.
The data presented here clearly demonstrate that PGRP-LE functions by two 
distinct mechanisms.  Unlike PGRP-LC and the mammalian Toll-like receptors, PGRP-
LE is not a transmembrane protein.  PGRP-LE was predicted to reside in the cytoplasm 
(Werner et al., 2000).  Here, we demonstrated that PGRP-LE is found in the cytoplasm 
and can function as an intracellular TCT receptor.  In addition, we showed that a 
fragment of PGRP-LE, corresponding to the PGRP domain alone, was found and 
functioned extracellularly to enhance PGRP-LC dependent recognition of TCT.  This is 
consistent with the non-autonomous manner in which PGRP-LE acted when 
overexpressed in the fat body.  In fact, the predominant form of PGRP-LE found in the 
cell-free fraction of hemolymph in vivo was a fragment consisting of the PGRP domain.  
Full-length PGRP-LE is found in the malphigian tubules as well as in hemocytes.  We 
propose that the extracellular activity of PGRP-LE is transduced to the cytoplasm by 
PGRP-LC.  As an extracellular PGN receptor, PGRP-LEpg appears to function 
analogously to CD14, in that it can bind PGN in the circulation (or culture media) and 
carry it to the appropriate cells (fat body and hemocytes), where the PGN–PGRP-LE 
complex then binds the cell surface receptor PGRP-LC and activates IMD signaling 
(Gioannini et al., 2004; Visintin et al., 2003).  
As an intracellular receptor, PGRP-LE functions independently of PGRP-LC.  It is  
not clear how TCT gains access to intracellular PGRP-LE.  Perhaps certain cell types 
(e.g. malphigian tubules) express transporters capable of importing small fragments of 
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PGN across the plasma membrane.  As intracellular receptor, PGRP-LE may have 
evolved to detect intracellular bacteria, bacteria that pump PGN into the cytoplasm via 
specialized secretions systems, and/or PGN actively imported into certain cell types, in 
a manner similar to that proposed for mammalian NOD proteins (Strober et al., 2006).  
PGRP-LE must have its own intrinsic ability to interact with and activate Imd pathway 
components.  This notion is supported by the essential role of the conserved RHIM-like 
motif of PGRP-LE.  
Surprisingly, the interaction between IMD and PGRP-LC, which is detected in 
transfection experiments, is not physiologically relevant or is superfluous for PGRP-LC-
mediated antimicrobial peptide gene induction.  Interaction with IMD requires a region 
(residues 87-148) within the cytoplasmic domain of PGRP-LC that is not required for 
PGRP-LC-mediated IMD pathway activation.  The RHIM-like domain of PGRP-LCx is 
also not required for PGRP-LCx homodimerization (data not shown).  Instead, we 
predict that in order to transduce a signal, the RHIM-like motifs of PGRP-LC and PGRP-
LE interact with an unidentified component of the IMD pathway, whose characterization 
will be the focus of future work.
Methods
Reagents
Insoluble peptidoglycan from E.coli was purchased from Invivogen.  Isolation of 
TCT from Bordetella pertusis was described previously reported (Cookson et al., 
1989a).  
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Fly stocks and microinjections
All fly strains used were previously published: PGRP-LC1 and PGRP-LC2 9,  
PGRP-LC∆E, imdshadok, key1, and DD1 strains (Rutschmann et al., 2000; Gottar et al., 
2002),  and the PGRP-LE112 and double PGRP-LC and PGRP-LE mutant flies (PGRP-
LC∆E,PGRP-LE112, PGRP-LC7454,PGRP-LE112) (Takehana et al., 2004).  Microinjections 
into 2- to 5-day-old adults were performed as described previously (Kaneko et al., 2004; 
Wu et al., 2001).  Twenty-four hours after infection, flies were harvested and stored at 
-80°C.  
RNA analysis
Total RNA from flies or cultured cells was isolated using the TRIzol reagent 
(Invitrogen), as described previously, and expression of the antimicrobial peptide gene 
diptericin and control RpL32 genes was analyzed by Northern blot, as previously 
described (Kaneko et al., 2004; Silverman et al., 2000).   Quantitative analysis of 
diptericin expression was analyzed by phosphoimager (Fuji) normalizing to the level of 
RpL32 expression.  In all S2* based experiments, cells were pretreated with 1 µM 20-
hydroxyecdysone for 24-40 h prior to a 7-8 h treatment with 500 µM copper sulfate, to 
induce expression of PGRPs and/or IMD.  Real-time RT-PCR using Light Cycler (Roche 
Diagnostics) was performed as described previously (Choe et al., 2002).
DNA cloning
A DNA fragment encoding the PGRP domain of PGRP-LE (residues 173-339) 
was amplified from a Berkeley Drosophila Genome Project cDNA EST clone and 
subcloned into a bacterial expression vector for recombinant protein production.  DNA 
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fragments encoding C-terminal V5-tagged WT PGRP-LE and PGRP-LEPG (residues 
172-345) were subcloned into pMT-V5-His vector (Invitrogen).  These vectors were 
cotransfected with pCoHygro (Invitrogen), and stably transfected cells were selected 
with Hygromycin B (Invitrogen) according to the manufacturer’s protocol. 
C- or N-terminal T7-tagged WT PGRP-LC, N-terminal Flag-tagged imd, or C-
terminal T7- or Flag-tagged PGRP-LE were PCR amplified from cDNA clones and 
subcloned into pRmHa3 (Bunch et al., 1988), for copper inducible expression, by 
standard techniques.  These constructs were transfected into the Drosophila S2* cells 
and stably transfected cells were selected with G418 (Invitrogen) or Hygromycin 
(Calbiochem) as described previously (Wu et al., 2001). 
Mutagenesis of the PGRP-LC and PGRP-LE RHIM-like domains was performed 
using PCR-based QuikChange® II XL Site-directed Mutagenesis Kit (Stratagene) 
according to the manufacturer’s protocol.  Mutagenesis of PGRP-LES232E was 
performed with PCR-based LA PCR in vitro Mutagenesis kit for pBluescript II (TAKARA 
BIO Inc.), and subcloned into pMT-V5-His vector.  All constructs were verified by 
sequencing.
The YFP-PGRP-LE fusion was constructed by standard protocols, by cloning the 
PGRP-LE coding region into a modified version of pPAC-PL that contains mYFP at the 
N-terminus, which allowed expression of the YFP-PGRP-LE fusion from the actin 
promoter.  The modified version pPAC-PL containing mYFP was constructed by 
standard protocols subcloning mYFP (gift of E. Latz) into pPAC-PL.
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To create PGRP-LES232E site-directed mutagenesis was performed with LA PCR 
in vitro Mutagenesis kit for pBluescript II (TAKARA BIO Inc.). The mutagenized fragment 
was subcloned into pMT-V5-His vector, and stably transfected in S2 cells.
Protein production and purification
The detailed procedure for the production of PGRP-LEpg was recently reported 
(Lim et al., 2006).
Gel filtration
Samples were injected into a Superdex 75 10/300 GL column (Amersham 
Phamacia) pre-equilibrated with buffer A. The protein content was monitored by 
absorbance at 280 nm. 
Clonal analyses and immunohistochemistry
Clonal analysis of PGRP-LE over-expression and immunohistochemistry of 
malpighan tubules were performed as previously described (Takehana et al., 2004).
Whole organ culture
Whole organ culture of Diptericin-LacZ-carrying third instar larvae were 
performed as previously described16.  TCT, to a final concentration of 10 µM, was added 
directly to the culture.  LacZ staining was performed as previously described (Takehana 
et al., 2004).
Localization studies
 A cell line stably expressing YFP-PGRP-LE was generated, via G418 selection.  
For confocal microscopy, stable cells were treated for 24 h with 20-hydroxyecdysone, 
then plated on Concanavalin A-treated 35 mm glass-bottom culture dishes, and 
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observed by fluorescent microscopy under the 63X objective of a Leica SP2 AOBS laser 
scanning microscope.  Nuclei were stained with Hoechst 34580 (Invitrogen), and 
images were produced by sequential scanning with a 514 nm laser excitation and a 
522-599 nm emission window for YFP and 405 nm laser excitation and a 523-600 nm 
emission window for Hoechst 34580.
For immunohistochemistry of V5-tagged PGRP-LE, the protein was induced by 
24 h treatment with 100 µM CuSO4 in stably transfected S2 cells. The cells were 
cultured for 1.5h on Concanavalin A-treated glass slides, fixed with 2% PFA, treated 
with PBS containing 1% BSA and 0.1% Triton X-100 for 1h, and stained with mouse 
monoclonal anti-V5 (Invitrogen), FITC-labeled anti-mouse IgG (Jackson 
Immunologicals), DAPI (Sigma), and rhodamine-labeled phalloidine (Molecular Probes). 
V5-tagged PGRP-LEpg was induced in stably transfected S2 cells with 24 h 
treatment with 100 µM CuSO4, after which cells were subjected to treatment of 1µM 
TCT for 4 h. Cells were then fixed with 2% PFA, incubated with PBS containing 1% 
BSA for 1h, and stained with anti-V5 (Invitrogen), FITC-labeled anti-mouse IgG, and 
DAPI.
RNAi, TCT transfection and real-time RT-PCR
dsRNAs used in RNAi experiments were synthesized and purified as described 
previously (Silverman et al., 2000).  Templates for dsRNA for PGRP-LE were amplified 
using primers 5’-
TAATACGACTCACTCACTATAGGGAGACCACAAAGTTGAGCCAGG-3’ and 5’-
TAATACGACTCACTCACTATAGGGAGACCACGA-3’.  dsRNAs were transfected into 
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S2* cells cultured in Schneider’s Drosophila medium containing 10% fetal bovine 
serum, as previously described (Silverman et al., 2000).  After 42 h, cultures were 
diluted to 1×106 cells/ml and treated with 1 µM 20-hydroxyecdysone and 100 µM CuSO4 
for 40 h prior to treatment with 100 nM TCT.  Twelve hours later, total RNA was isolated, 
as described above, and expression of antibacterial peptides was quantified by RT-PCR 
using a Light Cycler (Roche Diagnostics) as described previously(Takehana et al., 
2002).
For TCT transfections, pMT-V5-PGRP-LE stable S2 cells were first stimulated 
with copper sulfate (100 µM) for 1h or left untreated.  TCT was prepared by dilution into 
BBS pH 6.94, followed by the addition of CaCl2, and thoroughly vortexed, per standard 
transfection protocols.  After 15 min incubation at room temperature the suspension was 
added dropwise to the copper-treated or untreated S2-PGRP-LE cells. Total RNA was 
extracted from the cells after 12 h incubation at 25°C and assayed by real-time RT-
PCR.
Immunoblot and coimmunoprecipitation 
Cell lysates from S2* cells stably transfected with epitope-tagged PGRPs were 
prepared and protein expression was monitored by immunoblot using monoclonal anti-
Flag (M2 or M5, Sigma) or anti-T7 (Novagen) and anti-IgG-HRP secondary antibody 
(Amersham).  Images were visualized with West Pico SuperSignal (Pierce). 
For the analysis of the interaction between PGRPs and IMD, S2* cells were 
transiently co-transfected with both pRmHa3-PGRPs-T7 and pRmHa3-Flag-IMD for 3d 
and stimulated with 500 µM of copper for 5-7h. After preparing cell lysates in a non-ionic 
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detergent lysis buffer, coimmunoprecipitations were performed as described previously 
with Flag-M2-agarose (Sigma) or anti-T7 agarose (Novagen) (Silverman et al., 2000). 
Transformation and analysis of UAS-PGRP-LC mutants 
Mutated PGRP-LC genes were amplified by PCR and subcloned into the EcoRI 
and BglII sites of pUAST (Brand and Perrimon, 1993).  After sequence verification, P-
element mediated transformation was carried by standard techniques, at the Model 
Systems Genomic Center (Duke University).   For strong expression in the fat body, the 
C564 Gal4 driver was used (Harrison et al., 1995). For low expression no Gal4 driver 
was used.  Flies were infected, by pricking with an E. coli laden needle, RNA was 
extracted 8 h later and assayed by Northern blot for diptericin and RpL32 expression 
(Choe et al., 2002).
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CHAPTER III
Searching for new interactors of the RHIM-like motif through a yeast two-hybrid 
screen
89
Abstract
Two receptors, PGRP-LC and PGRP-LE both activate the IMD signaling pathway 
in response to DAP-type PGN.  These two receptors utilize a common motif in their N-
terminal domains, known as the RHIM-like domain, to trigger signal transduction.  
Genetic studies indicate that the IMD protein functions immediately downstream of the 
PGRP-LC receptor, yet the RHIM-like motif is not essential for IMD association with 
PGRP-LC.  Thus, the mechanism by which the RHIM-like domain functions in signaling 
is unclear, and I hypothesize that the RHIM-like domain interacts with an unidentified 
protein to mediate downstream signaling.  To test our hypothesis, I performed a yeast 
two-hybrid screen with the N-terminal, cytosolic domain of PGRP-LC as bait.  24 strong 
positive interactors were then counter screened with baits lacking a functional RHIM-
motif, thereby identifying 5 potential RHIM-interactors for further study.
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Introduction
Insects rely primarily on innate immune responses to fight pathogens and one of 
the key features of this response is the production of antimicrobial peptides (AMP) 
following an infection.  In Drosophila, two signaling pathways regulate the production of 
these antimicrobial peptides - the IMD and Toll pathways (Aggrawal and Silverman, 
2007).  Two receptors, PGRP-LC and PGRP-LE, are able to recognize DAP-type PGN 
at the cell surface or in the cytosol, respectively, and trigger the IMD pathway (Kaneko 
et al., 2006; Werner et al., 2000; Gottar et al., 2002; Ramet et al., 2001; Choe et al., 
2002; Takehana et al., 2002).
Upon binding DAP-type PGN, both PGRP-LC and PGRP-LE get activated and 
signal via a common motif in their N-terminal domains, known as the RHIM-like domain 
(Kaneko et al., 2006; Choe et al., 2005; Lim et al., 2006).  The RHIM-like domain is 
critical for signaling by either receptor, but the mechanism(s) involved remain unclear 
(Kaneko et al., 2006).  Genetic experiments suggest that the imd protein functions 
immediately downstream of PGRP-LC and upstream of all other known components of 
the pathway (Georgel et al., 2001).  IMD associates with both PGRP-LC and -LE but the 
interaction of  PGRP-LC with IMD is not mediated through its RHIM-like domain 
(Kaneko et al., 2006).  Therefore I hypothesize that an unidentified protein interacts with 
the RHIM- like domain of PGRP-LC and is important for signaling.  
In this study I performed a yeast two-hybrid screen to identify proteins that might 
interact PGRP-LC through its RHIM- like domain.  With this approach, I have identified 
five new proteins as potential RHIM-dependent PGRP-LC interactors.
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Results and Discussion
In order to find potential partners and regulators of the IMD pathway receptors, a 
yeast two-hybrid screen was performed with the cytoplasmic domain of PGRP-LC as 
bait and a Drosophila third instar cDNA library as prey (James et al., 1996; Silverman et 
al., 2000).  The Drosophila genome has approximately 15000 genes .  The cDNA library 
is composed of approximately 1 x 107 cDNA clones and we screened about 3x107 
clones.  From this, 242 PGRP-LC interacting clones were identified with a Ade2 reporter 
gene selection scheme.
A second round of assays was performed on all 242 interacting clones, taking 
advantage of a LacZ reporter gene to provide a more quantitative metric of interaction.  
In this case, β-galactosidase activity (produced from LacZ) is proportional to the 
strength of the protein-protein interaction monitored in the two-hybrid assay.  
Colorimetric X-gal  (5-bromo-4-chloro-3-indolyl-β-D-galactoside) substrate was used to 
monitor β-galactosidase activity, and the degree of blue X-gal staining was recorded, as 
indicated in the chart in Figure 3.1b.  The 24 strongly interacting clones were analyzed 
further.
A third round of screening was performed, on these 24 strongest hits to confirm 
the interaction was dependent on the PGRP-LC bait and to determine if the interaction 
involved the RHIM Type to enter text-like domain.  For this,  the clones were selected on 
FOA plates.  The presence of URA3 containin Type to enter text g plasmids allows for 
negative selection. URA3 encodes orotidine-5’phosphate decarboxylase, an enzyme 
which is required for the biosynthesis of uracil. Ura3- (or ura5-) cells can be selected on 
media containing FOA. The URA3+ cells are killed because FOA is converted to the 
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Figure 3.1: X gal screening
(a) Schematic representation of the yeast two hybrid screen and also the markers and reporters 
that are utilized in the screen.
(b) Quantitative analysis of X-gal screening.  Clones that interacted with cytoplasmic domain of 
PGRP-LC were plated on X-gal plates and categorized as strong, medium or weak interactions 
depending on how blue the colonies turned.
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toxic compound 5-fluoro deoxyuracil by the action of decarboxylase, whereas ura3- cells 
are resistant.  Thus, yeast that spontaneously lose the URA3 containing plasmid grow 
on FOA plates allowing for the selection of yeast cells that have lost the bait plasmid.  
The 24 clones were then re-transformed with wild-type PGRP-LC to confirm the 
interaction from the primary screen.  In addition, the clones were separately transformed 
with three different RHIM mutant baits to identify clones that interact only with wild type 
PGRP-LC but not the RHIM mutant.  And finally, irrelevant baits (IKKβ) or empty vector 
where used as additional negative controls.  Ten clones interacted strongly with both 
wild type and RHIM mutant PGRP-LC and were not studied further.  One clone 
interacted weakly even with wild type PGRP-LC and also was not pursued.  For 2 
clones, number 20 and 21, the retransformation failed and no useful data is available.  
The nine remaining clones interacted strongly with wild type PGRP-LC but not with the 
RHIM-like mutant baits, the irrelevant bait, or empty vector  (Table 3.2).  I was able to 
PCR amplify only six of these nine genes, and successfully obtained sequence from 
only five amplicons.  I then analyzed if they function in IMD signaling, through RNAi 
knockdown in immune responsive S2* cells.  Two of the five genes had marked 
phenotypes in these RNAi-based assay, and their role in IMD pathway will be discussed 
in detail in chapters IV and V.  Thus, by performing a yeast two hybrid screen we have 
identified two new regulators of the IMD pathway.  The other three hits from the 2-hybrid 
screen [Clone 4 (RfaBg) Clone 17 (Scylla) and Clone 24 (CG12935)] do not appear to 
affect IMD signaling, at least in these RNAi-based assays and have not been further 
explored (Figure 3.3).
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Table 3.2:  Interaction analysis to identify clones that interact with the RHIM-like motif of 
PGRP-LC 
24 clones that interacted strongly with the cytoplasmic domain of PGRP-LC were tested for 
interaction with several deletion and point mutants that alter the RHIM-like domain of PGRP-
LCx.  ++++, robust growth; ++, slow growth, - no growth.
Baits LCx WT LCx !172- 212 LCx !213- 242 LCx F218A DmIKK Empty vector
Clone 1 ++++ ++++ ++++ ++++ X X
Clone 2 ++++ ++++ ++++ ++++ X
Clone 3 (CG15678) ++++ ++ ++ ++ X X
Clone 4 (RfaBg) ++++ ++ X X X X
Clone 5 ++++ ++++ ++++ ++++ X X
Clone 6* ++++ ++ X X X X
Clone 7$ ++++ X X X X X
Clone 8 ++++ +++ ++ +++ X X
Clone 9 ++++ ++++ ++++ ++++ X X
Clone 10 ++++ ++++ ++++ ++++ X X
Clone 11 ++++ ++++ ++++ ++++ X X
Clone 12 (RYBP) ++++ ++ X X X X
Clone 13 ++++ ++++ ++++ ++++ X X
Clone 14$ ++++ ++ X + X X
Clone 15 ++++ ++++ ++++ ++++ X X
Clone 16 ++++ ++++ ++++ ++++ X X
Clone 17 (Scylla) ++++ ++ X X X X
Clone 18 $ ++++ ++ X ++ X X
Clone 19 ++ ++ + + X X
Clone 20 ++++ no data no data no data X X
Clone 21 ++++ no data no data no data X X
Clone 22 ++++ ++++ ++++ ++++ X X
Clone 23 ++++ ++++ X +++ X X
Clone 24 (CG12935) ++++ ++ X + X X
     : Clones for which no sequencing data was obtained
: Clones for which PCR amplification did not work
  : Clones that do not play a role in the IMD pathway
       : Clones that play a role in the IMD pathway
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Figure 3.3:  RfaBg, Scylla and CG12935 are not regulators of IMD signaling in cells.
Northern blot of Diptericn and rp49 expression in S2* cells treated with lacZ dsRNA or RfaBg, 
Scylla or CG12935 dsRNA, and then stimulated with PGN for 6 hours.
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Materials and Methods 
Yeast strains, transformations and media
The bait plasmid was transformed into PJ69- 4A.  All yeast transformations were done 
using the high efficiency LiAC method of Gietz and Woods and all media was prepared 
as per manufacturer’s instructions (Gietz and Woods, 2002). For X-gal plates (200ml), 
YPAD Agar in 175 ml water was autoclaved and supplemented with 25 ml 0.7M 
Potassium Phosphate Buffer pH 7.0 (KPO4) and X- gal (20mg/ ml in DMF) which was 
either added (50µl) on top of the plate and spread or was added (2ml) directly to the 
YPAD Agar before pouring the plates.  And for FOA plates (200ml), -Ura-Leu Agar in 
180 ml was was autoclaved and supplemented with 10 ml FOA (0.1%) and 10 ml uracil 
(10mM).
Yeast Two Hybrid Screen
The third instar larval library was cloned in the ACT vector and the first 290 amino acids 
of PGRP-LC were cloned into pGBDU (Durfee et al., 1993) (James et al., 1996).  Two 
hybrid selection was performed as described (James et al., 1996) with modification. In 
brief, PGRP-LC was cloned into pGBDU.  Two hybrid selection was performed as 
described (James et al., 1996) with modification. In brief,
Day 0
1. Inoculated 10ml of bait strain (pGBDU cyto PGRP-LCx) in -Ura medium over night at 
30oC at 250 rpm.Day 1
1. Thawed an aliquot of the library in 50 ml -Leu medium and grew it for 4-6 hours at 
30oC at 250 rpm.
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2. Mixed 50 OD600 units of bait strain and 75 units of library in 100 YPAD (spin cells and 
then re-suspend in 50 ml YPAD and mix).
3. Grew the culture overnight at 30oC at 150 rpm.
Day 2
1. Tittered mating on -Ura-Leu plates.
2. Pelleted 50 ml of mating and resuspended in 500 ml of -Ura-Leu media and grew it 
for 5-6 hours at 30oC at 250 rpm.
3. Pellet the -Ura-Leu culture and resuspended in 50 ml of freezing media (8% glycerol 
YPAD) made 1 ml aliquots and froze it at -80oC.
Day 3
1. Thaw an aliquot of the frozen culture and plated various dilution on -Ura-Leu to titre 
mating.
Day 4
1. Thawed aliquots of the frozen culture and plated 3 X 107 colonies (3X complexity of 
the library) on -Ade plates at incubated them at 30oC.
Day 5
1. Observed plates for up to 10 days and picked colonies that grew on -Ade plates and 
re streaked on -Ade plates
98
PREFACE TO CHAPTER IV
This chapter was previously published in Plos Pathogen (2008):
Kamna Aggarwal, Florentina Rus, Christie Vriesema-Magnuson , Deniz Ertürk-
Hasdemir, Nicholas Paquette & Neal Silverman.  Rudra interrupts receptor signaling 
complexes to negatively regulate the IMD pathway.  Plos Pathogen 2008 Aug 8, 4(8): 
e1000120.
Florentina Rus helped perform fly real-time PCR experiments
Christie Vriesema-Magnuson , Deniz Ertürk-Hasdemir and Nicholas Paquette 
provided reagents and tools for the experiments.
99
CHAPTER IV
Rudra interrupts receptor signaling complexes to negatively regulate the IMD 
pathway.
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Abstract 
Insects rely primarily on innate immune responses to fight pathogens. In 
Drosophila, antimicrobial peptides are key contributors to host defense.  Antimicrobial 
peptide gene expression is regulated by the IMD and Toll pathways. Bacterial 
peptidoglycans trigger these pathways, through recognition by peptidoglycan 
recognition proteins (PGRPs).  DAP-type peptidoglycan triggers the IMD pathway via 
PGRP-LC and PGRP-LE, while lysine-type peptidoglycan is an agonist for the Toll 
pathway through PGRP-SA and PGRP-SD.  Recent work has shown that the intensity 
and duration of the immune responses initiating with these receptors is tightly regulated 
at multiple levels, by a series of negative regulators. Through two-hybrid screening with 
PGRP-LC, we identified Rudra, a new regulator of the IMD pathway, and demonstrate 
that it is a critical feedback inhibitor of peptidoglycan receptor signaling.  Following 
stimulation of the IMD pathway, rudra expression was rapidly induced.  In cells, RNAi 
targeting of rudra caused a marked up-regulation of antimicrobial peptide gene 
expression.  rudra mutant flies also hyper-activated antimicrobial peptide genes and 
were more resistant to infection with the insect pathogen Erwinia carotovora carotovora.  
Molecularly, Rudra was found to bind and interfere with both PGRP-LC and PGRP-LE, 
disrupting their signaling complex. These results show that Rudra is a critical 
component in a negative feedback loop, whereby immune-induced gene expression 
rapidly produces a potent inhibitor that binds and inhibits pattern recognition receptors.  
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Introduction 
Insects rely primarily on innate immune responses to fight pathogens.  The 
Drosophila immune response has proven to be an experimentally powerful and 
conserved model system for the study of innate immunity (Brennan and Anderson, 
2004; Cherry and Silverman, 2006; Hultmark, 2003; Lemaitre and Hoffmann, 2007). In 
particular, the insect immune response relies on evolutionary conserved NF-κB 
signaling cascades for the control of inducible antimicrobial peptide (AMP) gene 
transcription. This antimicrobial peptide response is critical for protection against many 
microbial pathogens (Lemaitre et al., 1997; Meister et al., 1997). 
In Drosophila, two signaling pathways regulate the production of these 
antimicrobial peptides - the IMD and Toll pathways (Aggrawal and Silverman, 2007). 
The Toll pathway responds to many Gram-positive bacterial and fungal infections 
(Lemaitre et al., 1996), while the IMD pathway is potently activated by DAP-type 
peptidoglycan (PGN) from Gram-negative bacteria and certain Gram-positive bacteria 
(Leulier et al., 2003; Kaneko et al., 2004).  Two receptors, PGRP-LC and PGRP-LE, are 
able to recognize DAP-type PGN at the cell surface or in the cytosol, respectively, and 
trigger the IMD pathway (Kaneko et al., 2006; Werner et al., 2000; Gottar et al., 2002; 
Ramet et al., 2001; Choe et al., 2002; Takehana et al., 2002).  
Upon binding DAP-type PGN, both PGRP-LC and PGRP-LE multimerize and 
signal via a common motif in their N-terminal domains, known as the RHIM-like domain 
(Kaneko et al., 2006; Choe et al., 2005; Lim et al., 2006).  The RHIM-like domain is 
critical for signaling by either receptor, but the mechanism(s) involved remain unclear 
(Kaneko et al., 2006).  Genetic experiments suggest that the imd protein functions 
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immediately downstream of PGRP-LC and upstream of all other known components of 
the pathway (Georgel et al., 2001). IMD associates with both PGRP-LC and -LE, 
although the PGRP-LC RHIM-like motif is not required for this interaction (Kaneko et al., 
2006).  Nonetheless, the complexes formed on these receptors are likely to be critical to 
trigger further signal transduction.
Recent work has shown that the intensity and duration of the immune response 
is tightly regulated in Drosophila.  As in mammals, over-exuberant immune responses 
can be detrimental, and the proper down modulation of immunity is critical for health 
and fecundity (Flatt et al., 2005; Lang and Mansell, 2007; Zerofsky et al., 2005).  In 
order to keep the immune response properly modulated, the Toll and IMD pathways are 
controlled at multiple levels by a series of negative regulators.  For example, the 
amidases PGRP-LB and PGRP-SC reduce the immunostimulatory activity of PGN by 
digesting it (Bischoff et al., 2006; Zaidman-Remy et al., 2006).  Intracellularly, the IMD 
signaling pathway is further down–regulated by Dnr1, POSH, Caspar and the E3-ligase 
complex containing SkpA, dCullin and Slimb (Foley and O'Farrell, 2004; Khush et al., 
2002a; Kim et al., 2006; Tsuda et al., 2006).  Additionally, the JNK and Relish branches 
of the IMD pathway are thought to mutually inhibit each other (Park et al., 2004; Kim et 
al., 2007; Kim et al., 2005).
In this study, we identify and characterize a negative feedback regulator of the 
IMD pathway, dubbed rudra.  Expression of rudra was rapidly induced following immune 
challenge.  Moreover, in flies and cells, rudra is critical for controlling immune-induced 
gene expression.  Following infection, rudra mutant flies hyper-activated antimicrobial 
peptide gene expression resulting in increased resistance to microbial infection.  Using 
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various biochemical and genetic techniques, Rudra was found to interact with the 
receptors PGRP-LC and PGRP-LE and disrupt the signaling complex assembled on 
these receptors.  Due to its ability to destroy this receptor signaling complex and inhibit 
immune responses, rudra was named for Shiva, the Indian god of destruction, who in 
his Rudra phase of mind causes inhibition and destruction of all life on earth. 
Results
Isolation of Rudra 
In order to identify potential partners and regulators of the IMD pathway 
receptors, a yeast two-hybrid screen was performed with the cytoplasmic domain of 
PGRP-LC as bait (James et al., 1996; Silverman et al., 2000).  25 strongly interacting 
clones were further analyzed with a set of baits that carried mutations in the RHIM-like 
domain of PGRP-LC (or irrelevant control baits).  One clone interacted strongly with the 
wild-type cytoplasmic domain of PGRP-LC but weakly with the RHIM-like mutant baits 
(Table 4.1).  This clone encoded amino acids 30-197 of CG15678, and will be referred 
to as rudra from hereafter. 
To confirm the yeast two-hybrid results, co-immunoprecipitation experiments 
were performed.  Using epitope tagged constructs and transient transfection in 
Drosophila S2* cells, both PGRP-LE and PGRP-LC were found to associate with Rudra 
(Figure 4.2a, e).  In a heterologous system (HEK cells), similar robust associations 
were observed between Rudra and PGRP-LE or –LC (Figure 4.2b,c).  The interaction 
between Rudra and PGRP-LE was also readily detectable, by co-immunoprecipitation, 
when these proteins were produced in a rabbit reticulocyte in vitro translation system
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Table 4.1: Rudra interacts with cytoplasmic domain of PGRP-LC by yeast two-hybrid
The cytoplasmic domain of PGRP-LC was used as bait and Rudra was used as the prey in 
yeast two-hybrid assays. Rudra interacted well with the full cytoplasmic domain of PGRP-LC 
and the yeast cells grew robustly on Ade selection plates. However, Rudra interacted weakly 
with several deletion and point mutants that alter the RHIM-like domain of PGRP-LCx. ++++, 
robust growth; ++, slow growth, - no growth.
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Figure 4.2: Rudra interacts with the receptors PGRP-LE and PGRP-LC
(a,b) Immunoprecipitation (IP) and immunoblot (IB) analysis of lysates from S2* or HEK cells 
transiently transfected with expression plasmids for FLAG-tagged PGRP-LE and/or T7-tagged 
rudra. In the Drosophila S2* cells, the copper inducible metallothionein promoter was used for 
expression and cells were treated with CuSO4 or left untreated, as indicated. (c) Similar co-
immunoprecipitation experiments from lysates of HEK cells transiently co-transfected with T7-
tagged PGRP-LCx and FLAG-tagged rudra expression plasmids. (d) Schematic representation 
of the PGRP-LCx deletions mutants used in (E).  (e) IP-IB analysis of lysates from S2* cells 
transiently transfected with metallothionein promoter expression plasmids encoding wild-type 
and deletion mutants of V5-tagged PGRP-LCx and FLAG-tagged rudra, with or without 
CuSO4treatment, as indicated.  Data are representative of at least three independent assays.
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Figure 4.3:  PGRP-LE and Rudra interact in vitro
Co-immunoprecipitation of in vitro co-translated PGRP-LE and Rudra.  Co-immunoprecipitation 
was performed using anti–FLAG antibodies with 35S-methionine labeled in vitro translated T7-
Rudra and FLAG-PGRP-LE.
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Figure 4.4: Rudra interacts with all the deletion mutants spanning the cytoplasmic 
domain of PGRP-LCx.
IP-IB analysis of lysates from S2* cells transiently transfected with metallothionein promoter 
expression plasmids encoding T7-tagged PGRP-LCx (wild-type and deletion mutants) and 
FLAG-tagged rudra with or without CuSO4 treatment, as indicated.  Lower diagram indicates 
the regions deleted in each mutant form of PGRP-LC.
(Figure 4.3).  These data demonstrate that Rudra interacts directly with the receptors 
PGRP-LC and PGRP-LE.
In order to determine which domain(s) of the receptors interact with Rudra, co-
immunoprecipitation assays were performed with various mutant versions of PGRP-LC 
or PGRP-LE.  Consistent with the yeast two-hybrid data, which indicated involvement of 
the RHIM-like domain for interaction, a mutant form of PGRP-LE lacking the RHIM motif 
(Δ98-113) showed little interaction with Rudra (Figure 4.2a,b). Using a set of large 
deletions (Figure 4.2d), the N-terminal cytoplasmic domain of PGRP-LC was found to 
be essential for association with Rudra.  Removal of the first 144 amino acids 
decreased Rudra interaction, while removal of nearly the entire cytoplasmic (Δ1-253) 
domain abolished interaction.  The PGRP-LC extracellular domain was not involved in 
the interaction (Figure 4.2e).  We then attempted to map the PGRP-LC interaction more 
finely with a set of mutants that span the entire cytoplasmic domain with sequential 50 
amino acid deletions.  However, Rudra co-immunoprecipitated with all of these deletion 
mutants, suggesting some redundancy in the interaction mechanism (Figure 4.4).  The 
yeast two-hybrid data suggest that some of the interacting activity involves the PGRP-
LC RHIM domain, while the larger deletions suggest another interaction motif likely lies 
in the first 144 amino acids (Figure 4.2d,e).  Overall, we conclude that Rudra directly 
interacts with the signaling domains of PGRP-LC and PGRP-LE.  The interaction with 
PGRP-LE is largely mediated by the RHIM motif while the interaction with PGRP-LC 
appears to involve multiple, partly redundant, mechanisms. 
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Figure 4.5:  rudra, a negative feedback regulator of IMD signaling in cells 
(a) Real-time RT-PCR analysis of rudra transcript from S2* cells which were stimulated with 
PGN for various times.  Diptericin expression was quantified, by Northern blot, from these same 
cells.  (b) Northern blot of Diptericn, Attacin, Cecropin and rp49 expression in S2* cells treated 
with lacZ dsRNA or Rudra dsRNA, and then stimulated with PGN for various times.  Data are 
representative of at least three independent assays.  Error bars in (a) represent standard 
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Figure 4.6: Over-expression of rudra blocks IMD signaling in both cells and flies.
(a) Northern blot of Dpt and rp49 expression in S2* cells stably transfected with a 
metallothionein promoter–driven transgene expressing rudra.  Cells were treated with CuSO4 
for 1.5 hours and then stimulated with PGN for 5 hours, as indicated. (b) Northern blot of 
Diptericin and rp49 expression in adult flies carrying UAS promoter–driven transgenes 
expressing rudra (two independent transgenic lines).  Flies were heat shocked for 1.5 hours and 
then RNA was isolated 8 hours after septic infection with E.coli.  Data are representative of at 
least three independent assays.
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Figure 4.7: Rudra inhibits IMD signaling but not the Toll pathway
Northern blot of Drosomycin and Diptericin expression in S2* cells stimulated with SPZ-C106 
or PGN, respectively, with rp49 as a loading control.  Cells expressing rudra, from the 
actin promoter, failed to respond to PGN but displayed robust SPZ-induced Drosomycin 
expression.  Stimulation time as indicated.
Induction of rudra expression
 Previous microarray studies have suggested that rudra is a target of the IMD 
signaling pathway (Park et al., 2004; Boutros et al., 2002; De Gregorio et al., 2002)
[29,34,35].  In order to confirm and extend these findings, the expression of rudra was 
analyzed at various times after immune stimulation of S2* cells, by qRT-PCR.  rudra 
transcript was rapidly induced, peaking in 30-60 minutes and returning to near baseline 
levels within 24 hours (Figure 4.5a).  The kinetics of rudra expression were markedly 
faster and more transient than the expression of AMP genes.  For example, Diptericin 
mRNA levels, as measured by Northern blotting, did not peak until 6 hours after PGN 
stimulation, and then remained elevated for at least 24 hours (Figure 4.5a).  Even 
though the expression profiles of rudra and AMP genes are distinct, they both require 
the NF-κB factor Relish (De Gregorio et al., 2002; Kleino et al., 2005).
Rudra is a negative regulator of IMD signaling
Next, RNAi was used to characterize the function of rudra in the IMD pathway.  
S2* cells were transfected with dsRNA for rudra, and then stimulated with PGN for 
various times.  As monitored by Northern blotting, antimicrobial peptide genes Diptericin 
(Dpt), Attacin (Att)  and Cecropin (Cec) were induced to markedly higher levels in cells 
treated with rudra RNAi, compared to cells transfected with a control lacZ dsRNA 
(Figure 4.5b). These data suggest that rudra is a negative regulator of IMD signaling. 
To further test if rudra is a negative regulator of the IMD pathway, stable cell lines 
expressing rudra from a copper-inducible promoter were selected. These cell lines were 
treated with copper for 1.5 hours, to induce rudra expression, and then stimulated with 
PGN for 5 hours, to stimulate the IMD pathway.  rudra over-expression potently inhibited 
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Figure 4.8: Characterization of rudra mutant flies 
(a) Real-time RT-PCR analysis of rudra transcript from w1118, rudraEY00723, and rdrrescue flies that 
were infected with E.coli for various times. (b) Quantified Northern blotting data of 
Diptericin and rp49 expression in w1118, rudraEY00723 and rudrarescue flies following 
infection with E.coli. (c) Survival assays were performed following infection of w1118, 
rudraEY00723  and LE112;LCΔE flies with E. carotovora carotovora.  Infected animals were 
incubated at 29°C and the number of surviving flies were counted every 24 hours.  
Survival data is presented in Kaplan-Meier plots and significance was analyzed by log-
rank test.  (a) and (b) are representative of at least 3 independent experiments, while 
(c) is representative of 2 independent trials, with 60 or 100 animals.
the induction of Dpt (Figure 4.6a).  Also, to test if rudra negatively regulates the Toll 
pathway, stable cell lines expressing rudra from the actin promoter were selected. 
These cell lines were treated with SPZ-C106 for 18 hours to stimulate the Toll pathway.  
rudra over-expression did not robustly inhibit the induction of Drosomycin, as compared 
to its ability to inhibit PGN-induced Diptericin expression (Figure 4.7).  These data 
demonstrate that rudra is potent inhibitor of the IMD pathway but has little effect on Toll 
signaling. 
Using the UAS system and a heat shock Gal4 ‘driver’, transgenic flies that 
ectopically express rudra were also characterized.  rudra expression was induced with a 
1.5 hour heat shock and then flies were challenged with E.coli.  In two independent 
UAS-rudra lines, IMD signaling was strongly inhibited by rudra expression, as monitored 
by Northern blotting for Dpt induction (Figure 4.6a).  These results are consistent with 
the data from cultured cells, and argue that rudra is a potent negative regulator of the 
IMD pathway in vivo.
In order to phenotypically characterize the loss of rudra, a strain carrying a P-
element at position 123 in the 5’ UTR of rudra (EY00723) was analyzed [37,38,39].  
First, the level of rudra transcript in this strain was compared to a back-crossed white 
strain, by qRT-PCR (Figure 4.8a).  [To generate back-crossed mutant and wild-type 
strains, EY00723 was crossed with the white strain for six generations prior to these 
analyses]. Similar to the cell culture data, rudra transcription was rapidly induced 
following infection in wild-type flies.  Again, the induction of rudra expression occurs 
more rapidly, and is resolved more quickly, than does AMP gene expression (compare 
Figure 4.8a to 4.8b).  The transposon insertion in the 5’ UTR markedly inhibited rudra 
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expression, with nearly undetectable levels at all time points, demonstrating that this 
allele of rudra is a strong hypomorph.  Also, a transgenic rescue strain was constructed, 
using a 4.5 Kbp genomic fragment (rudrarescue).  This genomic rescue construct partially 
restored immune-inducible expression of rudra, but it did not completely return to wild-
type levels (Figure 4.8a).
Next, the immune response of wild-type, rudraEY00723 , and the rudrarescue strains 
were compared.  Diptericin expression, as monitored by Northern blotting at various 
times following septic E. coli infection, was elevated at all time points in rudraEY00723 
compared to the isogenic wild-type strain (Figure 4.8b).  The rudrarescue transgenic line 
restored Diptericin to levels between that observed in the wild-type and rudra mutant 
flies, consistent with partially restored levels of rudra expression observed in this line.  
rudra heterozygotes also displayed elevated AMP gene expression (data not shown). 
These results, together with the data from ectopic expression, demonstrate that rudra is 
a potent negative regulator of the IMD pathway in flies, as well as in cultured cell lines. 
We then asked what consequence these elevated AMP levels might have during 
an infection.  To this end, wild-type and rudraEY00723 flies were infected with the Gram-
negative pathogen Erwinia carotovora carotovora (Ecc).  As reported previously, Ecc is 
a mildly pathogenic infection in wild-type animals, such that most flies succumb over the 
course ~10 days  (Figure 4.8c) (Kim et al., 2006; Basset et al., 2000).  As expected, 
PGRP-LE; PGRP-LC double mutant flies, which lack both receptors involved in 
detecting DAP-type PGN, were rapidly killed by this infection (P=0.0252, compared to 
wild-type animals).  On the other hand, rudra mutants showed significantly improved 
survival compared to wild-type flies (P= 0.0052).  These results show that loss of rudra, 
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Figure 4.9: Rudra functions upstream of IMD, Dredd and Relish.
(a) Analysis of lysates from S2* cells stably transfected with a metallothionein promoter plasmid 
expressing T7-tagged rudra, with or without treatment with CuSO4 and PGN, as indicated.  IMD 
cleavage was analyzed by IP-IB (upper panel), while Relish phosphorylation and cleavage were 
analyzed by immunoblotting (in the middle two panels).  The asterisk marks heavy chain 
detected by the secondary antibody.  The lowest panel confirms Rudra expression with anti-T7 
IB.  (b) Northern blot of Diptericin and rp49 expression levels in S2* cells stably transfected with 
metallothionein promoter–driven transgenes expressing PGRP-LCx, PGRP-LE, or imd, with or 
without concurrent expression of rudra.  Cells were treated with CuSO4 (+) or left untreated (-), 
and RNA was extracted after 6 hours.  (c) Immunoblot analysis of Relish cleavage from S2* 
cells stably transfected with metallothionein promoter expression plasmid for Dredd, with or 
without concurrent expression of FLAG-tagged rudra.  CuSO4 was added, for 5 hours, to 
induce transgene expression, as indicated. Data are representative of at least three 
independent assays.
and the ensuing increase in AMP levels, enhances resistance to this Gram-negative 
pathogen.
Rudra inhibits signaling at the receptor
We next sought to determine the molecular mechanism(s) used by Rudra to 
control signal transduction.  Relish, the NF-κB precursor protein essential for IMD 
triggered gene expression, is regulated by immune-induced cleavage and 
phosphorylation (Stöven et al., 2000; Stöven et al., 2003; Erturk-Hasdemir et al., 2009).  
Rudra expression prevented both the cleavage and phosphorylation of Relish (Figure 
4.9a).  Recently, we also discovered that imd protein is rapidly cleaved following 
immune stimulation (unpublished data, N.P. and N.S) and expression of rudra potently 
inhibits this cleavage (Figure 4.9a).  These results suggest that Rudra functions 
upstream of Relish activation and IMD cleavage.  
AMP gene expression can be triggered by ectopically expressing certain 
components of the IMD pathway.  In particular, over-expression of either of the 
receptors, PGRP-LC or PGRP-LE, or imd is sufficient to drive AMP gene expression.  
Likewise, over-expression of the caspase Dredd is sufficient to drive Relish cleavage.  
To further analyze the position that Rudra acts in the IMD pathway, it was over-
expressed with these signaling components in doubly selected stable cell lines.  Rudra 
potently inhibited signaling induced by over-expression of the receptors PGRP-LC or 
PGRP-LE, but had no effect on the induction of Diptericin expression caused by IMD 
over-expression (Figure 4.9b).  Likewise, Rudra did not inhibit Relish cleavage caused 
by over-expressing the caspase Dredd (Figure 4.9c). These results suggest that Rudra 
functions upstream of Dredd and IMD, but downstream of the receptors, and is 
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Figure 4.10: Rudra disrupts the interaction between PGRP-LCx and IMD.
(a) IP-IB analysis of lysates of HEK cells transiently transfected with expression plasmids for 
FLAG-tagged imd or FLAG-tagged dFADD and T7-tagged rudra.  Rudra interacted with IMD but 
not dFADD.  (b, c) Similar co-immunoprecipitation experiments from lysates of HEK cells (b) or 
S2* cells (c) simultaneously co-transfected with T7 tagged PGRP-LCx, FLAG tagged IMD and/
or FLAG-tagged rudra.  Rudra interfered with the association between PGRP-LC and IMD. Data 
are representative of at least three independent assays. Data are representative of 3 
independent experiments.
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consistent with binding data demonstrating an association between Rudra and either 
PGRP-LC or PGRP-LE. 
In addition to interacting with the receptors, Rudra avidly bound to IMD.  The IMD 
association was detected by transient transfection/co-immunoprecipitation assays, in 
either S2* cells (data now shown) or HEK cells (Figure 4.10a).  On the other hand, 
Rudra did not associate with dFADD, another factor known to interact with IMD.  In all, 
these data argue that Rudra directly interacts with both IMD and the receptors PGRP-
LC and PGRP-LE.  These results suggest two possible models for the inhibition of IMD 
signaling by Rudra:  (1) Rudra may associate with both the receptor and its signaling 
adaptor (IMD), holding them together in an inactive confirmation; or (2) Rudra may 
interact with both PGRP-LC and IMD separately, disrupting the association between the 
receptor and its adaptor.  To probe these possibilities, co-immunoprecipitation 
experiments were performed with lysates from cells co-transfected with PGRP-LC (T7 
tag), imd (FLAG tagged) and/or rudra (also FLAG tagged).  In assays with just the 
receptor and either IMD or Rudra, PGRP-LC interacted with either the adaptor or the 
inhibitor, in both Drosophila and human cells (Figure 4.10b,c).  However, when all three 
proteins were simultaneously co-expressed, PGRP-LC and Rudra still robustly co-
precipitated, but the association between IMD and the receptor was markedly reduced.  
These data suggest that Rudra interferes with the interaction between PGRP-LC and 
IMD, and this disruption provides a molecular mechanism explaining how Rudra down-
modulates IMD signaling at the level of the receptor, consistent with the functional and 
binding data presented.  
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Discussion
Recent work has shown that the intensity and duration of the immune response 
is tightly regulated in Drosophila (Tsuda et al., 2006; Kim et al., 2006; Foley and 
O'Farrell, 2004; Zaidman-Remy et al., 2006; Bischoff et al., 2004). Over-exuberant 
immune responses can be dangerous and the proper down modulation of immunity is 
important for health and fecundity (Flatt et al., 2005; Zerofsky et al., 2005).  To keep the 
immune response properly modulated, the Toll and IMD pathways are controlled at 
multiple levels by multiple negative regulators.  In this study, we have characterized a 
new negative feedback regulator of the IMD pathway. rudra transcript is rapidly induced 
following septic infection, and rudra mutant flies or rudra knockdown cells over-express 
antimicrobial peptides.  In the case of Erwinia carotovora carotovora infection, this 
elevated level of AMP production leads to increased survival.  A similar phenotype was 
reported for mutants lacking Caspar, which is thought to inhibit downstream signaling 
events (Kim et al., 2006).  The results presented here, in cells and flies, demonstrate 
that rudra is a key component in a negative feedback loop that keeps the IMD pathway 
in check.  
In addition to these loss-of-function results, over-expression of rudra potently 
blocked signaling through the IMD pathway, both in cells and in flies.  Moreover, we 
exploited this activity to analyze which steps in the IMD pathway are inhibited by Rudra.  
Using various molecular assays to monitor different PGN-induced events in the IMD 
pathway, we found that Rudra interfered with cleavage of IMD.  Signaling mediated by 
receptor over-expression was also inhibited by Rudra, but this was not the case for 
signaling induced by over-expression of downstream components.  Together, these data 
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strongly support the notion that Rudra interferes with receptor function and is consistent 
with the association between Rudra and the receptors PGRP-LC or PGRP-LE.
Using assays in yeast, Drosophila, human cells and in vitro, Rudra was shown to 
interact directly with PGRP-LC and PGRP-LE.  The interaction between PGRP-LE and 
Rudra required the RHIM-like domain of PGRP-LE, which is also critical for signaling by 
this receptor.  However, the region through which PGRP-LC interacts with Rudra is less 
clear and likely involves multiple, partly redundant interfaces.  Rudra also interacted 
with the imd protein.  Moreover, Rudra interfered with the interaction between the 
receptor PGRP-LC and IMD, destabilizing the receptor signaling complex.  From these 
results, we propose that Rudra is a negative feedback regulator that down modulates 
the IMD pathway by binding the receptors and interrupting the associations with their 
cognate signaling adaptor IMD.  This regulatory loop is critical to properly regulate the 
immune response.  
In agreement with the data presented here, Kleino et al. (2008) recently reported 
that rudra/CG15678 is a negative regulator of the IMD pathway, although they refer to 
this gene as poor Imd response upon knock-in (pirk). They showed that rudra/ pirk is 
rapidly induced following infection, similar to the data presented here, and further 
demonstrated that rudra induction is dependent on Relish, both in cells and in flies.  
Using reporter assays in S2 cells, they found that Pirk inhibits IMD signaling but not the 
Toll pathway.  With transgenic RNAi fly lines, they also found that knockdown of pirk 
caused the hyper-expression of the antimicrobial peptide genes.  Also, flies over-
expressing Pirk blocked the activation of the IMD pathway and were more susceptible 
infection.  These results are consistent with the data presented here, although we have 
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characterized a mutant allele of rudra and additionally show that this mutant exhibits 
enhanced protection against Erwinia infection. The data presented here also expand on 
the findings of Kleino et al. (2008) by showing that Rudra not only interacts with both 
PGRP-LC and IMD, but also that these interactions with Rudra disrupt the direct 
association between PGRP-LC and IMD.  Kleino et al. (2008) reported that central 
portion of Rudra consists of two repetitive amino acid elements of unknown function and 
structure, which they named the Pirk domain.  The Pirk domain is required for the 
interaction with IMD, but not with PGRP-LC. Rudra does not contain obvious homology 
to any other protein motifs, and no mammalian homologs are readily detected (Kleino et 
al., 2008).
Another recent study also showed that rudra/CG15678 is a negative regulator of 
the IMD pathway, although they refer to this gene as PGRP-LC interacting inhibitor of 
IMD pathway (pims).  Lhocine et al show that PIMS not only down-modulates the 
immune response following systemic infection but it is also required to suppress the 
IMD pathway in response to commensal bacteria.  pims knockdown flies produce AMPs 
in the gut and to some extent in the fat body even in the absence of an infection.  
However, no AMPs are produced when the pims knockdown flies are grown under germ 
free conditions, suggesting that the commensal bacteria trigger constitutive activation of 
the IMD pathway when PIMS is not present.  This study also shows that PIMS interacts 
with the receptor PGRP–LC and leads to the relocalization of the receptor from the 
plasma membrane to perinuclear structures (Lhocine et al., 2008).  However, it is 
unclear if and how PIMS mediates this relocalization.  More experiments need to be 
done to validate this data.
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Recently, multiple mechanisms involved in regulating the Drosophila immune 
response have come to light.  Given that it is well-established that immune activation in 
flies has a cost, such as reduced fecundity (Zerofsky et al., 2005; Flatt et al., 2005) and 
hypersensitivity to infection (Bischoff et al., 2006; Ryu et al., 2008; Kim et al., 2006; 
Gordon et al., 2005; Zaidman-Remy et al., 2006), it is not surprising that multiple 
negative regulatory circuits control the immune response.  Similarly, in mammals, innate 
and adaptive immune responses are held in check by multiple mechanisms, in order to 
prevent inflammatory and autoimmune diseases while at the same time allowing an 
effective response to infection.  Future studies will address the possible negative 
consequences of the lack of proper IMD regulation observed in the rudra mutant 
animals. 
Materials and Methods
Reagents
Insoluble PGN from E. coli was purchased from Invivogen.
Fly stocks and survival experiment
rudra mutant line, EY00723, was originally isolated by the Drosophila Genome 
Project gene disruption consortium and provided by the Bloomington Drosophila Stock 
Center.  The flies were crossed for six generations to a w1118 strain in order to generate 
back-crossed stocks.  In all experiments, rudraEY00723 mutants were compared to back-
crossed w1118 animals.  PGRP-LE112 ;;PGRP-LC∆E, double mutant flies were reported 
previously (Takehana et al., 2004).  Survival experiments were performed with 60 flies 
at 29oC, following infection by pricking in the abdomen with a microsurgery needle 
dipped into a concentrated pellet of Erwinia carotovora carotovora 15 (Zaidman-Remy 
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et al., 2006).  Surviving flies were transferred to fresh vials and counted daily, until all 
wild-type flies died.  Kaplan-Meier plots are presented and P-values were calculated by 
log-rank test using GraphPad Sigma Plot.
RNA analysis and RT-PCR
Total RNA from flies or cultured cells was isolated with the TRIzol reagent 
(Invitrogen) as described previously (Silverman et al., 2000).  Expression of Diptericin, 
Attacin, Cecropin and the control rp49 (ribosomal protein) was analyzed by Northern 
blotting (Silverman et al., 2000).  Northern blots were quantified with a phosphoimager 
(Fuji) and AMP gene expression was normalized to rp49 levels.  For qRT-PCR, RNA 
was DNase treated and re-extracted with phenol-chloroform.  cDNA was synthesized 
using Superscript II (Invitrogen)  and quantitative PCR analysis was performed on a 
DNA engine Opticon 2 cycler (MJ Research, Watertown MA) using SYBR Green 
(Biorad).  The specificity of amplification was assessed for each sample by melting 
curve analysis and relative quantification was performed using a standard curve with 
dilutions of a standard.  The quantified data was normalized to rp49 levels. In all S2*-
based cell experiments, cells were pre-treated with 1 mM 20-hydroxyecdysone for 24 to 
40 hr before treatment with 500 mM CuSO4 and/ or PGN (100 ng/ ml).
RNAi experiments
dsRNA was generated and purified as reported previously (Di Nocera and Dawid, 
1983).  Cells were split 24 hours after transfection to 1.0 ×106/mL and then were treated 
with 1 mM 20-hydroxyecdysone.  After 24 hours, cells were treated (or left untreated) 
with PGN (100 ng/ml) for various time, as indicated. 
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Co-immunoprecipitation and immunoblotting assays
In vitro translation was performed following the protocol of the manufacturer 
(Promega).  Immunoprecipitations were carried out with rabbit anti-T7 (Bethyl labs) in 
lysis buffer (20 mM Tris at pH 7.6, 150 mM NaCl, 2 mM EDTA, 10% Glycerol, 1% Triton 
X-100, 1 mM DTT, NaVO4, glycerol 2-phosphate and protease inhibitors). For 
immunoprecipitation from cells, Schneider S2* cells were first transfected by calcium 
phosphate method with appropriate expression plasmids. Cells were split 24 hours after 
transfection to 1.0 ×106/mL and 24 hours later, were treated with 500 µM copper 
sulphate for 5 hr, when necessary, for expression from the metallothionein promoter.  
Immunoprecipitations were performed in lysis buffer and analyzed by SDS-PAGE 
followed by immunoblot analysis with anti-T7 MAb (Novagen), anti-V5 (Sigma), anti-IMD 
(gift of J.-M. Reichhardt) or anti-Flag (Sigma) antibodies.  Stable cell lines and 
immunoblotting were performed as described previously (Silverman et al., 2000).  The 
generation and characterization of phospho-specific Relish antibody will be detailed 
elsewhere (Erturk-Hasdemir et al., 2009).
Transgenesis and analysis of UAS-rudra and genomic rescue strains
For the UAS transgenic, the rudra ORF was amplified by PCR and subcloned 
into the EcoRI and BglII sites of pUAST.  For genomic rescue, a BAC clone (Drosophila 
Resource Center (Hoskins et al., 2002)) was used as a template to amplify a 4.5 Kbp 
genomic fragment containing the complete rudra locus plus flanking sequences, which 
was then cloned into the EcoRI and BamHI sites of pCaSpeR (Thummel et al., 1988).  
After sequence verification, standard techniques were used for P-element–mediated 
transformation at the MGH Drosophila transgenics facility.  For immune stimulation 
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assays, adults (males and females in equal numbers), were infected by pricking in the 
abdomen with a microsurgery needle dipped into a concentrated pellet of E. coli (1106), 
RNA was extracted 8 h later, and assayed by Northern blotting.
Stable cell lines
The rudra gene was cloned into pRmHa3 vector by standard methods to create 
constructs expressed from the metallothionein promoter. The constructs were then 
transfected into S2* cells in conjunction with pHs-Neo at a ratio of 50:1; stable 
transfectants were then selected with G418 (1 mg/ml). For double stable cell lines, the 
rudra expression plasmid was transfected into S2* cell lines that were previously 
selected to carry plasmids expressing either PGRP-LC, PGRP-LE, IMD or Dredd.  The 
rudra plasmid was selected with a second selectable marker, either G418 (1mg/ ml) or 
hygromycin (20 U/ml), as appropriate. 
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CHAPTER V
RYBP: a new component of the IMD pathway.
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Abstract 
DAP–type peptidoglycan triggers the IMD pathway via PGRP–LC or PGRP–LE, 
while lysine–type peptidoglycan is an agonist for the Toll pathway through PGRP–SA 
and PGRP–SD.  The receptors PGRP–LC and PGRP–LE share a short region of 
homology called the RHIM–like motif in their N terminus, and this motif is critical for 
signaling.  However,the molecular mechanisms by which the RHIM–like motif functions 
to activate IMD signaling remain a mystery.  In this chapter, I show that mutations 
affecting the PGRP–LC RHIM–like motif are defective in all known downstream 
signaling events, including IMD cleavage and ubiquitination,and, Relish cleavage and 
phosphorylation.  However, the RHIM–like mutant receptors are capable of serving as a 
platform for the assembly of all known components of a receptor proximal signaling 
complex.  These results suggest that another, unidentified component of the IMD 
signaling pathway may function to mediate interaction with the RHIM–like motif and I 
have identified a candidate interactor through a yeast two–hybrid screen (See Chapter 
3).  This factor is known as RYBP, it includes a highly conserved ubiquitin binding motif 
(NZF), and RNAi studies suggest that it is a critical component of the IMD pathway.
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Introduction 
Bacterial infections can trigger either the Toll or the IMD pathway, depending on 
the structure of the peptidoglycan (PGN) found in their cell wall.  The Toll signaling 
pathway is most robustly triggered by lysine–type peptidoglycan, while the IMD pathway 
is activated by the DAP–type peptidoglycan (Kaneko et al., 2004; Leulier et al., 2003; 
Mengin-Lecreulx and Lemaitre, 2005; Lemaitre, 2004).  In the IMD pathway, DAP–type 
PGN is detected by PGRP–LC and PGRP–LE (Kaneko et al., 2006; Gottar et al., 2002; 
Choe et al., 2002; Leulier et al., 2003; Ramet et al., 2002; Takehana et al., 2002; 
Takehana et al., 2004).  Double mutants, lacking both PGRP–LC and LE, are unable to 
induce AMPs in response to most Gram–negative bacteria and are highly susceptible to 
these infections (Takehana et al., 2004).  PGRP–LC is a type 2 transmembrane 
receptor, with an extracellular PGRP domain that is critical for recognizing extracellular 
bacteria, while PGRP–LE lacks a transmembrane domain and functions as an 
intracellular receptor for DAP–type PGN (Kaneko et al., 2006).  Binding of polymeric/
monomeric DAP type PGN by PGRP–LC and/or PGRP–LE triggers IMD signaling 
pathway which leads to the activation of the NF–κB precursor protein Relish.  
PGRP–LC and PGRP–LE detect DAP–PGN through their C–terminal PGN–
binding PGRP–domain and transduce signals through their extended N–terminal 
domains (Choe et al., 2005; Kaneko et al., 2006).  PGRP–LC and –LE share 
approximately 50% homology in the their C–terminal PGRP domain but in their N–
termini only a short stretch of about 20 amino acids displays any homology between 
these two receptors.  In both receptors, deletion or mutation within this conserved 
domain abrogates signaling (Kaneko et al., 2006).  This conserved signaling motif has 
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weak homology to the RHIM domain found in the mammalian RIP1 and TRIF proteins.  
In these mammalian NF–κB signaling proteins, the RHIM domain mediates a homotypic 
interaction between them.  Given the weak similarity to the mammalian RHIM domain, 
we refer to this conserved signaling motif in PGRP–LC and PGRP–LE as the RHIM–like 
domain.  The molecular mechanism by which the RHIM–like domains in PGRP–LC 
and–LE function is unclear.  One factor that interacts with both PGRP–LC and –LE is 
IMD, a death domain containing protein with significant similarity to the death domain of 
RIP1 (Aggarwal et al., 2008; Georgel et al., 2001; Choe et al., 2005; Kaneko et al., 
2006).  In the case of PGRP–LE, IMD binding requires the RHIM–like domain and this is  
a possible explanation for the RHIM–like domains function (data not shown).  However 
the association between IMD and PGRP–LC maps to another region, not the RHIM–like 
motif.  Curiously, the IMD interacting region of PGRP–LC does not appear to be critical 
for signaling; it is only the RHIM–like domain that is essential.  Together, these data 
suggest that the RHIM–like domain has a function beyond that of IMD recruitment and 
that direct IMD recruitment to these receptors may not always be necessary for 
signaling.
In this study we show that PGRP–LCx RHIM mutant are unable to activate any of 
the known events downstream of the receptor.  We also show that a receptor proximal 
complex can be assembled on PGRP–LC but is not markedly influenced by the RHIM–
like motif.  In addition, I have also  characterized a new component of the IMD pathway, 
known as RYBP, which may function through the RHIM–like motif.  
RYBP, is an ancronym for Ring and YY1 binding protein  (Garcia et al., 1999) and 
is also referred to as DED–associated Factor (DEDAF) (Zheng et al., 2001) or YEAF1 
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(Sawa et al., 2002).  RYBP belongs to the RYBP/ YAF–2 family of small, basic, NZF–
domain containing ubiquitin binding protein and is highly conserved from invertebrates 
to mammals (Arrigoni et al., 2006).  RYBP was first identified in a yeast two hybrid 
screen as an interacting partner of Polycomb group (PcG) of proteins.  RYBP and YAF–
2 share about 78% homology in their NZF domain and are less similar in there C 
terminal domain.  RYBP interacts with the PcG proteins Ring 1A, Ring 1B and M33, 
these are all components of the PRC1 complex.  The PRC1 multi–protein complex 
functions as transcriptional repressors (Simon and Kingston, 2009).  RYBP and YAF2 
both interact with the transcription factors YY1, E2F6 and hGABP/ E4TF1 and are 
proposed to function as an adaptor protein/ cofactor that recruits PcG.  Though RYBP 
and YAF2 are structurally similar they are functionally distinct.  RYBP mediates 
transcriptional repression and in contrast YAF2 activates transcription.  (Sawa et al., 
2002; Schlisio et al., 2002).  Available data also suggests that RYBP binds ubiquitnated 
H2A and this ubiquitnated H2A is important for PcG mediated gene silencing (Arrigoni et 
al., 2006).
In addition to its role in transcriptional repression RYBP is also implicated in 
promoting apoptosis.  RYBP interacts with various death effector domain (DED) 
containing proteins like DED–containing DNA–binding protein (DEDD), FADD and pro–
caspase 8 and 10 (Zheng et al., 2001).  DEDD is a nucleolar protein and it promotes 
apoptosis both in the nucleolus and in the cytoplasm.  RYBP promotes the formation of 
the death inducing signaling complex composed of Fas, FADD and procaspase 8 in 
293T cells and it also enhances Fas and caspase 10 DED–mediated apoptosis in 
lymphoma cell lines.  In contrast to RYBP data in zebrafish suggests that YAF2 inhibits 
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apoptosis and functions as a survival factor during early zebrafish development and 
embryogenesis (Stanton et al., 2006).  RYBP has also been shown to interact with the 
viral proteins Apoptin and Hippi and both these proteins are also pro–apoptotic (Stanton 
et al., 2007; Danen-van Oorschot et al., 2004).
RYBP deficient mice die around embryonic day (E) 5.5– 6.0 and lack the normal 
apoptotic responses that accompany implantation.  And RYBP heterozygous null mice 
exhibit an ex encephalic phenotype because of disrupted neural tube closure (Pirity et 
al., 2007).  The neural phenotypes observed with RYBP heterozygous mice are similar 
to those observed with caspase 3, 9 or apaf1 heterozygous null mice (Lossi and 
Merighi, 2003).
The Drosophila RYBP is a 150 amino acid protein and is expressed maternally 
and ubiquitously throughout development (Bejarano et al., 2005).  dRYBP protein 
behaves like a Polycomb dependent transcriptional repressor throughout development.  
Over–expressed dRYBP produces homeotic like phenotypes that can be repressed by 
mutations in PcG/ trxG genes.  However, dRYBP loss–of–function mutant phenotypes 
are variable both in their expression and penetrance.  dRYBP mutation results in many 
defects including, progressive lethality during development, defects in morphogenesis, 
reduced size of wing and cell differentiation defects (Gonzalez et al., 2008). These 
findings have been interpreted to suggest that dRYBP functions together with the PcG  
proteins.  Whether this model is correct or not is not yet clear, and certainly the 
molecular function of RYBP is very opaque.  One obvious possibility, due to its highly 
conserved NZF domain, is that RYBP functions through ubiquitin binding.
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Like the mammalian RYBP Drosophila protein is also suggested to have pro–
apoptotic phenotype.  Over–expression of dRYBP induces apoptosis in the imaginal 
discs and this death depends on the pro– apoptotic genes reaper, hid and grim.  Also, 
dRYBP induced apoptosis is dependent on FADD and DREDD which are not 
components of the canonical apoptosis pathway.  However, no apoptosis related 
phenotype is observed with dRYBP mutant flies (Gonzalez and Busturia, 2009).  The 
role of DREDD and FADD in the RYBP–induced death suggested to us that the IMD 
pathway may be involved.  In fact, hyper–activation of the IMD pathway is known to 
induce cell death, probably through the JNK pathway (Georgel et al., 2001).  In our 
present study, we identified a new component of the IMD pathway called dRYBP 
through a yeast two hybrid screen.  We show that dRYBP is critical for IMD signaling in 
S2* cells; knockdown of dRYBP abrogates IMD signaling.  Also, dRYBP interacts with 
the receptor PGRP–LC through the IMD interaction domain and the RHIM– like domain.
Results
PGRP–LCx RHIM mutants fail to activate any downstream event 
Various PGR–LCx over–expressing cell lines were used to determine the 
molecular mechanism(s) that are not initiated by the PGRP–LC RHIM like mutants.  
Over–expression of wild– type PGRP–LCx is sufficient to activate IMD pathway, as 
assayed by AMP induction, while over–expressed PGRP–LCx RHIM mutants are 
inactive (Kaneko et al., 2006)(Chapter 2).  The PGRP–LC RHIM–like mutants must fail 
to initiate some events in the IMD pathway that results in failure of induction of AMPs 
like Diptericin.  Therefore, series of biochemical assays were done to determine the 
events of IMD pathway that fail to initiate when the PGRP–LC RHIM–like mutants are 
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over–expressed.  Recently, work by our lab shows that imd protein is rapidly cleaved 
following immune stimulation (Paquette et al., 2010), and the data in Figure 5.1a shows 
similar result that over–expression of wild type PGRP–LC leads to the cleavage of IMD.  
However, the , PGRP–LC RHIM–like mutants fail to cleave IMD (Figure 5.1a).  Relish, 
the NF–κB precursor protein essential for IMD triggered gene expression, is regulated 
by immune–induced cleavage and phosphorylation (Stöven et al., 2000; Stöven et al., 
2003; Erturk-Hasdemir et al., 2009) and over–expressed wild type PGRP–LC similarly 
drives Relish cleavage and phosphorylation.  On the other hand, PGRP–LC RHIM–like 
mutants fail to cleave and phosphorylate Relish (Figure 5.1a).  Together, these results 
indicate that PGRP–LC RHIM–like mutants possibly fail to activate all molecular events 
downstream of the receptor, suggesting they are deficient in one or more essential 
signaling activities that must occur immediately downstream of the receptor.  
In transient transfection/co–immunoprecipitation assays, IMD interacts with both 
PGRP–LC and –LE. In the case of PGRP–LE, IMD binding requires the RHIM–like 
domain (data not shown), while the association between over–expressed IMD and 
PGRP–LC is not mediated by the RHIM–like domain but maps to another distinct region 
(Kaneko et al., 2006) (Chapter 2).  I next sought to examine the association of PGRP–
LC, wild type and RHIM–like mutant, with endogenously expressed IMD.  Note, I have 
access to an excellent IMD antisera that easily detects endogenous IMD, but no useful 
PGRP–LC antibody is available.  Therefore, I used stably transfected cell lines that 
express various PGRP–LC genes, wild type and mutant, from the copper–inducible 
metallothionein promoter.  The analysis of the interaction of endogenous IMD and 
PGRP–LC revealed a different finding, as compared to the above mentioned studies 
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with transient transfection, over–expression of both PGRP–LC and IMD.  In particular, 
we find that IMD interacts robustly with wild type PGRP–LC but weakly with the RHIM–
like mutants.  Also the PGRP–LC lacking the IMD interaction domain interacts weakly 
with IMD (Figure 5.1a).  This result suggest that the transient transfection experiments 
may be misleading, and that the RHIM–like motif may have an important role recruiting/ 
binding IMD.  In addition the IMD interaction domain may also have a role in IMD 
interaction.
Signaling pathways often rely on the transient assembly of large multiprotein 
signaling complexes on the cytosolic domains of activated receptors–so called receptor 
proximal signaling complexes (Micheau and Tschopp, 2003).  The assembly of these 
signaling hubs relies on post translational modification and one such modification is 
ubiquitination.  Ubiquitination plays an important role in mammalian TNF–R1 and TLR 
signaling (Bianchi and Meier, 2009; Haas et al., 2009).  Recent work by our lab shows 
that IMD is K63–ubiquitinated in a signal–dependent manner and this is important for 
signaling by the IMD pathway.  IMD is also ubiquitnated when the IMD pathway is 
activated by over–expressing the receptor PGRP–LCx but the PGRP–LC RHIM–like 
mutants fail to ubiquitinate IMD (Figure 5.1b).  Surprisingly, the ∆3 mutant also failed to 
drive robust IMD ubiquitination.  This is perhaps expected, because ∆3 interacts poorly 
(or not at all) with IMD, however it is capable of inducing AMP gene expression.
To date, receptor associated polyubiquitin has not been examined..  For this, I 
performed an immunoprecipitation of PGRP–LC from stable cell lines over expressing 
the receptor both the wild type and RHIM–like mutant and probed for ubiquitination.  
PGRP–LC co–precepitated as a highly ubiquitinated protein and RHIM–like mutants 
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(∆5, ∆6, F218A) failed to coprecipitate with polyubiquitin.  On the other hand, ∆3 mutant, 
which lacks the IMD–interaction domain precipitated a robust polyubiquitin signal, even 
more robust then wild type.  Another deletion mutant, ∆1, with strong signaling activity 
and no known deficiencies, was also associated with a robust ubiquitin signal.  This 
data suggests that either the receptor itself gets ubiquitinated or it associates with a 
protein that is ubiquitinated.  However, this ubiquitinated protein cannot be IMD because 
no IMD ubiquitination is observed in stable cells over–expressing PGRP–LC ∆3 Thus, 
the receptor associated ubiquitin most closely correlates with the signaling activity, or 
lack thereof, observed in various PGRP–LC forms and may be key to understanding the 
molecular mechanisms underlying receptor–mediated signal transduction.  
A receptor proximal complex is assembled when components of the IMD pathway 
are over–expressed
In the TNFR–1 signaling pathway it is well established that a receptor proximal 
complex(es) is assembled following ligand binding, and this complex is critical for 
signaling (Micheau and Tschopp, 2003).  To test if a receptor proximal complex is also 
assembled in the case of the IMD pathway co–immunoprecipitation experiments were 
performed.  In this experiment, wild–type receptor PGRP–LCx was co– transiently 
transfected with various components of a putative receptor proximal complex – IMD, 
FADD and DREDD.  PGRP–LCx interacted with IMD and FADD and a very weak 
interaction was observed with DREDD.  The interaction of PGRP–LCx with DREDD was 
weak even when IMD or FADD were included in the transient co–transfection.  However 
the interaction between DREDD and PGRP–LCx was markedly increased when both 
IMD and FADD were included (Figure 5.2a).  This data suggests that a receptor
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Figure 5.1:  PGRP–LCx RHIM mutants fail to activate any downstream event 
(a) Analysis of lysates from S2* cells stably transfected with a metallothionein promoter plasmid 
expressing T7–tagged wild–type or mutant PGRP–LC, with or without treatment with CuSO4 as 
indicated.  IMD cleavage, Relish phosphorylation and cleavage were analyzed by 
immunoblotting.  The asterisk marks heavy chain detected by the secondary antibody.  The 
lowest panel confirms PGRP–LCx expression with anti–T7 IP– IB.  IMD interaction with PGRP–
LC was monitored by IP–IB analysis.  (b)  IP– IB analysis of the ubiquitination status of 
endogenous IMD from S2* cells stably transfected with metallothionein promoter expression 
plasmids encoding T7–tagged PGRP–LCx (wild–type and deletion mutants) with or without 
CuSO4 treatment, as indicated.  (c)  IP– IB analysis of the ubiquitination status of 
immunoprecipitated receptor from S2* cells stably transfected with metallothionein promoter 
expression plasmids encoding T7–tagged PGRP–LCx (wild–type and deletion mutants) with or 
without CuSO4 treatment, as indicated. Lower diagram indicates the regions deleted in each 
mutant form of PGRP–LC.
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Figure 5.2:  A receptor proximal complex is assembled when components of the IMD 
pathway are over– expressed.
(a) IP–IB analysis of lysates of S2* cells transiently transfected with metallothionein promoter 
plasmid expressing T7–tagged PGRP–LCx, FLAG–tagged imd, FLAG–tagged dFADD and V5 
tagged DREDD.  DREDD is recruited to the receptor PGRP–LC in a FADD and IMD 
dependent manner.
(b) Similar co–immunoprecipitation experiments from lysates of S2* cells transiently 
transfected with metallothionein promoter plasmid expressing T7–tagged PGRP–LCx or 
various PGRP–LCx mutants.  DREDD is recruited normally even to the PGRP–LC RHIM–like 
mutants.
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proximal complex, including the caspase–8 like DREDD, is assembled when the 
receptor and all the known components of the receptor proximal complex are all 
expressed together.  More experiments are required to establish if a similar receptor 
proximal complex is assembled under physiological conditions.  Surprisingly, receptors 
lacking the RHIM–like motif were able to productively assemble this receptor proximal 
complex, at least to the level I was able to monitor in these rather crude assays.  
Likewise, the ∆3 mutant, which fails to interact with IMD in a binary co–transfection 
assays, was also able to assemble this receptor proximal complex.  Only double 
mutants, which lacked both the RHIM–like motif and ∆3 region, failed in this receptor 
proximal complex assay (Figure 5.2b).
RYBP interacts with the receptor PGRP–LC and it is a new component of the IMD 
pathway 
Given that the RHIM–like mutants displayed nearly normal assembly of this 
receptor proximal complex and the receptor–associated ubiquitination is altered, the 
RHIM–like motif may function through an unidentified protein that is involved in this 
ubiquitination event.  In order to identify potential partners and regulators of the IMD 
pathway receptors, a yeast two–hybrid screen was performed with the cytoplasmic 
domain of PGRP–LC as bait (Chapter 3).  The 24 most strongly interacting clones were 
further analyzed with a set of baits that carried mutations in the RHIM–like domain of 
PGRP–LC (or irrelevant control baits), as detailed in Chapter 3.  One clone interacted 
strongly with the wild–type cytoplasmic domain of PGRP–LC but very weakly with the 
RHIM–like mutant baits (Table 3.1).  This clone encoded for a gene called RYBP. 
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Figure 5.3:  RYBP interacts with the receptor PGRP–LC and it is a new component of the 
IMD pathway 
(a) IP–IB analysis of lysates of S2* cells transiently transfected with metallothionein promoter 
plasmid expressing T7–tagged PGRP–LCx (wildtype and mutant), and FLAG–tagged RYBP.  
RYBP fails to interact with the receptor that lacks both the IMD interaction domain and RHIM– 
like domain.  (b) Northern blot of Diptericn and rp49 expression in S2* cells treated with lacZ 
dsRNA or two different Rudra dsRNA, and then stimulated with PGN for 6 hours.
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To confirm the yeast two–hybrid results, co–immunoprecipitation experiments 
were performed.  Using epitope tagged constructs and transient transfection in 
Drosophila S2* cells, both PGRP–LC and PGRP–LE were found to associate with 
RYBP (Figure 5.3a and data not shown).  In order to determine which domain(s) of 
the receptors are required for interaction with RYBP, co–immunoprecipitation assays 
were performed with various mutant versions of PGRP–LC.  Removal of the IMD 
interaction domain (∆3) or the RHIM–like domain (∆5, ∆6) alone did not abrogate the 
interaction of RYBP with the receptor PGRP–LC.  However, when both the IMD 
interaction domain and the RHIM–like domain were mutated (∆3∆6, ∆3F218A) RYBP 
failed to interact with the receptor (Figure 5.3a).  Overall, we conclude that RYBP 
interacts with the receptors PGRP–LC and PGRP–LE.  The interaction with PGRP–LC 
is mediated by the IMD interaction domain and the RHIM motif, in a redundant manner.  
These results may suggest that RYBP interacts with two different motifs of PGRP–LC, 
or it may indicate that RYBP interacts by direct and indirect mechanisms.
Next, RNAi was used to characterize the function of RYBP in the IMD pathway.  
S2* cells were transfected with two different dsRNA for RYBP, and then stimulated with 
PGN for 6 hours.  Knockdown of RYBP by RNAi markedly inhibited Diptericin induction 
almost to the level seen with knockdown of various components of the IMD pathway like 
PGRP–LC (Figure 5.3b).  These data suggest that RYBP is a new component of the 
IMD pathway and is important for signaling in S2* cells. 
Discussions
In the last few years we have advanced our understanding about the molecular 
events that take place in the cytoplasm when the IMD pathway is activated (Aggarwal 
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and Silverman, 2008; Lemaitre and Hoffmann, 2007; Paquette et al 2010).  However, 
we still lack a clear understanding of the events that take place at the receptor.  Our 
earlier work showed that the receptors PGRP–LC and PGRP–LE share a short region 
of homology called the RHIM– like motif in there N terminal domains, and this motif is 
essential for signaling, in cells and in animals.  However, it is unclear how this RHIM–
like motif functions to support signaling (Kaneko et al., 2006).  In this study, we now 
show that the RHIM–motif seems to be critical for all previously characterized molecular 
events downstream of PGRP–LC, including IMD cleavage, ubiquitination and Relish 
activation consistent with the severe defects observed at the level of AMP gene 
induction.  
However, the role of the RHIM–like motif in the association of the receptor with 
various downstream components is less clear.  Based on over–expression (transient 
transfection co–immunoprecipitation) assays, the RHIM–like motif is not critical for the 
association of PGRP–LC and IMD.  Instead this association involves the ‘IMD 
interaction domain’, defined by ∆3.  The RHIM–like motif is also not essential for the 
formation of a receptor proximal complex containing PGRP–LC, IMD, FADD, and 
DREDD.  On the other hand, the endogenously expressed IMD appears to interact 
much more weakly with the RHIM–deficient PGRP–LCs.  This lack of interaction with 
endogenous IMD is also observed with the ∆3 mutant, and together, this may suggest 
redundant mechanisms are involved in recruiting IMD to PGRP–LC.  The weak 
association of endogenous IMD and the RHIM–mutant receptors is consistent with the 
greatly diminished signaling capacity of these mutants. Interestingly, I also discovered 
that PGRP–LC may be ubiquitinated and this modification correlates with the presence 
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of the RHIM–like motif.  Clearly, the receptor ubiquitination data presented here does 
not differentiate between direction conjugation of ubiquitin to PGRP–LC and the 
association with another ubiquitinated protein.  However, if the later is the case, it does 
not appear to IMD that is responsible for the ubiquitin signal associating with PGRP–LC. 
Further experiments are necessary to discriminate between these possibilities.  Also, 
given the lack of antibody reagents, I have so far been able to examine only over–
expressed PGRP–LC for this ubiquitin modification/association.
Most notable is the fact that this receptor–associated ubiquitin correlates best 
with the signaling activities of various PGRP–LC mutants.  While the ∆3 receptor signals  
near normal levels in cells and in flies, even in response to infection, it showed defects 
in IMD association, IMD cleavage, IMD ubiquitination, and Relish ubiquitination.  
Sometimes these defects were not as severe as that observed with the RHIM–like 
mutant receptors, but clearly this mutant has some defects in inducing all these 
molecular events.  On the other, receptor associated ubiquitin was more robust with the 
∆3 receptor while it was completely abrogated with the RHIM–like mutants, ∆5, ∆6 and 
F218A.  This robust receptor associated ubiquitination may explain the ability of ∆3 to 
support signaling, while the RHIM mutants are inactive.  We hypothesize that this 
receptor associated ubiquitin may provide a platform for the signaling complex to be 
assembled and trigger sufficient signaling to activate AMP gene expression.  In the case 
of the RHIM–like mutant receptors, no ubiquitination is observed–neither associated 
with IMD nor associated with the receptor and  PGRP–LC RHIM mutant is unable to 
signal.  Further support for this hypothesis is provided by the finding that even though 
PGRP–LC ∆3 does not bind IMD, cleaved and phosphorylated Relish can still be 
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detected albeit at levels lower then observed wtih wild– type PGRP–LC.  However, 
more experiments need to be done to explore this possibility. .
Additionally a new component of the IMD pathway called RYBP was also 
identified.  RYBP interacts with both the receptors PGRP–LE and PGRP–LC and its 
interaction with PGRP–LC is mediated through the IMD interaction domain and the 
RHIM– like motif, in a redundant manner.  This redundancy may be because RYBP 
interacts with two different motifs of PGRP–LC, or it may indicate that RYBP interacts by 
direct and indirect mechanisms.  One possibility is that RYBP interacts with another 
component of the IMD pathway which in turn interacts with the receptor.  Mammalian 
RYBP is known to interact with proteins containing a DED domain.  Thus,RYBP might 
interact with FADD and DREDD as they both contain a DED domain and preliminary 
data suggests that RYBP interacts with DREDD.  Knock–down of RYBP in S2* cells 
inhibits IMD signaling.  RYBP is a new regulator of the IMD pathway and it may do so by 
interacting with the RHIM domain of PGRP–LC.  The presence of a NZF domain in the 
N terminal of RYBP suggests that it is a ubiquitin binding receptor.  A better 
understanding about the role of RYBP in IMD signaling might provide some insights into 
the receptor proximal events.  
Methods
RNA analysis
Total RNA from flies or cultured cells was isolated with the TRIzol reagent 
(Invitrogen) as described previously (Silverman et al., 2000).  Expression of Diptericin 
and the control rp49 (ribosomal protein) was analyzed by Northern blotting (Silverman 
et al., 2000).  In all S2*–based cell experiments, cells were pre–treated with 1 mM 20–
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hydroxyecdysone for 24 to 40 hr before treatment with 500 mM CuSO4 and/ or PGN 
(100 ng/ ml).
RNAi experiments
dsRNA was generated and purified as reported previously (Di Nocera and Dawid, 
1983).  Cells were split 24 hours after transfection to 1.0 ×106/mL and then were treated 
with 1 mM 20–hydroxyecdysone.  After 24 hours, cells were treated (or left untreated) 
with PGN (100 ng/ml) for approximately 6 hours.
Co–immunoprecipitation and immunoblotting assays
Immunoprecipitations were carried out with rabbit anti–T7 (Bethyl labs) in lysis 
buffer (20 mM Tris at pH 7.6, 150 mM NaCl, 2 mM EDTA, 10% Glycerol, 1% Triton X–
100, 1 mM DTT, NaVO4, glycerol 2–phosphate and protease inhibitors).  For 
immunoprecipitation from cells, Schneider S2* cells were first transfected by calcium 
phosphate method with appropriate expression plasmids.  Cells were split 24 hours 
after transfection to 1.0 ×106/mL and 24 hours later, were treated with 500 µM copper 
sulphate for 5 hr, when necessary, for expression from the metallothionein promoter.  
Immunoprecipitations were performed in lysis buffer and analyzed by SDS–PAGE 
followed by immunoblot analysis with anti–T7 MAb (Novagen), anti–IMD (gift of J.–M. 
Reichhardt), anti ankyrin, anti V5 (Sigma) or anti–Flag (Sigma) antibodies.  Stable cell 
lines and immunoblotting were performed as described previously (Silverman et al., 
2000).
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CHAPTER VI
DISCUSSION: 
Speculations on the regulation of IMD pathway via the RHIM–like motif and the 
connection with ubiquitination
147
Overview
This thesis research has focused on understanding the molecular mechanisms of 
innate immune signal transduction in the Drosophila IMD pathway.  This work 
demonstrates that receptors PGRP–LC and –LE both recognize DAP type PGN and full 
length PGRP–LE acts as an intracellular receptor for monomeric PGN.  Microarray data 
suggests that PGRP-LE is expressed in all barrier and immune competent tissues in 
larvae and adults suggesting that it is critical for recognition of intracellular DAP type 
PGN (Chintapalli et al., 2007).  Additionally, we show that PGRP–LC and PGRP–LE 
signal through a RHIM–like motif (Chapter 2).  In this work, we also characterize two 
new members of the IMD pathway.  RYBP is a  new component of the IMD pathway and 
Rudra is a feedback negative regulator of the IMD pathway (Chapter 4 and 5).
As a whole, the work presented in this thesis adds more detail to the molecular 
events that take place proximal to the receptor (Figure 6.1).  Binding of PGN by the 
receptors PGRP–LC and LE activates downstream signaling.  I hypothesize that PGN–
induced receptor clustering or multimerization then activates downstream signaling.  
The RHIM–like motif of these two receptors is very important for this activation.  No 
downstream signaling events are initiated when the RHIM–like motif is mutated or 
deleted.  However, the RHIM–like mutant receptors are capable of serving as a platform 
for the assembly of all known components of a receptor proximal signaling complex.  
These results suggest that another, unidentified component of the IMD signaling 
pathway may function to mediate the function of , and perhaps interact with, the RHIM–
like motif. 
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Figure 6.1 Comprehensive IMD signaling pathway model
A comprehensive model of IMD pathway signaling as described in the text.
A yeast two–hybrid screen was performed to identify proteins that might interact 
with the receptor PGRP–LC through its RHIM–like domain (Chapter 3).  With this 
approach, two new components of the IMD pathway were identified.  The first 
component I characterized is called Rudra and it is a critical feedback inhibitor of 
peptidoglycan receptor signaling.  The other factor is known as RYBP, it includes a 
highly conserved ubiquitin binding motif (NZF), and RNAi studies suggest it is a critical 
component of the IMD pathway.  Further characterization of this protein might shed light 
on how the RHIM–like motif of PGRP–LC regulates the IMD pathway.  
Receptor activation leads to the cleavage of IMD.  Cleavage of IMD allows it to 
interact with the E3 ligase DIAP2.  In concert with the E2 conjugating enzymes, Uev1a, 
Bendless and Effete, IMD is then K63–polyubiquitinated.  In a manner similar to that 
seen in mammalian NF–κB signaling, it is then proposed that this K63–polyubiquitin 
chain acts as a scaffold for recruitment and activation of the downstream kinase TAK1.  
TAK1 then activates two different arms of the IMD pathway: the JNK and the NF–κB 
arms (Takaesu et al., 2001; Jiang et al., 2002; Wang et al., 2001; Sakurai et al., 2000; 
Kishimoto et al., 2000; Xia et al., 2009).
Recent work from our lab has exemplified the importance of ubiquitination in 
regulation of the IMD pathway, hence I provide a small overview of ubiquitination before 
proceeding to discuss my work (Paquette et al., 2010). 
Ubiquitination
Ubiquitin is a highly conserved 76 amino acid polypeptide and it is best characterized 
for its role in protein degradation.  However, a recent body of literature provides ample 
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evidence that ubiquitination is a critical regulator of cellular functions like chromatin 
dynamics, membrane trafficking, DNA repair, and protein kinase activation, independent
of its role in protein turnover (Chen and Sun, 2009; Pickart, 2004; Bianchi and Meier, 
2009; Hershko, 1983).  
The ubiquitin molecule itself has 7 lysine residues that can act as acceptor sites 
for the conjugation with additional ubiquitin molecules leading to ubiquitin polymers.  
The two most well studied ubiquitin polymers are K48 and K63.  In addition, recently it 
has been demonstrated that ubiquitin can also form linear chains, where one ubiquitin is 
conjugated to the next in a classic peptide–bond connecting the N–termini of one 
ubiquitin to the C–terminus of another (Tokunaga et al., 2009; Xu et al., 2009b; Hoeller 
et al., 2006).  K48–linked polyubiquitin chains promote protein degradation, by directing 
polyubiquitinated proteins to the proteasome.  On the other hand, K63–linked 
polyubiquitin chains are not linked to proteasomal degradation and is thought to function 
by serving as a scaffold in various biological contexts.  Recent work by Xu et al. 
provides evidence for the existence of free K63 chains that are not conjugated to a 
target protein and these unanchored chains are also serve as a scaffold in TLR 
signaling (Xia et al., 2009).  Similarly linear chains are also thought to function as scaffold 
for the regulation IL-1 and TNF signaling (Rahighi et al., 2009) (Haas et al., 2009).
The conjugation of ubiquitin is a three step process.  The first step involves the 
ubiquitin activating enzyme (E1) that binds to the processed ubiquitin via a thioester 
bond between the active cysteine of the E1 and the C–terminal glycine of the ubiquitin 
moiety.  This ‘activated’ ubiquitin is then transferred to a ubiquitin conjugating enzyme 
(E2) via the formation of another thioester bond.  Lastly the ubiquitin protein ligase (E3) 
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transfers the ubiquitin molecule from E2 to the lysine residue of the substrate.  The E3 
determines the substrate specificity, through its protein–target binding activity.  However, 
it is usually the E2 that determines what kind of ubiquitin chains will be added (Jin et al., 
2008; Kirkpatrick et al., 2006; Hofmann and Pickart, 1999; Windheim et al., 2008; Ye 
and Rape, 2009).  
Ubiquitin receptors recognize ubiquitinated proteins and recruit/ link them to 
downstream processes (Hoeller et al., 2006; Dikic et al., 2009).  All ubiquitin receptors 
have a small ubiquitin binding domain (UBD) which often detect distinct ubiquitin 
linkages.  For example, TAB2 contains a zinc finger type UBD called an NZF that 
specifically binds K63 polyubiquitin chains (Kulathu et al., 2009; Sato et al., 2009).  In 
contrast NEMO contains two UBD domains, a coiled–coil UBD called UBAN that 
specifically binds linear polyubiquitin chains and a zing finger type UBD that binds K63 
polyubiquitin chains (Laplantine et al., 2009; Lo et al., 2009; Komander et al., 2009; 
Yoshikawa et al., 2009).
Ubiquitination Regulates Innate Immune Signaling 
One of the pathways most well studied in the context of polyubiquitination is the 
TNF signaling pathway.  The most popular model of TNF signaling is that the TNF 
receptor upon activation leads to the recruitment of the adaptor protein TRADD, the E3 
ligases TRAF2, TRAF5, cIAP1 and cIAP2 and the kinase RIP1 (Micheau and Tschopp, 
2003).  RIP1, once recruited to the receptor, is K63–polyubiquitinated. by the E2 
enzymes Ubc13/ Uev1a and the E3 ligase TRAF2 (Ea et al., 2006; Li et al., 2006; Wertz 
et al., 2004; Newton et al., 2008).  The Ub chains on RIP1 then recruit TAK1 via the Ub 
receptor TAB2/ TAB3 and IKK complex via the Ub receptor NEMO.  The UBD domains 
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of both TAB2 and NEMO bind K63 polyubiquitin.  Once recruited to the scaffold, TAK1 
activates IKKβ which in turn phosphorylates IκB and targets it for K48 –linked 
polyubiquitination and proteasome–mediated degradation (Xu et al., 2009a)(Rothwarf et 
al., 1998; Mercurio et al., 1997; Zandi et al., 1997; Hacker and Karin, 2006; Chen et al., 
1996).  Degradation of IκB liberates NF–κB and leads to its translocation into the 
nucleus and activation of target gene transcription . 
Although the above mentioned model is a widely accepted model for TNF 
signaling, recent data challenges this model and suggest a different scenario.  Data 
from various groups suggests that that TRAF2 may play only a minor role as the E3 
ligase for RIP1.  Instead, TRAF2 seems to play a critical role as an adaptor linking 
cIAP1/2 to the TNFR complex, and these, in turn, functions as the E3 ligase in the TNF–
induced RIP1 K63–polyubiquitination reaction (Wu et al., 2007; Bertrand et al., 2008).  
cIAPs can bind to several different E2s like Ubc13/ Uev1 and UbcH5 and hence it is 
unclear which kind of polyubiquitin chains it synthesizes (Yang and Du, 2004; 
Varfolomeev et al., 2008).  Also, results from several groups suggest that K63 
polyubiquitin chains generated by Ubc13 are not required for TNF signaling, instead 
polyubiquitin chains generated by Ubc5 are required for IKK activation (Rahighi et al., 
2009; Tokunaga et al., 2009; Xu et al., 2009a).  The identity of these non–K63 
polyubiquitin chains is unclear, however linear ubiquitin chains are the leading 
candidate.
Several pieces of data support the possibility that linear chains are critical for 
TNF signaling.  First, NEMO binds linear chains with much higher efficiency as 
compared to K63 polyubiquitin chains (Rahighi et al., 2009).  Secondly, NEMO mutants 
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that fail to bind linear Ub are unable to complement NEMO knockout cells.  Finally, 
NEMO also gets conjugated with linear polyubiquitin.  The only E3 ligase known to 
generate linear chains is LUBAC (Linear Ub Assembly Complex) and it is composed of 
two RING finger proteins: HOIL–1L (heme–oxidized iron–regulatory protein 2 ubiquitin 
ligase 1) and HOIP (HOIL–1L–interacting protein) (Kirisako et al., 2006).  LUBAC can 
interact with several different E2 enzymes like UbcH5, E2–25K and UbcH10 to 
generates linear chains.  This data suggests that the E3 ligase rather than the E2  
enzyme determines linear polyubuqiutin chain synthesis (Kirisako et al., 2006; Haas et 
al., 2009).
A new working model for TNF–R1 suggests that the activated receptor recruits 
the adaptors TRADD and TRAF2 which in turn recruit the E3 ligase cIAP1/2.  cIAP then 
K63 ubiquitnates itself and RIP1 and maybe other components of this complex.  The 
K63 polyubiquitination leads to the recruitment of TAK1/TAB2/TAB3, NEMO/IKKα/IKKβ.  
LUBAC is also recruited to this scaffold through the UBD (NZF type) of HOIP.  Once 
recruited, LUBAC adds linear ubiquitin chains to NEMO and maybe other components 
(Haas et al., 2009).  These linear chains significantly stabilize the complex, which in turn 
leads to the activation of the downstream events. 
The role of ubiquitin in TNF signaling is complicated, but IL–1β signaling may 
provide a more simple example of the role of ubiquitin in NF–κB signaling.  Stimulation 
of cells with IL–1 leads to the recruitment of IRAK1 and IRAK4 to the IL–1R complex, 
which in turn recruit TRAF6.  TRAF6 is an E3 ligase, which in conjunction with the E2 
enzymes Uev1a/ Ubc13, mediates K63 polyubiquitination of target proteins including 
NEMO, IRAK and TRAF6 itself.  The K63 polyubiquitin chains provides a scaffold for the 
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recruitment of the Ub receptor TAB2/ TAB3 which lead to the recruitment and auto 
phosphorylation of TAK1.  IKK?/ IKKβ are also recruited to the scaffold via the ubiquitin 
receptor NEMO.  Possibly the proximity of IKKβ and TAK1 allows TAK1 to 
phosphorylate and activate IKK.  TAK1 also phosphorylates MKK4/7 which in turn 
activate the JNK and p38 kinase cascade (Chen, 2005; Rowe et al., 2006).  Unlike the 
TNFR pathway, K63 ubiquitin chains are essential for IL–1R signaling (Xu et al., 2009a).
The simple view of IL–1 signaling may not hold for very long as recent reports 
suggest that other kinds of ubiquitin chains also regulate this pathway.  Available data 
suggests that NEMO gets conjugated to linear ubiquitin and this is important for its 
ability to activate NF–κB and not the MAPK pathway (Tokunaga et al., 2009).  The role 
of linear chains in IL–1 signaling is controversial as recent work by Xu et al shows that 
only K63 polyubiquitination is essential for IKK activation.  Interestingly work by Chen 
and colleagues also suggests that unanchored K63 polyubiquitin chains, which are not 
conjugated to any target protein, are enough to activate TAK1 and NF–κB signaling.  
Recruitment of TAK1 to free K63 polyubiquitin through TAB2 leads to its 
autophosphorylation and hence activation. 
Though a lot is known about the role of polyubiquitination in the regulation of NF–
κB signaling a number of questions still remain.  First, it is still unclear which kind of 
linkages are involved in the regulation of TNF and IL–1 signaling.  The role of K63, 
linear and mixed linkages in each pathway is unclear.  Second, what are the 
components of the two pathways that are ubiquitinated, which specific conjugation 
targets, if any, are critical for signaling?.  Following stimulation, TNFR–1 and TRADD 
migrate as higher weight proteins and it is speculated that they get also ubiquitinated, 
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but no one has tested this hypothesis directly.  Third it is unclear what kind of 
polyubiquitin chains cIAP synthesizes under physiological conditions as it has the ability 
to interact with different E2s.  Fourth the specificity of all the ubiquitin receptors is 
unclear.  TAB2 specifically binds K63 polyubiquitin chains but the specificity of NEMO is 
still unresolved.  Additionally recent work by some groups suggest that K63–
polyubiquitination is not important for TNF signaling.  Therefore, it is unclear how TAB2 
functions as a ubiquitin receptor in TNF signaling.
Analysis of the role of ubiquitination in a less complex model system like 
Drosophila may help address some of the above questions.  The IMD signaling pathway 
provides an ideal platform for these studies.  Even though the receptor PGRP–LC is not 
homologous to TLRs, other components of the IMD pathway are conserved.  Also, the 
signaling components downstream of the receptor PGRP–LC share homology to both 
the MyD88–independent TLR signaling pathway and TNFR pathway.
Regulation of IMD signaling via the RHIM–like motif
PGRP–LC and PGRP–LE detect DAP–PGN through their C–terminal PGN–
binding PGRP domain and transduce signaling through their extended N–terminal 
domains (Choe et al., 2005; Kaneko et al., 2006).  PGRP–LC and LE share 
approximately 50% homology in the their C–terminal PGRP domain but there is only a 
short stretch of about 20 amino acids that is homologous in the N–terminal domains of 
PGRP–LC and –LE.  In both receptors, deletion or mutation within this conserved 
domain abrogates signaling (Figure 2.7).  This conserved signaling motif shows weak 
homology to the RHIM domain found in the mammalian RIP and TRIF proteins, which 
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mediates homotypic interactions between them.  The molecular mechanism by which 
the RHIM–like domains in PGRP–LC function is unclear.  
The receptor PGRP–LC interacts with the downstream protein IMD.  However, 
the interaction between IMD and PGRP–LC, which is detected in transfection 
experiments, does not map to the RHIM–like domain but maps to another distinct region 
(∆3) (Figure 2.9a).  Our data suggests that the IMD interaction domain of PGRP–LC is 
not important for signaling as flies expressing PGRP–LC∆3 are able support E.coli 
infection–induced diptericin (Figure 2.9c).  This data suggest that the RHIM–like domain 
has a function beyond the recruitment of IMD and that direct IMD recruitment to these 
receptors may not always be necessary for signaling.  However, a caveat of the 
transient transfection/co–immunoprecipitation experiment is that both the receptor and 
IMD are over–expressed and sometimes over–expression data does not reflect the 
actual interactions that occur under physiological conditions.  Therefore, to get a more 
physiologically relevant picture, I analyzed the interaction of over–expressed wild type 
and RHIM–mutant receptor with endogenous IMD.  We had to rely on stable cell lines 
over–expressing PGRP–LC because of the lack of a good PGRP–LC antibody, and, of 
course, the RHIM–mutant receptors must be expressed exogenously.  However, we 
have an excellent antibody to detect endogenous IMD.  I found that endogenous IMD 
interacts robustly with wild–type PGRP–LC, but weakly with the RHIM–like mutants 
(Figure 5.1a).  Also the PGRP–LC lacking the IMD interaction domain also interacts 
weakly with IMD.  This data differs from the transient transfection/ co–
immunoprecipitation experiments (Figure 5.1a) and suggests that the RHIM–like motif 
may play a significant role in recruiting IMD.
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In this study, moving back to the cotransfection/coimmuniprecipitaiton assays, I 
also show that a receptor proximal complex assembles on PGRP–LC.  In particular, 
DREDD is recruited to the receptor in a FADD–and IMD–dependent manner (Figure 
5.2a).  My data suggests that the RHIM–like mutant of PGRP–LCx is not defective in 
assembly of this receptor proximal complex (Figure 5.2b).  However, it is important to 
note that the biggest caveat of this experiment is that the analysis is based on over–
expression of various components of the IMD pathway.  In order to analyze the actual 
receptor proximal events, we are in the process of making antibodies against all the 
components of the IMD pathway.
Various biochemical assays were carried out to determine the molecular events 
that fail to initiate when PGRP–LC RHIM–like mutant receptors are over–expressed in 
S2* cells (Note, receptor over–expression is sufficient to drive signalign).  Analysis of 
downstream signaling events following receptor over–expression suggests that PGRP–
LC RHIM–like mutants fail to activate all the downstream molecular events including 
IMD cleavage, IMD ubiquitination, Relish cleavage and Relish phosphorylation (Figure 
5.1a).  This data again suggests that the RHIM–like motif is critical for signaling.  
Interestingly, when cell lines over–expressing PGRP–LC lacking the IMD interaction 
domain (∆3) were analyzed no cleaved or ubiquitinated IMD was detectable but low 
levels of cleaved and phosphorylated Relish could be observed.  This data suggests 
that PGRP–LC ∆3 might be a hypomorph.  To test if PGRP–LC∆3 is a hypomorph, flies 
expressing PGRP–LC∆3 will be infected with E.coli and then a time course of diptericin 
induction will be done.  It is unclear how PGRP–LC∆3 can cleave and phosphorylate 
Relish.  One possibility is that IMD is cleaved and ubiquitinated at low, nearly 
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undetectable, levels but this is enough for Relish cleavage and phosphorylation.  
Another possibility is that over–expressed PGRP–LC∆3 can somehow bypass the 
requirement for cleaved and ubiquitinated IMD, directly leading to the cleavage and 
phosphorylation of Relish.  If this hypothesis is correct, knockdown of IMD in cells over–
expressing PGRP–LC∆3 will not effect induction of AMPs genes.
Analysis of the receptor associated ubiquitination showed that PGRP–LC RHIM–
like mutants failed to associate with any poly ubiquitin signal whereas wild–type and 
PGRP–LC∆3 precipitated a robust ubiquitination signal (Figure 5.1c).  This data 
suggests that the either the receptor itself is ubiquitinated or it associates with a protein 
that is ubiquitinated.  However, this ubiquitinated protein cannot be IMD because no 
IMD ubiquitination is observed in stable cells over–expressing PGRP–LC∆3 (Figure 
5.1b).  Also, the receptor PGRP–LC associates with polyubiquitin signal even after imd 
has been knocked by RNAi.  The receptor associated ubiquitination most closely 
reflects the phenotype observed with AMP induction when the various PGRP–LC 
mutants are over–expressed (Figure 2.7a)  Therefore, a better understanding of these 
receptor associated ubiquitination events may provide an insight into the role of the 
RHIM–like motif.  One hypothesis that may explain why PGRP–LC∆3 induces AMPs but 
the RHIM mutants fail do so,  is that under wild–type conditions ubiquitinated IMD 
provides a platform for the assembly of a receptor proximal complex, however, in a 
situation where IMD cannot interact with the receptor (like PGRP–LC∆3) another 
component of the IMD pathway that also gets ubiquitinated provides the platform for the 
assembly of the signaling complex.  And in the case of the RHIM–like mutant, no 
molecular events down stream of the receptor are activated because no component of 
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the IMD pathway can be ubiquitinated and/or the ubiquitinated components fail to 
interact with the receptor.
Analysis of receptor associated ubiquitination raises many important questions.  
First what is the target protein that is getting detected in the receptor associated 
ubiquitination assays?  Second, what kind of ubiquitin chains are conjugated to this 
target protein and what are the E2 and E3 enzymes involved?
RYBP is a new component of the IMD pathway
I performed a yeast two–hybrid screen to identify new components of the IMD 
pathway that interact with the receptor PGRP–LC via the RHIM–like domain (Chapter 
3).  One protein that interacted with the receptor through its RHIM–like motif was RYBP 
(Figure 3.2).  RYBP is a 150 amino acid protein and contains an NZF domain in its N 
terminus.  Knock–down of RYBP in S2 cells inhibits signaling via the IMD pathway 
(Figure 5.3b).  Additionally, analysis of the interaction of RYBP with PGRP–LC in S2 
cells, showed that this interaction is mediated through both IMD interaction domain and 
the RHIM–like motif of PGRP–LC in a redundant manner (Figure 5.3a) [This is not the 
case in yeast, where the two–hybrid data suggest the PGRP–LC/RYBP interaction is 
strictly dependent on the RHIM–like motif].  This data suggests that RYBP may either 
mediate its interaction with the receptor through multiple domains, or that RYBP may 
interact directly with PGRP–LC via the RHIM–like motif and indirectly, through other 
components of the pathway, with the IMD interaction domain.  Interaction studies need 
to be done in an another heterologous system to tease apart direct interactions from 
indirect ones.  In mammals RYBP interacts with all death effector domain (DED) 
containing proteins, such as caspase 8, 10, FADD and DEDD (Zheng et al., 2001).  
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Therefore, it will not be surprising if we find that RYBP interacts with DREDD and/or 
FADD , because both proteins have a DED like domain.  Indeed preliminary data 
suggests that RYBP interacts with DREDD.
The presence of the NZF domain in the N terminal of RYBP raises the possibility 
that it is a ubiquitin receptor like TAB2 (which also has a NZF domain in its C terminus) 
(Bejarano et al., 2005; Arrigoni et al., 2006).  TAB2 specifically recognizes K63 linked 
polyubiquitin chains and this specificity is determined by residues that mediate 
interaction with the distal and proximal ubiquitin (Komander et al., 2009; Kulathu et al., 
2009; Sato et al., 2009).  Residues that allow TAB2 to specifically bind K63 polyubiquitin 
are not conserved in the NZF domains of HOIL–1L and HOIP (components of the E3 
ligase LUBAC).  HOIL–1 does not bind K48 Ub, but it binds linear Ub and K63 Ub 
chains and HOIP preferentially binds K63 chains (Haas et al., 2009).  Like the HOIL–1 
and HOIP NZF domains, the residues that mediate interaction with distal and proximal 
ubiquitins in K63 chains are not conserved in RYBP, hence it is possible that RYBP can 
interact with different polyubiquitin chains (Figure 6.2). 
Work in our lab suggests that ubiquitination plays an important role in the 
regulation of IMD pathway, however, the exact mechanisms are unclear.  One possible 
scenario, suggested from this work is that following ligand stimulation the receptor gets 
ubiquitinated (in addition to the ubiquitination of IMD).  These chains could be linear, 
K63, mixed or other.  The ubiquitinated receptor may then be detected by the ubiquitin 
receptor RYBP.  RYBP interacts with the receptor transiently through the polyubiquitin 
chains on the receptor but then forms more stable interactions through the RHIM–like 
motif.  Another possibility is that the interaction of RYBP with the polyubiquitin chains 
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6.2: Sequence alignment of NZF domains containing proteins
Conserved residues are shown with blue background. Green and red boxes denote residues at 
the distal and proximal ubiquitin binding sites, respectively.
and the RHIM–like motif of PGRP–LC are important for the assembly of a stable 
receptor proximal complex.  RYBP in turn recruits DREDD to the receptor.  IMD maybe 
interacts with the receptor PGRP–LC even before it is activated or IMD may be gets 
recruited to the receptor following stimulation.  FADD is an adaptor protein, interacting 
with both IMD and DREDD, and it helps stabilize the receptor proximal complex.  The 
recruitment of DREDD to the receptor somehow activates its proteolytic activity.  The 
proximity between DREDD and IMD then allows DREDD to cleave IMD and lead to its 
ubiquitination.  K63 polyubiquitinated IMD then acts as a platform to recruit downstream 
signaling complexes and lead to the activation of NF–κB and JNK signaling (Figure 6.3)
Recent work highlights the complexity of ubiquitination and its important role in 
the regulation of signaling pathways in mammals and Drosophila.  It will be exciting to 
learn in greater detail how ubiquitination regulates the IMD pathway and how this 
compares to mammalian NF–κB signalign pathways.  It will also be interesting to see 
how similar or different the regulation of IMD pathway is in comparison to TNF and TLR 
signaling.  Homologs of signaling pathway components involved in Drosophila innate 
immunity have been identified in humans and other organisms.  Lacking an adaptive 
immune response, Drosophila serves as an important model system for further 
understanding of innate immunity and host/pathogen interactions.  To that end, this 
research sheds light on the regions of the receptor that are important for immune 
signaling and it begins to illuminate the receptor proximal events that may play a role in 
insect NF–κB signaling.  A better understanding of the signaling events in the IMD 
pathway may help shed light on some of the prominent questions in the mammalian 
innate immune signaling pathways.
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Figure 6.3 Proposed model of IMD signaling pathway
A comprehensive model of the proposed IMD pathway signaling as described in the text.
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